paclitaxel has been researched along with Lymph Node Metastasis in 492 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 28 (5.69) | 18.2507 |
| 2000's | 216 (43.90) | 29.6817 |
| 2010's | 226 (45.93) | 24.3611 |
| 2020's | 22 (4.47) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, M; Morita, S; Nakamoto, S; Ohtani, S; Watanabe, J | 1 |
| Ak, R; Aksoy, S; Aktas, BY; Bas, O; Diker, O; Dizdar, O; Guven, DC; Kertmen, N; Koylu, B; Oksuzoglu, B; Olgun, P; Taban, H | 1 |
| Duan, X; Gu, Z; Li, A; Lou, X; Pan, L; Qin, Z; Wan, J; Wang, F; Wang, M; Yao, X; Zhang, L; Zhu, L | 1 |
| Fukada, M; Goto, A; Kumazawa, I; Mizuno, M; Nishio, K; Sano, H; Tanaka, K | 1 |
| Hattori, S; Itoh, Y; Matsuno, Y; Nagasawa, S; Suematsu, Y; Taguchi, K; Takahashi, M; Takane, Y; Teranishi, N; Uetake, H; Wakabayashi, K; Yan, M | 1 |
| Fan, Y; Kang, Y; Li, Q; Luo, Y; Ma, F; Wang, J; Wang, X; Xu, B; Yuan, P; Yue, J; Zhang, P | 1 |
| Deng, T; Guo, R; He, Q; He, X; Li, J; Li, M; Li, T; Wang, Y; Zang, S; Zhang, L | 1 |
| Ding, Y; Liu, L; Qiu, S; Si, L; Yan, W; Zhang, Q | 1 |
| Ariake, K; Mitachi, K; Motoi, F; Unno, M | 1 |
| Asch, D; Beatty, GL; Domchek, SM; Nathanson, KL; O'Dwyer, PJ; Reiss, KA; Rosen, MA; Siegelman, ES; Wattenberg, MM; Yu, S | 1 |
| Alves, M; Chollet, C; Fougeray, T; Franchet, C; Garmy-Susini, B; Gomez-Brouchet, A; Guillermet-Guibert, J; Lacazette, E; Martinez, LO; Najib, S; Prats, AC; Tatin, F; Therville, N; Vaysse, C; Zamora, A | 1 |
| Bae, DS; Bae, JH; Choi, CH; Choi, HJ; Kim, BG; Kim, TJ; Lee, JW; Lee, YY | 1 |
| Liang, MR; Liu, H; Wang, YN; Zeng, SY; Zhong, ML | 1 |
| Boekhoff, MR; Borggreve, AS; Defize, IL; Haj Mohammad, N; Meijer, GJ; Mook, S; Ruurda, JP; Takahashi, N; van Hillegersberg, R; van Lier, ALHMW | 1 |
| Hara, F; Iwamoto, T; Mukai, H; Ohashi, Y; Uemura, Y; Watanabe, T | 1 |
| Fan, Z; He, Y; Li, J; Li, Y; Ouyang, T; Wang, L; Wang, T; Xie, Y | 1 |
| Ihira, K; Kaneuchi, M; Kato, T; Kobayashi, N; Konno, Y; Mitamura, T; Murakami, G; Nozaki, A; Sakuragi, N; Shimada, C; Todo, Y; Umazume, T; Watari, H | 1 |
| Eguchi, H; Goda, K; Hashimoto, Y; Ikeda, M; Imaoka, H; Kan, M; Kimura, G; Mitsunaga, S; Ohno, I; Otsuru, T; Sasaki, M; Suzuki, Y; Takahashi, H; Umemoto, K; Watanabe, K | 1 |
| Kacem, M; Nahmias, C; Nehlig, A; Rodrigues-Ferreira, S | 1 |
| Cha, HS; Hwang, JH; Kim, J; Kim, JW; Kim, MJ; Lee, JC; Lee, WJ; Park, P; Shin, DW; Woo, SM; Yang, SY | 1 |
| Chen, Y; He, Y; Tang, N; Tang, Y; Xing, J; Zhao, N | 1 |
| Amini, A; Chen, J; Chen, Y; Fan, M; Hamaji, M; Haque, W; Jeong, BK; Jia, H; Li, J; Li, L; Li, Y; Lin, Q; Lu, S; Mo, M; Nie, Y; Rivin Del Campo, E; Shridhar, R; Simone, CB; Tang, H; Wang, J; Wu, C; Wu, S; Xia, Y; Ye, J; Zhang, Z; Zhao, K; Zhao, W; Zhou, J; Zhu, H; Zhu, Z | 1 |
| Exner, F; Flentje, M; Höcht, S; Kleine, P; Mantel, F; Müller, E; Polat, B; Richter, A; Ströhle, S; Weick, S; Zimmermann, M | 1 |
| Chen, C; Chen, KN; Dai, L; Du, M; Fang, Y; Gong, L; Hou, Y; Jiang, H; Jiao, J; Li, H; Li, K; Li, W; Li, Z; Lian, C; Liao, Y; Liu, J; Shen, Y; Tan, L; Tang, H; Wang, H; Wu, H; Xie, D; Yin, J; Zeng, Z; Zhao, Q; Zheng, B; Zhu, J | 1 |
| Cooper, L; De León, LE; Dezube, AR; Dumontier, C; Enzinger, P; Frain, LN; Jaklitsch, MT; Kucukak, S; Mamon, H; Mazzola, E; Wee, JO | 1 |
| Funakoshi, T; Hirai, I | 1 |
| Deng, W; Liu, J; Yue, J; Zhang, W; Zhang, Y | 1 |
| Bergzoll, C; Eva, L; Jamieson, A; Simcock, B; Sykes, P | 1 |
| Chen, T; Jing, Z; Wu, S; Zhang, X | 1 |
| Arena, J; Bergamin, S; Chua, TC; Clarke, S; Diakos, C; Gibbs, E; Gill, AJ; Hruby, G; Itchins, M; Kim, S; Kneebone, A; Maher, R; Mittal, A; Nahm, CB; Pavlakis, N; Rabindran, J; Samra, J; Wong, M | 1 |
| Altan, B; Asao, T; Azuma, Y; Bai, T; Bao, P; Iijima, M; Kaira, K; Kawabata-Iwakawa, R; Kuwano, H; Mogi, A; Nagashima, T; Nakazawa, S; Nishiyama, M; Obayashi, K; Ohtaki, Y; Onozato, R; Shimizu, K; Watanabe, A; Yajima, T; Yokobori, T | 1 |
| Airoldi, M; Bossi, P; Caldara, A; Caponigro, F; Denaro, N; Ferrari, D; Ferrau, F; Hollander, L; Licitra, L; Lo Vullo, S; Locati, LD; Miceli, R; Moretti, G; Moro, C; Nolè, F; Rinaldi, G; Sponghini, A; Tettamanzi, F; Vaccher, E; Vecchio, S | 1 |
| du Bois, A; Harbeck, N; Hinke, A; Huober, J; Jackisch, C; Konecny, GE; Kuhn, W; Kurbacher, C; Lück, HJ; Möbus, V; Nitz, U; Runnebaum, IB; Schneeweiss, A; Thomssen, C; Untch, M; von Minckwitz, G | 1 |
| Atkins, JN; Biggs, DD; Brufsky, AM; Cecchini, RS; Fehrenbacher, L; Flynn, PJ; Ganz, PA; Geyer, CE; Gross, HM; Jeong, JH; Mamounas, EP; Polikoff, J; Rastogi, P; Romond, EH; Seay, TE; Swain, SM; Wade, JL; Wahl, TA; Wolmark, N; Zapas, JL | 1 |
| Alvarez, R; Caruso, R; Cubillo, A; Diaz, E; Duran, H; Fabra, I; Ferri, V; Ielpo, B; Kalivaci, D; Lazzaro, S; Malavé, L; Plaza, C; Quijano, Y; Vicente, E | 1 |
| Baehner, FL; Butler, SM; Cherbavaz, DB; Costantino, JP; Jamshidian, F; Jeong, JH; Julian, TB; Kim, SR; Lawrence Wickerham, D; Lembersky, BC; Liu, Q; Mamounas, EP; Paik, S; Shak, S; Sing, AP; Tang, G; Wolmark, N | 1 |
| Fujii, K; Ishizuka, S; Saeki, S; Sakata, S; Sasaki, J; Sato, R | 1 |
| Aktas, B; Bangemann, N; Braun, M; Christgen, M; Clemens, M; Forstbauer, H; Gluz, O; Grischke, EM; Hackmann, J; Harbeck, N; Kates, R; Kohls, A; Kreipe, HH; Kuemmel, S; Liedtke, C; Lindner, C; Nitz, U; Potenberg, J; Schumacher, C; Schumacher, J; Staib, P; Uleer, C; von Schumann, R; Warm, M; Wuerstlein, R | 1 |
| Chen, C; Chen, Y; Jiang, X; Li, S; Shi, F; Wang, X; Xiong, H; Yan, T; Zhang, W; Zhu, Y | 1 |
| Furukawa, H; Hiraki, Y; Imamoto, H; Imano, M; Iwama, M; Kato, H; Kimura, Y; Shinkai, M; Shiraishi, O; Yasuda, A; Yasuda, T | 1 |
| Fujiyama, J; Hiramoto, H; Kawamura, Y; Masuyama, M; Nakashima, S; Nishida, M; Ochi, F; Shibamoto, J; Takashima, Y; Tsujiura, M | 1 |
| Lei, B; Pang, D; Wan, L; Wang, P; Wu, H; Xia, B; Xu, S; Zhang, D; Zhang, G; Zhang, J; Zhang, X | 1 |
| Borel, C; Burgy, M; Leblanc, J | 1 |
| Attianese, D; Cosio, S; Fabrini, MG; Ferrero, A; Gadducci, A; Guerrieri, ME; Laliscia, C; Rossi, A | 1 |
| Geyer, CE; Golshan, M; Huober, J; Liu, X; Loibl, S; Maag, D; McIntyre, K; McKee, MD; Metzger Filho, O; O'Shaughnessy, J; Ponce Lorenzo, JJ; Rastogi, P; Rugo, HS; Sikov, WM; Sullivan, D; Symmans, WF; Untch, M; von Minckwitz, G; Wolmark, N | 1 |
| He, Q; Li, M; Liu, Y; Mei, L; Rao, J; Zhang, Z | 1 |
| Kimura, B; Shimoyama, T | 1 |
| Ebisui, C; Fukuchi, N; Furukawa, J; Kinuta, M; Kitahara, T; Minoji, T; Okamura, S; Tamai, K; Watanabe, N; Yamamura, N; Yokouchi, H | 1 |
| Abbasi, AN; Ali, N; Hafiz, A; Mansha, MA; Qureshi, BM; Valimohammad, AT | 1 |
| Chiba, Y; Hiraki, Y; Imano, M; Iwama, M; Kato, H; Kimura, Y; Nishida, S; Shinkai, M; Shiraisi, O; Tsubaki, M; Yasuda, A; Yasuda, T | 1 |
| Chang, HM; Hwang, I; Ip, HNN; Jeong, JH; Kang, J; Kim, KP; Ryoo, BY; Yoo, C | 1 |
| Du, B; Gao, XY; Huang, XB; Huang, YF; Lan, YQ; Lin, XY; Qiu, HQ; Que, WC; Wang, XL; Wu, RP; Zhong, DT | 1 |
| Aieta, M; Chiriacò, G; Conca, R; Multari, AG; Paganini, G; Petrioli, R; Rosellini, P; Roviello, G | 1 |
| Akagi, K; Dono, K; Hamabe, A; Hirota, M; Imamura, H; Iwazawa, T; Kawase, T; Kujime, Y; Morita, S; Nagase, H; Noguchi, K; Oshima, K; Tanida, T; Tomimaru, Y | 1 |
| Akiyama, N; Asada, K; Enomoto, N; Fujii, M; Fujisawa, T; Furuhashi, K; Hozumi, H; Inami, N; Inui, N; Kaida, Y; Karayama, M; Matsuda, H; Matsui, T; Matsuura, S; Nakamura, Y; Suda, T; Suzuki, Y; Toyoshima, M; Uto, T; Yasui, H | 1 |
| Hu, K; Liu, X; Meng, Q; Wang, W; Zhang, F | 1 |
| Hou, MF; Lee, YC; Wang, CH; Wang, YY; Yang, YF; Yuan, SF | 1 |
| Albain, KS; Barry, WT; Bellon, JR; Burstein, HJ; Carey, LA; Dang, CT; Ellis, M; Guo, H; Hudis, CA; Krop, I; Marcom, PK; Moy, B; Overmoyer, BA; Partridge, AH; Rugo, HS; Tolaney, SM; Winer, EP; Wolff, AC; Yardley, DA | 1 |
| Guo, Y; Li, R; Yan, H; Zhang, Y; Zheng, R | 1 |
| Allen, PK; Broaddus, RR; Chapman, BV; Eifel, PJ; Jhingran, A; Klopp, AH; Lu, KH; Ning, MS; Pardeshi, V; Soliman, PT; Swanick, CW; Westin, SN | 1 |
| Hirose, Y; Ishii, A; Ishimoto, U; Iwaku, A; Kinoshita, A; Koike, K; Mizuno, Y; Saruta, M; Shibata, K; Shoji, R; Yokota, T | 1 |
| Bingjing, Z; Hu, L; Liang, G; Rufu, X; Xiangdong, Z; Yuliang, W | 1 |
| Gilhuijs, KG; Koolen, BB; Rodenhuis, S; Rutgers, EJ; Valdés Olmos, RA; Vincent, AD; Vogel, WV; Vrancken Peeters, MJ; Wesseling, J | 1 |
| Cliby, WA; Janco, JM; Markovic, SN; Weaver, AL | 1 |
| Han, W; Im, SA; Moon, HG; Moon, WK; Noh, DY; Park, IA; Park, SJ; Shin, HC | 1 |
| Amm, HM; Buchsbaum, DJ; DellaManna, D; Egger, ME; Eltoum, IE; Frederick, PJ; Grizzle, WE; Kerr, EH; McNally, LR; Oelschlager, DK; Sellers, J; Stockard, CR; Straughn, JM | 1 |
| Armstrong, DK; Copeland, LJ; Java, J; Landrum, LM; Lanneau, GS; Mathews, CA; Walker, JL | 1 |
| Almhanna, K; Chuong, MD; Hoffe, SE; Karl, RC; Meredith, K; Shridhar, R; Weber, JM | 1 |
| He, XM; Xiang, H; Yang, HJ; Yu, Y; Zong, XY | 1 |
| An, G; Chen, W; Wei, P; Yan, D | 1 |
| Nautiyal, V; Pandey, KC; Pant, NK; Revannasiddaiah, S | 1 |
| Chen, J; Chen, M; Li, J; Liao, Z; Liu, J; Pan, J; Zheng, X; Zhu, K | 1 |
| Bains, MS; Gerber, N; Goodman, KA; Ilson, DH; Janjigian, YY; Kelsen, DP; Rizk, N; Rusch, VW; Wu, AJ; Zhang, Z; Zheng, J | 1 |
| Abu-Rustum, NR; Alektiar, KM; Barakat, RR; Kollmeier, MA; Milgrom, SA; Sonoda, Y; Tew, WP | 1 |
| Isohashi, F; Ito, K; Kimura, T; Mabuchi, S; Ogata, T; Ogawa, K; Takahashi, R; Tsutui, T; Yokoi, T; Yoshioka, Y | 1 |
| Abi-Raad, R; Brachtel, EF; Corben, AD; Koerner, FC; Macklin, EA; Popa, I; Taghian, AG; Teo, CH | 1 |
| Emoto, S; Ishigami, H; Kaisaki, S; Kitayama, J; Watanabe, T; Yamaguchi, H; Yamashita, H | 1 |
| Bourdarias, L; Brouste, V; Croce, S; Floquet, A; Guyon, F; Stoeckle, E; Thomas, L | 1 |
| Fan, T; Fan, Z; Li, J; Lin, B; Ouyang, T; Wang, T; Xie, Y | 1 |
| Biermann, K; Shapiro, J; ten Kate, FJ; van Hagen, P; van Lanschot, JJ; Wijnhoven, BP | 1 |
| Audhuy, B; Berdah, JF; Buyse, M; Delbaldo, C; Greget, S; Laplaige, P; Mousseau, M; Piedbois, P; Priou, F; Quinaux, E; Serin, D; Teissier, E; Zelek, L | 1 |
| Boughey, JC; Buzdar, AU; Ellis, MJ; Ewer, MS; Hunt, KK; Leitch, AM; McCall, LM; Meric-Bernstam, F; Royce, M; Suman, VJ; Unzeitig, G | 1 |
| Jakobsen, JN; Santoni-Rugiu, E; Sørensen, JB | 1 |
| Feng, ZY; Liao, QP; Liu, TY; Ma, K; Wen, HW; Yang, X; Yang, YH | 1 |
| Abraham, J; Caldas, C; Chan, S; Dean, S; Dunn, J; Earl, HM; Fenwick, N; Gallagher, C; Gounaris, I; Harries, M; Hickish, T; Hiller, L; Houston, S; Hughes-Davies, L; Iddawela, M; Laing, R; McAdam, K; Provenzano, E; Ritchie, D; Skene, A; Vallier, AL; Wishart, G; Young, J | 1 |
| Li, K; Lu, JQ; Ma, LL; Sun, JW; Zhang, PP | 1 |
| Enomoto, T; Habiro, T; Hatate, K; Hayashi, K; Oshida, S; Sengoku, N; Watanabe, M | 1 |
| Cao, J; Huang, XE; Liu, J; Lu, YY; Wu, XY | 1 |
| Hulshoff, JB; Plukker, JT; Smit, JK; van der Jagt, EJ | 1 |
| Ghaemmaghamia, F; Karimi-Zarchi, M; Modarress-Gilania, M; Mousavia, AS; Vahidi, S | 1 |
| Ditto, A; Lorusso, D; Mancini, M; Ramondino, S; Raspagliesi, F; Zanaboni, F | 1 |
| Kitagawa, Y; Kitajima, M; Matsuda, S; Oyama, T; Ozawa, S; Takeuchi, H | 1 |
| Chan, WW; Choy, TS; Ho, PP; Khong, PL; Kwong, DL; Lam, KO; Lee, EY; Lee, VH; Leung, DK; Leung, TW | 1 |
| He, W; Jiang, J; Liu, P; Wu, C; Zhang, D | 1 |
| Alba, E; Brase, JC; Caballero, R; Calvo, L; Carrasco, E; Casas, M; Crespo, C; Fisch, K; Krappmann, K; Kronenwett, R; Martin, M; Munarriz, B; Petry, C; Rodriguez, CA; Rodriguez-Lescure, A; Ruiz, A; Ruiz-Borrego, M; Weber, KE | 1 |
| Cheng, Y; Cun, Y; Li, M; Li, Z; Peng, Y; Qian, C; Ren, T; Wang, D; Xia, L; Xiong, Y; Zhang, S | 1 |
| An, SM; Badakhshi, H; Chen, Y; Deng, JY; Guo, XM; Jiang, GL; Ma, HF; Tang, HR; Zhang, JH; Zhang, Z; Zhao, KL | 1 |
| Hori, Y; Itagaki, R; Iwata, H; Maekawa, S | 1 |
| Chen, Y; Chen, Z; Ma, C; Ma, L; Zhang, W | 1 |
| Cortot, A; Hossein-Foucher, C; Olivier, A; Petyt, G; Scherpereel, A | 1 |
| Chi, Y; Song, Y; Wang, J; Yang, L; Zhou, A | 1 |
| Chen, J; Chen, M; Li, J; Lin, Y; Liu, J; Pan, C; Pan, J; Zhu, K | 1 |
| Becker, HP; Berry, DA; Burstein, HJ; Cirrincione, CT; Hudis, CA; Kimmick, G; Martino, S; Muss, H; Norton, L; O'Regan, R; Perez, EA; Schneider, CJ; Shapiro, CL; Shulman, LN; Winer, EP | 1 |
| Morikawa, A; Nagata, C; Okamoto, A; Saito, M; Suzuki, J; Suzuki, K; Takahashi, K; Takakura, S; Tanabe, H; Yanaihara, N | 1 |
| Hirokaga, K; Maekawa, Y; Matsuo, Y; Miki, M; Takao, S; Tane, K; Yoshida, S | 1 |
| Kahraman, A; Ortac, F; Sertcelik, A; Taskin, S; Tulek, F | 1 |
| Abe, A; Kato, K; Kondo, E; Matoda, M; Nomura, H; Okamoto, S; Omatsu, K; Sueoka, K; Takeshima, N; Umayahara, K; Usami, T; Yamamoto, A | 1 |
| Du, K; Gong, HY; Gong, ZM | 1 |
| Hao, L; Li, C; Wang, C; Zhang, B; Zhao, X | 1 |
| Athanasiadis, A; Boukovinas, I; Christophyllakis, C; Georgoulias, V; Kakolyris, S; Kentepozidis, N; Kouroussis, C; Makrantonakis, P; Malamos, N; Mavroudis, D; Polyzos, A; Saloustros, E; Ziras, N | 1 |
| Azodi, M; Damast, S; Higgins, SA; Mani, S; Ratner, E; Rutherford, T; Schwartz, PE; Silasi, DA; Young, MR; Yu, JB | 1 |
| Arakawa, H; Deguchi, T; Horie, K; Kato, H; Kubota, Y; Matsuoka, K; Nagai, S; Nakano, M | 1 |
| Ayala, AG; Choi, EK; Divatia, M; Miles, BJ; Okoye, E; Ro, JY | 1 |
| Castelo, B; Espinosa, E; Pinto, A; Redondo, A; Zamora, P | 1 |
| Sueoka, N; Tsubota, Y; Yamamoto, D | 1 |
| Ardizzoni, A; Barni, S; Bighin, C; Bisagni, G; Boni, C; Bruzzi, P; Cavazzini, G; Cognetti, F; Colantuoni, G; De Laurentiis, M; De Placido, S; Del Mastro, L; Durando, A; Forestieri, V; Gamucci, T; Garrone, O; Giuliano, M; Gravina, A; Montemurro, F; Nisticò, C; Papaldo, P; Puglisi, F; Turletti, A; Valle, E | 1 |
| Aksoy, S; Altundag, K; Berk, V; Karaca, H; Ozdemir, N; Ozkan, M; Ozturk, B; Sendur, MA; Yazici, O; Yazilitas, D; Zengin, N | 1 |
| Bono, P; Diéras, V; Dirix, LY; Gonçalves, A; Guastalla, JP; Hurvitz, SA; Jassem, J; Jerusalem, G; Lakshmaiah, KC; Li, A; Limentani, SA; Pickett, CA; Pienkowski, T; Roché, H; Romieu, G; Sánchez-Rovira, P; Seguí Palmer, MÁ; Slamon, DJ; Sun, YN; Wildiers, H | 1 |
| Guo, F; Li, HZ; Lin, MC; Liu, CM; Qian, BJ; Zhang, C | 1 |
| Han, L; Kang, CS; Liu, X; Mei, M; Ren, Y; Song, X; Tian, WP; Wang, QX; Yang, JJ; Zhang, L; Zhao, XH; Zhou, X; Zhu, ZY | 1 |
| Andre, F; Arnould, L; Beuzeboc, P; Coeffic, D; Ferrero, JM; Lortholary, A; Spano, JP | 1 |
| Hou, C; Tan, T; Yang, N; Zhu, L | 1 |
| Bishr, AM; Deme, D; Nizar, J; Telekes, A | 1 |
| Huang, CB; Huang, LL; Lin, SJ; Pan, JJ; Qiu, SF; Xu, YJ; Zheng, W; Zong, JF | 1 |
| Leunen, K; Moerman, P; Neven, P; Salihi, R; Van Limbergen, E; Vergote, I | 1 |
| Barry, WT; Berry, D; Cirrincione, CT; Citron, M; Ellis, M; Gradishar, W; Hudis, CA; Ingle, JN; Ligibel, JA; Liu, M; Mardis, E; Martino, S; Michaelson, R; Perou, CM; Sikov, W; Winer, E | 1 |
| Chen, S; Deng, Q; Jing, S; Li, J; Li, X; Ma, S; Tang, R; Wu, K; Wu, Z; Zheng, Z | 1 |
| Ando, N; Harada, K; Inozume, T; Kawamura, T; Matsuzawa, M; Onuma, T; Sano, S; Shimada, S | 1 |
| Aloisi, A; Angioli, R; Capriglione, S; Fiore, L; Luvero, D; Montera, R; Panici, PB; Plotti, F; Scaletta, G; Terranova, C | 1 |
| Bi, Y; Chen, X; Chen, Y; Cheng, C; Cheng, X; Cui, H; Cui, Y; Guo, J; Guo, S; Hu, X; Jia, J; Jia, Z; Kong, P; Li, G; Li, H; Li, Q; Li, Y; Liang, J; Liu, H; Liu, J; Qian, Y; Shi, R; Song, B; Wang, C; Wang, F; Wang, J; Wang, T; Xi, Y; Xu, E; Yan, T; Yang, B; Yang, J; Zhan, Q; Zhang, L; Zhang, Y; Zhao, Z; Zhou, Y | 1 |
| Amillano, K; Aura, C; Balmaña, J; Baselga, J; Bermejo, B; Bonnefoi, H; Casas, A; Charpentier, E; Delaloge, S; Di Cosimo, S; Garcia-Ribas, I; Gavilá, J; Gonzalez-Santiago, S; Harbeck, N; Llombart-Cussac, A; Manso, L; Morales, S; Radosevic-Robin, N; Roché, H; Sánchez-Rovira, P; Villanueva, C | 1 |
| Shen, B; Yang, C; Zhang, J; Zhang, Q | 1 |
| Fujiwara, Y; Goto, Y; Horinouchi, H; Kanda, S; Nokihara, H; Ohe, Y; Sumi, M; Tamura, T; Yamamoto, N | 1 |
| Emoto, S; Hata, K; Ishigami, H; Ishihara, S; Kawai, K; Kazama, S; Kitayama, J; Kiyomatsu, T; Nishikawa, T; Nozawa, H; Sunami, E; Tanaka, J; Tanaka, T; Watanabe, T; Yamaguchi, H | 1 |
| Ebisui, C; Fukuchi, N; Kinuta, M; Murata, K; Nushijima, Y; Okada, K; Okamura, S; Yanagisawa, T; Yokouchi, H | 1 |
| He, X; Huang, J; Liang, X; Wu, K; Wu, Y; Yue, X; Zhang, W; Zhao, P | 1 |
| Enomoto, T; Isohashi, F; Ito, K; Kimura, T; Mabuchi, S; Ogawa, K; Shiki, Y; Takemura, M; Yokoi, T; Yoshino, K | 1 |
| Qin, RQ; Wang, WP; Wen, YS; Xi, KX; Yu, XY; Zhang, LJ | 1 |
| Costantini, M; Di Leone, A; Ferrucci, M; Franceschini, G; Masetti, R; Mulè, A; Sanchez, AM; Scaldaferri, A | 1 |
| Cheng, H; Ding, H; Han, X; Li, A; Liu, Y; Lv, J; Shao, L; Si, X; Sun, L; Sun, Y; Yang, N; Yang, Y; Zhang, XA; Zhu, D | 1 |
| Cao, K; Cao, P; Huang, C; Jin, L; Li, X; Luo, Y; Ma, J; Shen, S; Tan, M; Tang, X; Zhou, M | 1 |
| Chen, KN; Chen, Y; Li, XT; Sun, YS; Wang, ZL | 1 |
| de Graaf, H; de Groot, SM; Drooger, JC; Erdkamp, FL; Hamberg, P; Heijns, JB; Honkoop, A; Imholz, AL; Jager, A; Kroep, JR; Linn, SC; Portielje, JE; Sleijfer, S; Ten Tije, AJ; van Leeuwen-Stok, AE; van Rossum-Schornagel, QC; van Tinteren, H | 1 |
| Cho, Y; Chun, KH; Kang, H; Kim, HY; Kim, SJ; Song, J; Yim, YS | 1 |
| Fei, Z; Jin, X; Li, L; Lin, B; Pan, Q; Su, H; Xie, C; Xue, S; Zhang, X; Zhao, H; Zhao, L | 1 |
| Baron, MH; Bessette, P; Colombo, A; Creutzberg, CL; de Boer, SM; Fyles, A; Haie-Meder, C; Katsaros, D; Khaw, P; Kitchener, HC; Kruitwagen, RF; Ledermann, JA; Mileshkin, L; Nijman, HW; Nout, RA; Ottevanger, PB; Powell, ME; Putter, H; Smit, VT; Verhoeven-Adema, KW | 1 |
| Dang, YZ; Hu, J; Li, WW; Li, X; Ping, LJ; Shi, M; Wei, LC; Zhang, Y; Zhao, LN | 1 |
| Mehta, RS; Nangia, CI; Tran, PN; Zhuang, L | 1 |
| Barillot, I; Charra Brunaud, C; Haie-Méder, C; Kerr, C; Peignaux, K; Thomas, L | 1 |
| Arbea, L; Cano, D; Ceniceros, L; Chopitea, A; Diaz-Gonzalez, JA; Hernandez, JL; Iragorri, Y; Legaspi, J; Martin-Romano, P; Martínez-Regueira, F; Ponz-Sarvise, M; Rodríguez, J; Sola, JJ; Subtil, JC | 1 |
| Chen, S; Di, GH; Jiang, YZ; Jin, X; Shao, ZM | 1 |
| Hanai, K; Higure, T; Hoshi, A; Kawamura, Y; Nakajima, N; Nitta, M; Shimizu, Y; Terachi, T | 1 |
| Hier, M; Kay-Rivest, E; Mascarella, MA; Mlynarek, A; Roskies, M; Sultanem, K | 1 |
| Hirano, M; Nomura, Y; Shima, S; Tamura, H; Toriumi, T | 1 |
| Elkhuizen, PH; Koolen, BB; Rodenhuis, S; Rutgers, EJ; Stokkel, MP; Teixeira, SC; Valdés Olmos, RA; van der Noort, V; Vrancken Peeters, MT | 1 |
| Allegrini, G; Arrighi, G; Bocci, G; Bona, E; Coltelli, L; Falcone, A; Ferrarini, I; Filidei, M; Finale, C; Fontana, A; Ginocchi, L; Goletti, O; Lucchesi, S; Marcucci, L; Salvadori, B; Scalese, M | 1 |
| Bahary, N; Bednar, F; Hogg, ME; Ocuin, LM; Steve, J; Winters, S; Zeh, HJ; Zenati, MS; Zureikat, AH | 1 |
| Asakage, M; Ishigami, H; Kitayama, J; Yamaguchi, H; Yamashita, H | 1 |
| Baehner, FL; Butler, SM; Cherbavaz, DB; Costantino, JP; Jamshidian, F; Jeong, JH; Julian, TB; Kim, SR; Lembersky, BC; Liu, Q; Mamounas, EP; Paik, S; Shak, S; Sing, AP; Tang, G; Wickerham, DL; Wolmark, N | 1 |
| Abe, N; Abe, S; Aoto, K; Kimijima, I; Ohtake, T; Okano, M; Tachibana, K; Takenoshita, S; Yasuda, M; Yoshida, S | 1 |
| Browne, JD; D'Agostino, RB; Greven, KM; McGuirt, WF; White, DR; Williams, DW | 1 |
| Holzgraefe, M; Schneider, I; Schröder, M | 1 |
| Hino, M; Homma, K; Sano, M; Sato, N | 1 |
| Hee, SW; Leong, SS; Lim, WT; Poon, D; Rajan, S; Tan, EH; Tay, MH; Toh, CK; Wee, J | 1 |
| Heinrich, G; Loibl, S; Müller, L; Murmann, C; Nekljudova, V; Schwedler, K; von Minckwitz, G; Warm, M | 1 |
| Anan, K; Hirose, N; Mitsuyama, S; Ogawa, S; Saimura, M; Shimada, K; Tamaki, N; Tamura, K; Tanaka, M; Tomisaki, S | 1 |
| Gu, Y; Shu, Y; Xu, Q | 1 |
| DiSilvestro, P; Morrison, A; von Gruenigen, VE; Walker, JL | 1 |
| Gong, Y; Hou, M; Huang, M; Lu, Y; Ren, L; Wang, J; Wei, Y; Zhou, L; Zhou, X; Zhu, J | 1 |
| Chae, YS; Chung, HY; Do, YR; Hyun, MS; Jung, JS; Kim, GC; Kim, JG; Kim, MK; Kwon, KY; Lee, KH; Lee, WS; Sohn, CH; Sohn, SK; Song, HS; Yu, W | 1 |
| Hakenberg, OW | 1 |
| Cai, RG; Li, Q; Wang, JY; Wu, WH; Xu, BH; Yuan, P; Zhang, P; Zhao, LM; Zhou, AP | 1 |
| Chen, Z; Cho, K; Müller, S; Nie, S; Saba, NF; Shin, DM; Tighiouart, M; Wang, X | 1 |
| Amano, S; Enomoto, K; Kitajima, A; Sakurai, K; Shiono, M; Tani, M | 1 |
| Johnston, MR; Kwong, E; Liu, J; Meisner, D; Wu, XY | 1 |
| Ahn, SD; Choi, EK; Kim, JH; Kim, YM; Kim, YS; Kim, YT; Lee, SW; Nam, JH; Shin, SS | 1 |
| Fujii, K; Miyahara, S; Miyake, T; Nakamura, H; Tadokoro, K; Taniguchi, M; Tanimura, M; Yamamura, K | 1 |
| Hidemura, A; Ishigami, H; Kaisaki, S; Kamei, T; Kitayama, J; Miyato, H; Nagawa, H; Otani, K; Soma, D; Yamashita, H | 1 |
| Chen, JR; Tzen, CY; Yang, YC | 1 |
| Asaga, T; Chishima, T; Doi, T; Hamaguchi, Y; Ichikawa, Y; Inaba, M; Ishikawa, T; Kasahara, A; Katayama, K; Kito, A; Matsumoto, C; Momiyama, N; Morita, S; Narui, K; Ohta, I; Shimada, H; Shimizu, D; Shimizu, S; Suda, T; Tanabe, M; Yamaguchi, N; Yoshimoto, M | 1 |
| Kitajima, Y; Miyazaki, K; Nakafusa, Y; Ohtsuka, T; Sato, S; Tanaka, M; Yakabe, T | 1 |
| Huwer, H; Leutz, M; Schäfers, HJ; Schlimmer, P; Sybrecht, G; Ukena, D | 1 |
| Fujiwara, H; Ichikawa, D; Ikoma, H; Kikuchi, S; Kokuba, Y; Kubota, T; Nakanishi, M; Ochiai, T; Okamoto, K; Okamura, H; Otsuji, E; Sakakura, C; Sonoyama, T; Taniguchi, H | 1 |
| Burges, A; Ditsch, N; Hillemanns, P; Kuemper, C; Lenhard, M; Mueller-Egloff, S; Strauss, A | 1 |
| Fujimori, T; Fushimi, K; Kadowaki, M; Miyazaki, M; Nagashima, T; Nakatani, Y; Onai, Y; Sakakibara, M; Suzuki, H; Yokomizo, J | 1 |
| Hanada, S; Hirata, K; Iwata, T; Izumi, N; Kimura, T; Kudoh, S; Nagano, K; Nishiyama, N; Suehiro, S; Tsukioka, T | 1 |
| Li, J; Li, Y; Lu, M; Shen, L; Xiao, Y; Zhang, J; Zhang, XD | 1 |
| Fu, JF; Hong, ZW; Wang, B | 1 |
| Eifel, PJ; Gershenson, DM; Jhingran, A; Klopp, AH; Lu, K; Ramondetta, L | 1 |
| Bajorin, DF; Iasonos, A; Maluf, FC; Milowsky, MI; Mironov, S; Nanus, DM; Regazzi, A; Riches, J; Shi, W | 1 |
| Boonstra, JJ; Koppert, LB; Tilanus, HW; Tran, TC; Van Dekken, H; Van der Gaast, A; Wijnhoven, BP | 1 |
| Gilbert, BE; Kline, K; Latimer, P; Menchaca, M; Sanders, BG; Snyder, RM; Yu, W | 1 |
| Hoshino, S; Ishii, F; Maki, K; Naito, M; Shibata, R; Shinohara, T; Tanaka, S; Yamaguchi, R; Yamashita, Y | 1 |
| Che, G; Gong, Y; Hou, M; Huang, M; Li, L; Li, T; Li, W; Liu, L; Liu, Y; Lu, Y; Ren, L; Tang, B; Wang, J; Xu, Y; Zhou, L; Zhu, J; Zou, B | 1 |
| Akiya, T; Higuchi, K; Koizumi, W; Nakayama, N; Sakuyama, T; Sasaki, T; Sato, A; Sekikawa, T; Tanabe, S; Yamaguchi, K | 1 |
| Kawauchi, A; Mikami, K; Miki, T; Nakamura, T; Shiraishi, T; Takaha, N | 1 |
| Bekaii-Saab, TS; Carson, WE; Ferketich, AK; Grever, MR; Guenterberg, KD; Lamb, TA; Ramaswamy, B; Roda, JM; Shapiro, CL; Young, DC | 1 |
| Albain, KS; Bramwell, V; Burnell, M; Chalchal, H; Chapman, JA; Gelmon, K; Levine, MN; O'Brien, P; Perez, EA; Pritchard, K; Rugo, H; Shepherd, LE; Vandenberg, T; Walley, B | 1 |
| Fukumoto, R; Hashimoto, M; Hirabayashi, S; Honda, I; Mase, T; Morioka, Y; Nagata, J; Nakanishi, K; Nishi, T; Onishi, E; Oya, H | 1 |
| Cataruozolo, PE; Chuang, E; Collier, M; Gowland, PA; Huang, X; Kern, KA; Kozloff, M; Miller, K; Starr, A; Verkh, L | 1 |
| Aizawa, N; Hayashi, N; Hayashida, H; Higaki, N; Ichihara, T; Ikeda, T; Kan, K; Murakami, M; Nakano, K; Niju, T; Saito, N; Sakon, M; Soma, I | 1 |
| Díaz-Rubio, E; López-Tarruella, S; Manzano, A; Martin, M; Puente, J | 1 |
| Hikichi, T; Ikeda, T; Imamura, H; Irisawa, A; Obara, K; Ohira, H; Sato, A; Sato, M; Shibukawa, G; Suzuki, R; Takagi, T; Takahashi, Y; Terashima, M; Wakatsuki, T | 1 |
| Cai, YP; Lin, SJ; Xu, S | 1 |
| Chen, CM; Chen, XS; Lu, JS; Nie, XQ; Shao, ZM; Shen, KW; Shen, ZZ; Wu, J; Wu, JY | 1 |
| Daugaard, G; Gothelf, A; Møller, AK; Pedersen, KD | 1 |
| Brandwein-Gensler, M; Garg, MK; Haigentz, M; Levine, D; Shifteh, K; Smith, RV; Staffenberg, DA; Tlemcani, K | 1 |
| du Bois, A; Harbeck, N; Hinke, A; Huober, J; Jackisch, C; Konecny, GE; Kreienberg, R; Kuhn, W; Kurbacher, C; Lueck, HJ; Moebus, V; Nitz, U; Runnebaum, IB; Schneeweiss, A; Thomssen, C; Untch, M; von Minckwitz, G | 1 |
| Kawaguchi, H; Koga, C; Nakamura, Y; Nishimura, S; Nishiyama, K; Ohno, S; Shigematsu, H; Shiotani, S; Taguchi, K; Tanaka, K | 1 |
| Groshen, S; Lee, AS; Lee, E; Nichols, P; Spicer, D | 1 |
| Costantino, JP; Jeong, JH; Kidwell, K; Kim, C; Mamounas, EP; Nguyen, D; Paik, S; Swain, SM; Wolmark, N; Yang, SX | 1 |
| Asmar, L; Blum, JL; Boehm, KA; Burris, HA; Greco, FA; Hainsworth, JD; Holmes, F; Jones, S; Lindquist, D; Loesch, D; McIntyre, K; Modiano, MR; Pippen, J; Robert, N; Sandbach, J; Sedlacek, S; Senzer, NN; Vukelja, SJ; Zhan, F | 1 |
| Borroni, G; Brazzelli, V; Ciocca, O; Fiandrino, G; Rosso, R; Vassallo, C | 1 |
| Fang, Q; Li, P; Ou, W; Sun, HB; Wang, SY; Yang, H; Ye, X; Zhang, BB | 1 |
| Matsunaga, N; Nakagawa, Y; Noda, S; Yanagawa, K | 1 |
| Kitagawa, Y; Oyama, T; Shimizu, Y; Takeuchi, H; Ueda, M | 1 |
| Daliani, D; Kincaid, M; Osai, W; Pagliaro, LC; Pettaway, CA; Thall, PF; Wen, S; Williams, DL; Williams, MB | 1 |
| Akazawa, N; Imai, A; Iwaki, H; Kikuchi, H; Minato, M; Taguchi, K | 1 |
| Burris, H; Hainsworth, J; Inhorn, R; Melnik, M; Peacock, N; Raefsky, E; Shipley, D; Yardley, D | 1 |
| Davidson, NE; Dueck, AC; Gralow, JR; Harris, LN; Hillman, DW; Ingle, JN; Jenkins, RB; Kaufman, PA; Ketterling, RP; Lingle, WL; Martino, S; Perez, EA; Reinholz, MM; Schroeder, MJ; Sledge, GW; Tenner, KS; Visscher, DW | 1 |
| DeCamp, MM; Flickinger, JC; Medford-Davis, LN; Recht, A; Schaefer, E; Varlotto, JM | 1 |
| An, HY; Cao, XF; Ji, L; Lü, J; Tao, L; Wang, DD; Wang, S; Wu, BC; Zhu, B | 1 |
| Berthillot, C; Gaertner, S; Miréa, C; Stephan, D; Welsch, M | 1 |
| Chung, HH; Kang, SB; Kim, K; Kim, MJ; Kim, YH; Lee, JY; Park, NH; Song, YS | 1 |
| Adams, S; Bauer, JA; Chakravarthy, AB; Donach, M; Formenti, SC; Goldberg, JD; Hochman, T; Lymberis, S; Muggia, F; Pietenpol, JA; Schneider, RJ; Singh, B; Spicer, D | 1 |
| Ahn, EH; Eno, ML; Im, DD; Matsuo, K; Rosenshein, NB; Shahzad, MM; Sood, AK | 1 |
| Li, XR; Liao, N; Wang, K; Yao, M; Zhang, GC; Zu, J | 1 |
| Bravencová, Z | 1 |
| Fujita, S; Fukuhara, A; Hata, A; Hatachi, Y; Kaji, R; Katakami, N; Kim, YH; Masago, K; Mio, T; Mishima, M | 1 |
| Arumugham, T; Burris, HA; Dar, MM; Dowlati, A; Fang, L; Gainer, SD; Hodge, JP; Infante, JR; Jones, SF; Lager, JJ; Nishioka, J; Suttle, AB; Tan, AR | 1 |
| Chen, D; Ding, LJ; Ren, XC; Teng, XD; Xia, AL; Xia, HP; Xu, ST; Xue, DB; Zhang, SJ | 1 |
| Chen, C; Chen, P; Jin, ZL; Li, K; Li, N; Zhang, CC | 1 |
| Fietkau, R; Iro, H; Klautke, G; Kuwert, T; Lell, M; Linke, R; Semrau, S; Uder, M; Waldfahrer, F | 1 |
| Chen, JS; Cheng, JC; Chuang, TH; Hsu, CH; Hsu, HH; Huang, PM; Kuo, SW; Lee, JM; Lee, YC; Lin, CC; Shun, CT; Wang, YH; Wu, MT; Yang, PW; Yang, SY | 1 |
| Chen, X; Hou, Y; Li, C; Li, X; Lou, G; Meng, F; Sun, M; Yin, M; Zhang, H; Zhao, F | 1 |
| Emoto, S; Ishigami, H; Kaisaki, S; Kitayama, J; Nagawa, H; Yamaguchi, H; Yamashita, H | 1 |
| Bröcker, EB; Klink, T; Meyer, KM; Ugurel, S | 1 |
| Bento, S; Dávila, C; Ferreira, A; Pereira, D; Rodrigues, A; Rodrigues, H; Vieira, C | 1 |
| Arakawa, K; Hirai, K; Ogawa, H; Sunose, Y; Takeyoshi, I; Totsuka, O; Toya, H; Yoshinari, D | 1 |
| He, L; Huang, L; Huang, X; Li, JD; Liu, JH; Ren, YF; Wang, HY; Xiong, Y; Zheng, M | 1 |
| Chougule, P; DiSiena, MR; Koness, RJ; McRae, RG; Nigri, PT; Radie-Keane, K; Rathore, R; Ready, N; Wanebo, HJ | 1 |
| Ando, M; Fujiwara, Y; Hirata, T; Katsumata, N; Ono, M; Shimizu, C; Tamura, K; Yamamoto, H; Yonemori, K | 1 |
| CHEN, XD; LÜ, WG; QIN, JL; SHI, HY | 1 |
| Blijham, GH; Erdkamp, FL; Knibbeler-van Rossum, CT; Lalisang, RI; Loosveld, OJ; Nortier, JW; Rodenburg, CJ; Schouten, HC; Slee, PH; Smals, AE; Tjan-Heijnen, VC; van Bochove, A; Voest, EE; Wals, J; Wils, JA | 1 |
| Hirano, M; Kataoka, H; Kiriyama, T; Kitauchi, T; Saito, K; Ueno, S | 1 |
| Goto, H; Haruta, J; Ina, K; Iwase, H; Kumada, T; Shimada, M; Shinoda, M; Sugihara, M; Tsuzuki, T | 1 |
| Chiba, F; Kiyozaki, H; Konishi, F; Saito, M; Shuto, C; Takata, O; Yamada, S; Yoshida, T | 1 |
| Blasco, A; Cabrera, A; Camps, C; Carrato, A; Gil, M; Gómez-Aldaraví, L; González-Larriba, JL; Guijarro, R; Iranzo, V; Jantus, E; Massuti, B; Provencio, M; Rossell, R; Sanmartín, E; Sirera, R; Velasco, A | 1 |
| Berry, DA; Bleiweiss, IJ; Broadwater, G; Cowan, D; Dressler, LG; Edgerton, S; Ellis, MJ; Goldstein, LJ; Hayes, DF; Henderson, IC; Hudis, CA; Ingle, JN; Lara, JF; Martino, S; Norton, L; Thor, AD; Winer, EP | 1 |
| Beck, T; Bromund, J; Brufsky, A; Frontiera, M; Hainsworth, J; Hoelzer, K; Keaton, M; Krill-Jackson, E; Kroener, J; Marciniak, MD; Middleman, E; Nadella, P; Obasaju, C; Orlando, M; Panella, T; Paul, D; Tai, F; Whorf, R; Zhao, L | 1 |
| Baba, Y; Kim, SJ; Kishi, K; Nakayama, T; Naoi, Y; Noguchi, S; Shimazu, K; Shimomura, A; Tamaki, Y; Yasojima, H | 1 |
| An, X; He, Y; Li, Y; Wang, F; Wang, Z; Xu, R; Zhou, N | 1 |
| Imamoto, H; Imano, M; Itoh, T; Kato, H; Okuno, K; Peng, YF; Satou, T; Shinkai, M; Shiozaki, H; Shiraishi, O; Takeyama, Y; Yasuda, A; Yasuda, T | 1 |
| Albers, P; Fimmers, R; Niegisch, G; Park, SI; Siener, R | 1 |
| Endo, S; Endo, T; Hasegawa, T; Hironaka, M; Nakano, T; Nakayama, M; Sugiyama, Y | 1 |
| Fujioka, S; Haruki, T; Miwa, K; Nakamura, H; Takagi, Y; Taniguchi, Y; Yurugi, Y | 1 |
| Kanto, S; Konishi, S; Sakamoto, K; Uehara, M; Yokoyama, D; Yoshino, K | 1 |
| Chera, B; Hayes, DN; Rosenberg, L; Rosenman, J; Shockley, W; Weissler, M; Zanation, A | 1 |
| Bafaloukos, D; Batistatou, A; Bobos, M; Briasoulis, E; Christodoulou, C; Dafni, U; Dimopoulos, MA; Eleftheraki, AG; Fountzilas, G; Gogas, H; Kalofonos, HP; Karanikiotis, C; Karina, M; Kosmidis, P; Markopoulos, C; Papadimitriou, C; Papakostas, P; Pectasides, D; Samantas, E; Stathopoulos, GP; Timotheadou, E | 1 |
| Aguirre-González, EH; Verduzco-Aguirre, HC; Verduzco-Rodríguez, L | 1 |
| Bacoyiannis, C; Bafaloukos, D; Boukovinas, I; Dimopoulos, MA; Fountzilas, G; Kalofonos, HP; Kosmidis, PA; Pavlidis, N; Pectasides, D; Skarlos, D; Syrigos, K | 1 |
| Furuya, T; Hirowatari, H; Ito, K; Izawa, H; Karasawa, K; Mitsuhashi, N; Ozawa, S; Saito, M; Suzuki, T | 1 |
| Fu, J; Leng, H; Liang, L; Liu, YL; Xing, W; Zhang, HW | 1 |
| Bai, P; Li, B; Li, HJ; Li, SM; Li, W; Wu, LY; Zhang, R | 1 |
| Blank, S; Lordick, F; Lorenzen, S; Ott, K; Siewert, JR | 1 |
| Coleman, T; Gangireddy, Vg; Liles, GB; Sostre, GD | 1 |
| Bouchardy, C; Dehler, S; Ess, S; Frick, H; Joerger, M; Konzelmann, I; Savidan, A; Thürlimann, B | 1 |
| Burrows, W; Choy, H; Edelman, MJ; Gore, E; Krasna, M; Paulus, R; Suntharalingam, M; Wilson, LD | 1 |
| Baird, RD; Barton, DP; Kaye, SB; Khan, AZ; Moreno, V; Vitfell-Pedersen, J; Yap, TA | 1 |
| Mason, DP | 1 |
| Chiantera, V; Köhler, C; Mangler, M; Piek, JM; Schneider, A; Speiser, D; Vercellino, GF | 1 |
| Ge, FJ; Lin, L; Liu, LJ; Wang, Y; Xu, JM; Zhao, CH; Zhuang, QX | 1 |
| Aloisi, A; Angioli, R; Benedetti-Panici, P; Capriglione, S; De Cicco Nardone, C; Luvero, D; Montera, R; Muzii, L; Plotti, F; Terranova, C | 1 |
| Atkins, JN; Becker, HP; Berry, DA; Cirrincione, CT; Hudis, C; Kimmick, G; Martino, S; Mayer, E; Muss, H; Norton, L; O'Regan, R; Perez, EA; Schneider, CJ; Shulman, LN; Winer, EP | 1 |
| Abotouk, N; Halim, A | 1 |
| Kim, J; Kim, JH; Kim, JY; Kim, YS; Yoon, MS | 1 |
| Anai, S; Harada, T; Ijichi, K; Koga, T; Kubo, N; Nakanishi, Y; Otsubo, K; Takayama, K; Yoneshima, Y | 1 |
| Atkins, JN; Azar, CA; Biggs, DD; Brufsky, A; Ewer, MS; Fehrenbacher, L; Flynn, PJ; Geyer, CE; Gross, HM; Jeong, JH; Mamounas, EP; Polikoff, J; Rastogi, P; Rathi, V; Romond, EH; Swain, SM; Tan-Chiu, E; Wolmark, N; Yothers, G; Zapas, JL; Zheng, P | 1 |
| Drage, MG; Haddad, RI; Lichtman, AH; Shah, SM | 1 |
| Hall, KL; Rajput, S; Ran, S; Volk-Draper, LD; Wilber, A | 1 |
| Du, XH; Mao, WM; Wang, SY; Xu, YP; Zhang, SZ | 1 |
| Hirayama, M; Kato, J; Kawano, Y; Kobune, M; Kuroiwa, G; Miyanishi, K; Sato, T; Sato, Y; Takada, K; Takahashi, S; Takimoto, R | 1 |
| Amano, S; Enomoto, K; Hagiwara, M; Hara, Y; Matsumoto, K; Nagashima, S; Sakurai, K; Tani, M; Ueda, Y; Waga, E | 1 |
| Bargiela-Iparraguirre, J; Belda-Iniesta, C; Dominguez, G; García Alfonso, P; Gutiérrez-González, A; Perona, R; Sanchez-Perez, I | 1 |
| Fang, Q; Li, Y; Ou, W; Qin, J; Sun, HB; Wang, SY; Zhang, L | 1 |
| Lu, XY; Wang, ML; Wang, X; Yang, JF; Yu, HG; Zhou, LY | 1 |
| Goto, T; Korenaga, T; Morio, A; Nakahara, K; Ohse, Y; Tahara, M; Yakumaru, K | 1 |
| Alvarez Castelo, L; Blanco Díez, A; Fernández Rosado, E; González Martín, M; Rodríguez Gómez, I; Sánchez Rodríguez Losada, J; Suárez Pascual, G | 1 |
| Ishihara, A; Ishiodori, H; Koga, Y; Kudo, S; Nakamura, T; Ochiai, T; Ogata, K; Ohchi, T | 1 |
| Asaumi, Y; Hara, T; Hirano, M; Kikkawa, H; Kikuchi, T; Murakami, N; Nozawa, H; Takizawa, M; Uno, Y | 1 |
| Ajarim, D; Al Malik, OA; Al-Sobhi, SS; Baslaim, MM; Chaudhary, MA; Ezzat, A; Ibrahim, E; Sorbris, RA; Tulbah, A | 1 |
| Gotoh, T; Masuda, S; Morio, A; Nakahara, K; Ohse, Y; Tahara, M; Yakumaru, K | 1 |
| Karaveli, S; Pesterelli, E; Simsek, M; Simsek, T; Trak, B | 1 |
| Fukuda, K; Hosono, M; Kimura, F; Kokufu, I; Tamaoka, K; Tanei, T; Taniguchi, H; Yamada, K; Yamamoto, M; Yano, T | 1 |
| Kokai, H; Nikkuni, K; Saito, M; Tsukahara, A | 1 |
| Chida, N; Imai, G; Ishibashi, J; Iwabuchi, M; Matsuda, Y; Mochida, A; Shiina, M; Suzuki, S; Suzuki, T; Tadokoro, K; Takahashi, H; Yamada, K; Yokoyama, H | 1 |
| Hirai, I; Honda, K; Kokawa, Y; Okamura, Y; Oura, S; Sakurai, T; Sasaki, R; Tanino, H; Yoshimasu, T | 1 |
| Fukushima, M; Ono, Y; Sawada, M | 1 |
| Dörken, B; Krenn, V; Kretzschmar, A; Reichardt, P; Thuss-Patience, PC | 1 |
| Berry, DA; Carpenter, JT; Cirrincione, CT; Cooper, MR; Demetri, GD; Duggan, DB; Fleming, G; Frei, E; Goldstein, LJ; Hayes, DF; Henderson, IC; Holland, JF; Ingle, JN; Martino, S; Muss, HB; Norton, L; Schilsky, RL; Tkaczuk, KH; Wood, WC | 1 |
| Bonneterre, J; Fumoleau, P; Luporsi, E | 1 |
| Altmeyer, P; Ardabili, M; Gambichler, T; Hoffmann, K; Rotterdam, S; Stücker, M | 1 |
| Cho, MJ; Kim, JS; Kim, Ki; Kim, SY | 1 |
| Huang, MN; Li, N; Liu, LY; Wang, GX; Wu, LY; Zhang, R | 1 |
| Betticher, DC; Cerny, T; Egli, F; Furrer, M; Habicht, J; Hansen, E; Honegger, H; Hsu Schmitz, SF; Joss, C; Pless, M; Ris, HB; Roth, AD; Schmid, RA; Spiliopoulos, A; Stahel, R; Stupp, R; Tötsch, M; von Briel, C; Weder, W; Wernli, M | 1 |
| Sasaki, F; Taguchi, K; Takahashi, H; Takahashi, M; Todo, S | 1 |
| Kou, Y; Okamoto, Y; Okuyama, N; Sawada, T; Tominaga, T | 1 |
| Dellian, M; Krasnici, S; Michaelis, U; Naujoks, K; Sauer, B; Schmitt-Sody, M; Schulze, B; Strieth, S; Teifel, M | 1 |
| Dousei, T; Emoto, T; Fujii, M; Fujikawa, M; Komaki, T; Naka, Y; Nezu, R; Yoshikawa, K; Yoshioka, Y | 1 |
| Bando, T; Hasegawa, S; Inui, K; Kambayashi, T; Miyahara, R; Ri, M; Wada, H; Yanagihara, K | 1 |
| Baba, S; Egawa, S; Fujita, T; Kuruma, H; Shitara, T; Yokoyama, E | 1 |
| Beer, TM; Eilers, KM; Garzotto, M; Henner, WD; Wersinger, EM | 1 |
| Bratengeier, K; Flentje, M; Hagen, R; Helms, J; Hoppe, F; Pfreundner, L; Preisler, V; Willner, J | 1 |
| Emi, Y; Ezaki, T; Ikegami, T; Ishida, T; Iwanami, T; Kido, A; Kohso, H; Okazaki, J; Tomiyasu, M | 1 |
| Hamada, K; Ito, S; Kubota, K; Mikami, H; Nakagawa, A; Okada, T; Tagaya, N | 1 |
| Iwamoto, M; Kobayashi, T; Lee, SW; Nohara, T; Sumiyoshi, K; Tanigawa, N | 1 |
| Damon, L; Demirer, T; Derigs, G; Ferrante, P; Kröger, N; Rosti, G; Wandt, H; Zander, AR | 1 |
| Fidler, IJ; Herbst, RS; Isobe, T; Itasaka, S; Ki Hong, W; O'Reilly, MS; Onn, A; Wu, W | 1 |
| Bilezikci, B; Demirhan, B; Erkanli, S; Haberal, A; Kuscu, E; Oktem, M | 1 |
| Breitbach, P; Eggemann, H; Elling, D; Kohls, A; Krocker, J; Kümmel, S; Morack, G; Schlosser, H | 1 |
| Bruzzi, P; Conte, P; Donati, S; Gennari, A; Guarneri, V; Landucci, E; Orlandini, C; Ricci, S; Rondini, M; Salvadori, B | 1 |
| Atallah, D; Camatte, S; Castaigne, D; Duvillard, P; Joulie, F; Lhommé, C; Morice, P; Pautier, P; Rey, A; Thoury, A | 1 |
| Fjaestad, K; Ostenstad, B; Risberg, T; Sommer, HH; Wist, EA | 1 |
| Gillessen, S; Joerger, M; Klaeser, B; Kluckert, JT; Schmid, HP; Warzinek, T | 1 |
| Aebersold, DM; Altermatt, HJ; Berclaz, G; Djonov, V; Greiner, RH; Gruber, G; Hlushchuk, R | 1 |
| Fukushima, M; Higure, A; Hirata, K; Inoue, Y; Itoh, H; Konishi, T; Nagata, N; Nakayama, Y; Okamoto, K; Shibao, K; Tsurudome, Y | 1 |
| Hata, T; Hikino, H; Kanazawa, A; Nagaoka, S; Nakamura, K; Ozaki, N; Sugimoto, S; Tokuka, A; Yamada, T | 1 |
| Chou, H; Fujita, Y; Kawakami, S; Ogaki, M; Shiomi, A; Takashina, K | 1 |
| Hamanaka, K; Miyagawa, Y; Munakata, Y; Nishimura, H; Ohno, Y; Sakai, H; Seki, H | 1 |
| Adair, C; Arciero, C; Peoples, GE; Shriver, CD | 1 |
| Audring, H; Gutermuth, J; Haas, N; Trefzer, U; Voit, C | 1 |
| Horiguchi, J; Iijima, K; Iino, Y; Kanoh, T; Kikuchi, M; Koibuchi, Y; Morishita, Y; Oyama, T; Takata, D; Yoshida, M; Yoshida, T | 1 |
| Wu, SX; Xie, CY; Zhang, P | 2 |
| Bearden, JD; Gray, JR; Greco, FA; Hainsworth, JD; Houston, GA; Litchy, S; Shaffer, DW | 1 |
| Kamimura, K; Kaneko, I; Kida, A; Kii, E; Murata, T; Tanaka, T; Tsubono, M | 1 |
| Fujio, N; Fukuda, Y; Ihara, T; Koyama, I; Osugi, H; Takatori, H; Terakura, M; Tsukazaki, T; Tsukazaki, Y | 1 |
| Doyle, A; Edelman, MJ; Gamliel, Z; Hausner, P; Krasna, M; Patel, AB; Sonett, JR; Suntharalingam, M | 1 |
| Aravantinos, G; Bafaloukos, D; Dimopoulos, AM; Fountzilas, G; Gogas, H; Kalofonos, C; Kosmidis, P; Linardou, H; Papadimitriou, C; Papakostas, P; Skarlos, D | 1 |
| Garg, K; Lemos, LB; Papasozomenos, S; Qu, Z | 1 |
| Cui, HJ; Li, Y; Tan, HY; Wu, XQ | 1 |
| Guan, ZZ; Hawkins, M; Liu, DG; Luo, HY; Soon-Shiong, P; Teng, XY; Yao, ZW; Zhou, NN | 1 |
| Hihara, J; Mizuiri, H; Shimizu, K; Suzuki, T; Tanabe, K; Taomoto, J; Wada, Y; Yoshida, K | 1 |
| Buyse, M; Diéras, V; Fumoleau, P; Guastalla, JP; Kerbrat, P; Maillart, P; Mauriac, L; Namer, M; Pénault-Llorca, F; Pouillart, P; Pujade-Lauraine, E; Romieu, G; Tubiana-Hulin, M | 1 |
| Ando, M; Fujiwara, Y; Katsumata, N; Kouno, T; Matsumoto, K; Shimizu, C; Takeuchi, M; Tokunaga, S; Uno, H; Yamanaka, Y; Yonemori, K | 1 |
| Camatte, S; Castaigne, D; Dubernard, G; Duvillard, P; Lhommé, C; Morice, P; Pautier, P; Rey, A | 1 |
| Aoki, Y; Fukada, T; Horiguchi, K; Kobayashi, J; Kobayashi, N; Miyazaki, M; Morishima, Y; Nakano, M; Shiramatsu, K; Suzuki, I; Tazawa, Y; Toyoda, Y; Yamamoto, K; Yokoyama, K | 1 |
| Abali, H; Altundag, K; Atahan, IL; Baltali, E; Engin, H; Erman, M; Guler, N; Karaoglu, A; Onat, D; Ozisik, Y; Sayek, I; Tekuzman, G | 1 |
| Altmann, KH; Hattenberger, M; McSheehy, PM; Muller, M; O'Reilly, T; Vaxelaire, J; Wartmann, M; Wenger, F | 1 |
| Gligorov, J; Nabholtz, JM | 1 |
| Avril, N; Bader, M; Dose Schwarz, J; Hemminger, G; Jänicke, F; Jenicke, L | 1 |
| Biel, MA; El-Naggar, AK; Machtay, M; Rosenthal, DI; Sinard, RJ; Weber, RS; Yom, SS | 1 |
| Chou, W; Lee, N; Puri, DR | 1 |
| Byun, JR; Cho, SH; Chung, IJ; Kim, HJ; Kim, YK; Lee, JJ; Na, KJ; Song, SY; Yang, DH | 1 |
| Chijiiwa, K; Eto, TA; Hotokezaka, M; Iwamura, T; Shibata, N | 1 |
| Deguchi, Y; Kamimura, K; Kaneko, I; Kii, E; Murata, T; Tsubono, M; Yasumizu, R | 1 |
| Aratake, K; Itabashi, M; Kameoka, S; Mitsuhashi, M; Ogawa, S; Seshimo, A; Shirotani, N | 1 |
| Brown, A; Bryant, J; Ewer, M; Fehrenbacher, L; Geyer, CE; Keefe, D; Mamounas, EP; Rastogi, P; Romond, E; Seay, TE; Shannon, RP; Swain, SM; Tan-Chiu, E; Vogel, VG; Wolmark, N; Yothers, G | 1 |
| De Petris, L; Friesland, S; Lax, I; Sirzén, F | 1 |
| Akerman, P; Barnett, JM; Cioffi, W; Cruff, D; Dipetrillo, T; Iannitti, D; Kennedy, T; Maia-Acuna, C; Martel, D; Miner, T; Remis, M; Safran, H | 1 |
| Abrams, M; Abu-Khalaf, MM; Ananthanarayanan, G; Burtness, BA; Chung, GG; DiGiovanna, MP; Ebisu, K; Farber, LR; Haffty, BG; Hsu, AD; Reiss, M; Salikooti, S; Windsor, S; Zelterman, D | 1 |
| Bang, YJ; Choi, IS; Heo, DS; Im, SA; Kim, DW; Kim, JH; Kim, NK; Kim, TY; Lee, JS; Lee, KW; Na, Ii; Oh, DY; Shin, H; Song, EK; Yun, T | 1 |
| Cai, XC; Chen, Q; Chen, YG; Fan, NF; Guo, ZQ; Lu, X; Ouyang, XN; Wu, XA; Xu, S; Yang, JW; Zhang, YH | 1 |
| Jingu, K; Kagaya, A; Ochiai, T; Sasagawa, K | 1 |
| Marutaka, M; Miyake, M; Suguri, T; Yoshimura, K | 1 |
| Blohmer, JU; Breitbach, GP; Budner, M; Elling, D; Kohls, A; Krocker, J; Kümmel, S; Lichtenegger, W; Morack, G | 1 |
| Adamo, V; Altavilla, G; Cascinu, S; Ferraù, F; Girlando, A; Maisano, R; Numico, G; Palazzolo, C; Pergolizzi, S; Russi, E; Santacaterina, A; Settineri, N; Spadaro, P | 1 |
| Ahn, JB; Cho, BC; Choi, HJ; Kim, CB; Kim, JH; Lee, YC; Sohn, JH | 1 |
| Bandobashi, K; Kodama, H; Miyoshi, I; Ohtsuki, Y; Saito, T; Taguchi, H | 1 |
| Inoue, K; Iwase, H; Kawazoe, T; Nagamoto, N; Nakahara, O; Ohsako, T; Sakamoto, N; Yamamoto, Y; Yoshida, Y | 1 |
| Fukasawa, T; Gotoh, H; Shoji, T; Taniwaka, K | 1 |
| Cooper, DL; Higgins, SA; Kluger, HM; Murren, JR; Noronha, V | 1 |
| Hatanaka, N; Hiraoka, K; Mizutani, S; Nakahara, M; Nakao, K; Okuma, K; Oyama, T; Sueyoshi, K; Taira, M; Takahashi, H; Tori, M; Uchikoshi, F; Ueshima, S; Yamagami, Y; Yoshidome, K | 1 |
| Duan, Z; Freeman, J; Giordano, SH; Goodwin, JS; Hortobagyi, GN; Kuo, YF | 1 |
| Blohmer, JU; Breitbach, GP; Budner, M; Elling, D; Kohls, A; Krocker, J; Kümmel, S; Morack, G | 1 |
| Colville, JA; Ginsberg, MS; Hricak, H; Ilson, D; Kalaigian, J; Mazumdar, M; Schwartz, GK; Schwartz, LH; Wang, L | 1 |
| Bagchi, S | 1 |
| Busby, JE; Do, KA; Fan, D; Fidler, IJ; He, J; Kim, SJ; Logothetis, C; Mathew, P; Maya, M; Nakamura, T; Uehara, H; Wang, X; Yazici, S | 1 |
| Kobayashi, M; Miyashita, Y; Nagata, N; Oba, K; Sakamoto, J; Tsuburaya, A | 1 |
| Habara, K; Kawamura, S; Okumura, S; Shimada, E; Sumi, Y; Tei, M; Yamagishi, D | 1 |
| Ben Yosef, R; Sarid, D; Shalmon, A; Sperber, F; Weinstein, Y; Yaal-Hahoshen, N | 1 |
| Safra, T; Yaal-Hahoshen, N | 1 |
| Chiba, N; Hanada, M; Ishioka, C; Kakudo, Y; Kato, S; Noguchi, S; Ohori, H; Otsuka, K; Sakayori, M; Shibata, H; Shimodaira, H; Takahashi, M; Takahashi, S; Yamaura, G; Yasuda, K; Yoshioka, T | 1 |
| Anai, H; Anegawa, G; Honda, M; Kai, T; Kaneko, S; Masuda, T; Nakamura, Y; Ohta, R; Saeki, H; Yokoyama, S | 1 |
| Battelli, N; Braconi, C; Cascinu, S; Cobelli, S; Dinota, A; Giacomini, G; Giorgi, F; Manzione, L; Massacesi, C; Morale, D; Pilone, A; Scanni, A; Sturba, F; Tummarello, D | 1 |
| Nakagawa, S; Nashimoto, A; Yabusaki, H; Yamaguchi, K | 1 |
| Hayashi, T; Murayama, Y; Shimizu, H; Watanabe, N; Yoshizawa, M | 1 |
| Kawate, S; Morishita, Y; Takeyoshi, I | 1 |
| Inoue, K; Nagamoto, N; Nakahara, O; Ohsako, T; Yoshida, Y | 1 |
| Busby, JE; Do, KA; Fan, D; Fidler, IJ; He, J; Kim, JS; Kim, SJ; Maya, M; Nakamura, T; Wang, X; Yazici, S | 1 |
| Anan, K; Fujiyoshi, K; Mitsuyama, S; Tamura, K; Taniguchi, H; Tateishi, T; Yamamoto, Y | 1 |
| Enomoto, T; Katagiri, M; Kusachi, S; Nagao, J; Nagao, S; Nakamura, Y; Saida, Y; Sumiyama, Y; Watanabe, M | 1 |
| Gejyo, F; Kagamu, H; Suzuki, E; Tanaka, H; Tanaka, J; Tsuboi, K; Watanabe, S; Yoshizawa, H | 1 |
| Karakuzu, A; Koc, M; Ozdemir, S | 1 |
| Canales Ugarte, S; Cassinello Espinosa, J | 1 |
| Iwama, T; Karasawa, K; Kato, K; Sato, S; Sato, T; Takahashi, T; Tsunozaki, H | 1 |
| Aebi, S; Ballabeni, P; Gick, U; Hess, V; Lanz, D; Mingrone, W; Pestalozzi, B; Rauch, D; Rochlitz, C | 1 |
| Sakamoto, J; Sekine, T | 1 |
| Aoe, M; Ibaragi, S; Kishimoto, K; Kiura, K; Mese, H; Oyama, K; Sasaki, A; Shimo, T; Tsukamoto, G | 1 |
| Arai, W; Haruta, H; Hirashima, Y; Hosoya, Y; Hyodo, M; Kurashina, K; Nagai, H; Saito, S; Sakuma, K; Yasuda, Y; Yokoyama, T; Zuiki, T | 1 |
| Droz, JP; Fléchon, A | 1 |
| Bhuta, S; Head, CS; Nabili, V; Sercarz, JA; Tan, JW | 1 |
| Okamoto, H; Watanabe, K | 1 |
| Imai, S; Jitsuko, A; Nishikawa, H; Otoshi, M; Takahara, S; Tsubono, M; Wada, Y | 1 |
| Hirata, K; Ito, T; Sato, T; Takashima, T | 1 |
| Cho, H; Hasegawa, S; Kobayashi, O; Osaragi, T; Sairenji, M; Tsuburaya, A; Yoshida, T; Yoshikawa, T | 1 |
| Fujino, M; Maruhashi, K; Mitsudou, Y; Nakamura, T; Shimomatsuya, T; Shiraishi, S; Yonezawa, K | 1 |
| Géczi, L | 1 |
| Chiba, N; Gamoh, M; Ishioka, C; Kakudo, Y; Kato, S; Murakawa, Y; Nishino, Y; Ohori, H; Ohtsuka, K; Sakayori, M; Shibata, H; Shimodaira, H; Suzuki, T; Takahashi, M; Takahashi, S; Yamaura, G; Yasuda, K; Yoshioka, T | 1 |
| Berry, DA; Budman, DR; Cirrincione, C; Citron, ML; Henderson, IC; Hudis, CA; Muss, HB; Norton, L; Winer, EP | 1 |
| Guan, JH; Huan, HY; Mao, F; Sun, Q; Zhou, YD | 1 |
| Baick, CH; Butler, JA; Hsiang, DJ; Lane, KT; Mehta, RS; Su, MY; Yamamoto, M | 1 |
| Faerber, GJ; Weizer, AZ; Wolf, JS | 1 |
| Hiraoka, M; Imagunbai, T; Inoue, T; Mitsumori, M; Negoro, Y; Sai, H; Sasaki, S; Sasaki, Y; Shikama, N; Takegawa, H; Teshima, T; Yamauchi, C | 1 |
| Jin, ML; Li, J; Li, Y; Shen, L; Zhang, XD; Zhang, XT | 1 |
| Carbone, A; Fagotti, A; Fanfani, F; Ferrandina, G; Guerriero, M; Ludovisi, M; Petrillo, M; Scambia, G; Zannoni, G | 1 |
| Bafaloukos, D; Briasoulis, E; Dafni, U; Dimitrakakis, K; Dimopoulos, AM; Fountzilas, G; Gogas, H; Kalofonos, HP; Karanikiotis, C; Karina, M; Linardou, H; Makrantonakis, P; Markopoulos, C; Papadimitriou, C; Papakostas, P; Pectasides, D; Pisanidis, N; Polichronis, A; Samantas, E; Skarlos, D; Stathopoulos, GP; Tzorakoeleftherakis, E; Varthalitis, I; Xiros, N | 1 |
| Eisele, DW; Glastonbury, CM; Lin, D; Rafaelian, O; Wang, SJ | 1 |
| Chang, J; Cho, BC; Choi, HJ; Chung, KY; Kim, DJ; Kim, JH; Kim, SH; Kim, SK; Park, MS; Shin, SJ; Sohn, JH | 1 |
| Berry, DA; Broadwater, G; Demetri, GD; Duggan, D; Hayes, DF; Henderson, IC; Hopkins, J; Hudis, CA; Kaufman, PA; Lin, N; Liu, MC; Lyss, A; Marcom, PK; Norton, L; Robert, NJ; Tkaczuk, K; Winer, EP; Younger, J | 1 |
| Aikou, T; Aridome, K; Hokita, S; Ishigami, S; Natsugoe, S; Sasaki, K | 1 |
| Blum, JL; Clawson, A; Edelman, G; Geister, BV; Kirby, RL; O'Shaughnessy, JA; Pippen, JE; Robert, NJ; Savin, MA | 1 |
| Fujitani, K; Furukawa, H; Goto, M; Imamoto, H; Imamura, H; Imano, M; Ishida, H; Kimura, Y; Narahara, H; Shimokawa, T; Takiuchi, H | 1 |
| Akashi-Tanaka, S; Ando, M; Fujiwara, Y; Hojo, T; Katsumata, N; Kinoshita, T; Kohno, T; Seki, K; Shibata, T; Shien, T; Shimizu, C | 1 |
| Adelstein, DJ; Mekhail, TM; Murthy, S; Rice, TW; Saxton, JP; Suh, JH; Videtic, GM | 1 |
| Fang, SH; Gao, YL; Yu, AJ | 1 |
| Andre, F; Hortobagyi, GN; Liedtke, C; Pusztai, L; Sotiriou, C; Symmans, WF; Tordai, A; Wang, J; Yan, K | 1 |
| Chang, YL; Cheng, JC; Hsu, CH; Hsu, FM; Lee, JM; Lee, YC; Lin, CC; Tsai, YC | 1 |
| Hino, N; Ikushima, Y; Miyake, H; Ogasawara, T; Ohura, R; Sohnaka, Y; Tsuyuguchi, M; Wada, D; Yamamoto, Y; Yamasaki, S | 1 |
| Belani, CP; Christie, NA; Cooper, K; Gibson, MK; Land, SR; Landreneau, RJ; Luketich, JD; Pennathur, A; Schuchert, M; Ward, J | 1 |
| Baselga, J; Fennelly, D; Hudis, CA; Norton, L; Raptis, G; Seidman, AD | 1 |
| Hudis, CA; Norton, L; Seidman, AD | 1 |
| Akerley, W; Choy, H | 1 |
| Beller, U; Hiller, N; Hornreich, G; Lavie, O; McDaniel, C; Neuman, M; Winograd, B | 1 |
| Hayakawa, S; Sato, S; Takano, T; Wagazuma, S; Yajima, A | 1 |
| Choyke, PL; Cowan, KH; Fisherman, JS; O'Shaughnessy, JA; Pestalozzi, BC; Sotos, GA | 1 |
| Adachi, I; Aoyama, H; Horikoshi, N; Narabayashi, M; Taguchi, T; Takashima, S; Watanabe, T | 1 |
| Cheung, KL; Luk, IS; Ma, L; Shek, TW | 1 |
| Baselga, J; Currie, V; Fennelly, D; Gilewski, T; Hudis, CA; Lebwohl, D; Moynahan, ME; Raptis, G; Seidman, AD; Sklarin, N | 1 |
| Sovak, M | 1 |
| Au, JL; Wientjes, MG; Yen, WC | 1 |
| Schrijvers, D; van Dam, P; van Oosterom, A | 1 |
| Edwards, CL; Kavanagh, JJ; Kudelka, AP; Loyer, E; Piamsomboon, S; Termrungruanglert, W; Verschraegen, CF | 1 |
| Pestalozzi, BC | 1 |
| Ames, F; Asmar, L; Buzdar, AU; Hortobagyi, GN; McNeese, M; Rahman, Z; Singletary, S; Theriault, RL | 1 |
| Kokawa, Y; Oura, S; Sakurai, T; Tamaki, T; Umemura, T; Yoshimura, G | 1 |
| Eisele, DW; Forastiere, AA; Lee, DJ; Westra, WH | 1 |
| Hirabayashi, N; Kanamaru, R; Kurihara, M; Ota, J; Sakata, Y; Suminaga, M; Taguchi, T | 1 |
| Furue, H; Hirabayashi, N; Kanamaru, R; Kurihara, M; Mai, M; Ota, J; Sakata, Y; Suminaga, M; Taguchi, T | 1 |
| Kurihara, M; Matsuno, S; Ohashi, Y; Okada, S; Sakata, Y; Sasaki, Y; Taguchi, T | 1 |
| Kokawa, Y; Naito, Y; Oura, S; Sakurai, T; Suzuma, T; Tamaki, T; Tanino, H; Umemura, T; Yoshimura, G | 1 |
| Acito, L; Angiona, S; Bilancia, D; Costanzo, FD; Fioriti, L; Gasperoni, S; Giustini, L; Manzione, L; Sdrobolini, A; Valenti, L | 1 |
| Hayashi, K; Kuroi, K; Nagai, S; Toi, M; Tominaga, T | 1 |
| Friedberg, JS | 1 |
| Anagnostopoulos, A; Aravantinos, G; Bakoyannis, C; Bamias, A; Deliveliotis, C; Dimopoulos, MA; Fountzilas, G; Georgoulias, V; Giannopoulos, A; Karayannis, A; Kosmidis, P; Kyriakakis, Z; Moulopoulos, LA; Pantazopoulos, D; Papadimitriou, C; Varkarakis, I; Zervas, A | 1 |
| Atassi, G; Guilbaud, N; Jan, M; Kraus-Berthier, L; Naze, M; Pierré, A | 1 |
| Almagro, M; Fonseca, E; Garcia, J; Pozo, JD; Vasquez, A | 1 |
| Antonopoulos, M; Kosmas, C; Malamos, NA | 1 |
| Achterrath, W; Feldmann, HJ; Heinrich, B; Hesse, K; Kau, R; Molls, M; Sommer, G; Zimmermann, F | 1 |
| Ames, FC; Buzdar, AU; Feig, BW; Hunt, KK; Lenert, JT; Mirza, NQ; Ross, MI; Singletary, SE; Vlastos, G | 1 |
| Bartholomeus, S; Crown, J; Di Leo, A; Dolci, S; Duffy, K; Larsimont, D; Nogaret, JM; O'Higgins, N; Paesmans, M; Piccart, MJ; Riva, A; Rowan, S | 1 |
| Ah-See, AK; Chilcott, F; Eremin, O; Gilbert, FJ; Heys, SD; Hutcheon, AW; Miller, ID; Payne, S; Sharp, PF; Smith, IC; Waikar, S; Welch, AE; Whitaker, T | 1 |
| Au, JL; Gan, Y; Song, S; Wientjes, MG | 1 |
| Kunisue, H; Kurebayashi, J; Shimozuma, K; Sonoo, H; Tanaka, K; Udagawa, K; Yamamoto, S; Yamamoto, Y | 1 |
| Baronius, W; Bokemeyer, C; Clemens, M; Haag, C; Hartmann, JT; Hempel, V; Kanz, L; Kollmannsberger, C; Lingenfelser, T; Quietzsch, D; Schroeder, M | 1 |
| Ames, FC; Bedi, D; Buzdar, AU; Feig, BW; Fornage, BD; Hunt, KK; Lenert, JT; Mirza, NQ; Ross, MI; Singletary, SE; Tolley, SM; Vlastos, G; Winchester, DJ | 1 |
| Fukuda, H; Fukuda, K; Kim, YH; Kitano, H; Kokufu, I; Taniguchi, H; Yamada, K; Yamamoto, M; Yano, T | 1 |
| Naito, Y; Oura, S; Tanino, H | 1 |
| Ames, FC; Breslin, TM; Buzdar, AU; Cohen, L; Delpassand, ES; Feig, BW; Fleming, JB; Hortobagyi, GN; House, R; Hunt, KK; Kuerer, HM; Newman, LA; Ross, MI; Sahin, A; Singletary, SE | 1 |
| Naito, Y; Sakurai, T; Suzuma, T; Tamaki, T; Umemura, T; Yoshimura, G | 1 |
| Briasoulis, E; Constantopoulos, S; Froudarakis, M; Milionis, HJ; Pavlidis, N; Peponis, I | 1 |
| Börgermann, C; Krege, S; Otto, T; Rembrink, V; Rübben, H | 1 |
| Bruns, CJ; Davis, DW; Dinney, CP; Hicklin, DJ; Inoue, K; McConkey, DJ; Perrotte, P; Radinsky, R; Slaton, JW; Sweeney, P | 1 |
| Randal, J | 1 |
| Ashizawa, T; Katayanagi, S; Katsumata, K; Koyanagi, Y; Kusama, M; Murohashi, T; Sumi, T; Yamamoto, K | 1 |
| Kamata, S; Kiyosawa, Y; Kudo, T; Nakagawa, T; Ogawa, J; Onuki, M; Seto, T | 1 |
| Dirkx, M; Senan, S; van Meerbeeck, J; van Sörnsen de Koste, J; Voet, P | 1 |
| Alvarnas, J; Chow, W; Doroshow, JH; Forman, SJ; Kogut, N; Leong, LA; Longmate, J; Margolin, KA; Morgan, RJ; Raschko, JW; Reardon, D; Schriber, J; Shibata, SI; Somlo, G; Synold, T; Tetef, ML; Yen, Y | 1 |
| Akashi-Tanaka, S; Fukutomi, T; Hasegawa, T; Katsumata, N; Miyakawa, K; Takahashi, T; Tsuda, H; Watanabe, T | 1 |
| Oka, M; Saito, K; Takano, N; Tangoku, A | 1 |
| Fukuda, K; Kim, Y; Kitano, H; Kokufu, I; Taniguchi, H; Yamada, K; Yamamoto, M; Yano, T | 1 |
| Assaad, SI; Kuter, I; Niemierko, A; Powell, SN; Roche, M; Schoenthaler, R; Taghian, AG; Younger, J | 1 |
| Currie, V; D'Andrea, G; Fornier, MN; Gilewski, T; Hudis, C; Moasser, M; Moynahan, ME; Norton, L; Panageas, KS; Salvaggio, R; Seidman, AD; Sklarin, N; Theodoulou, M | 1 |
| Brugnatelli, S; Danova, M; De Bella, MT; Manuguerra, G; Palmeri, S; Riccardi, A; Vaglica, M | 1 |
| Arkad'eva, TV; Artamonova, EV; Davidenko, IS; Manziuk, LV; Poddubnaia, IV | 1 |
| Kaneko, M; Oguchi, S; Saida, T; Uhara, H | 1 |
| Fukuda, K; Kimura, F; Kokufu, I; Taniguchi, H; Yamada, K; Yamamoto, M; Yano, T | 1 |
| Fukuda, K; Kimura, F; Kokufu, I; Tanei, T; Taniguchi, H; Yamada, K; Yamamoto, M; Yano, T | 1 |
| Baronius, W; Bokemeyer, C; Haag, C; Hartmann, JT; Hempel, V; Honecker, F; Kanz, L; Kollmannsberger, C; Quietzsch, D; Schroeder, M; Spott, C | 1 |
20 review(s) available for paclitaxel and Lymph Node Metastasis
| Article | Year |
|---|---|
[A Case of Neuroendocrine Carcinoma of the Stomach Treated with TAS-102].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Female; Gastrectomy; Humans; Immune Checkpoint Inhibitors; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Nivolumab; Paclitaxel; Stomach Neoplasms | 2022 |
Any place left for induction chemotherapy for locally advanced head and neck squamous cell carcinoma?
Topics: Antineoplastic Agents, Phytogenic; Carboplatin; Chemoradiotherapy; Cisplatin; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Lymph Nodes; Lymphatic Metastasis; Neoplasm Recurrence, Local; Paclitaxel; Squamous Cell Carcinoma of Head and Neck; Survival Rate | 2018 |
De novo large cell neuroendocrine carcinoma of the prostate gland with pelvic lymph node metastasis: a case report with review of literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cisplatin; Cystoscopy; Disease Progression; Etoposide; Fatal Outcome; Humans; Immunohistochemistry; Laparoscopy; Leuprolide; Lymph Node Excision; Lymphatic Metastasis; Male; Meningeal Neoplasms; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Paclitaxel; Pelvis; Prostatic Neoplasms; Robotic Surgical Procedures; Time Factors; Tomography, X-Ray Computed; Transurethral Resection of Prostate; Treatment Outcome | 2014 |
Squamous cell carcinoma presenting as a solitary growing cyst in lung: a diagnostic pitfall in daily clinical practice.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cysts; Diagnostic Errors; Frozen Sections; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Neoplasm Staging; Paclitaxel; Pneumonectomy; Solitary Pulmonary Nodule; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2009 |
Molecular diagnosis and translymphatic chemotherapy targeting sentinel lymph nodes of patients with early gastrointestinal cancers.
Topics: Animals; Antineoplastic Agents, Phytogenic; Drug Carriers; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Methacrylates; Molecular Diagnostic Techniques; Paclitaxel; Phosphorylcholine; Rats; Stomach Neoplasms | 2010 |
The role of surgery for locally advanced non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Erlotinib Hydrochloride; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Staging; Paclitaxel; Positron-Emission Tomography; Prognosis; Protein Kinase Inhibitors; Quinazolines; Survival Rate; Tomography, X-Ray Computed | 2012 |
Efficacy of induction chemoradiotherapy in thymic cancer: report of a successful case and review of the literature.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Radiography, Thoracic; Remission Induction; Thymus Neoplasms | 2002 |
Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Brachytherapy; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Dose Fractionation, Radiation; Female; Follow-Up Studies; Hematologic Diseases; Humans; Hysterectomy; Life Tables; Lymphatic Irradiation; Lymphatic Metastasis; Middle Aged; Nausea; Neoplasm Metastasis; Paclitaxel; Radiation Injuries; Radiotherapy, Adjuvant; Radiotherapy, High-Energy; Retrospective Studies; Survival Analysis; Treatment Outcome; Uterine Cervical Neoplasms | 2003 |
[A case of endobronchial squamous cell lung cancer successfully treated with weekly chemotherapy of carboplatin and paclitaxel].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Carboplatin; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasms, Multiple Primary; Paclitaxel | 2003 |
Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.
Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Epirubicin; Female; Humans; Incidence; Leukemia, Myeloid; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Leukemia, Radiation-Induced; Lymphatic Metastasis; Melphalan; Middle Aged; Mitoxantrone; Neoplasms, Second Primary; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Radiotherapy, Adjuvant; Thiotepa; Transplantation Conditioning; Transplantation, Autologous | 2003 |
Management of advanced-stage primary carcinoma of the fallopian tube: case report and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta, Thoracic; Appendectomy; Cisplatin; Cystadenocarcinoma, Serous; Diagnosis, Differential; Fallopian Tube Neoplasms; Fallopian Tubes; Female; Humans; Hysterectomy; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Omentum; Ovariectomy; Paclitaxel; Pelvic Neoplasms; Second-Look Surgery | 2003 |
Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Length of Stay; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Pancoast Syndrome; Pneumonectomy; Postoperative Complications; Radiotherapy Dosage; Radiotherapy, Conformal; Radiotherapy, High-Energy; Retrospective Studies; Salvage Therapy; Survival Analysis; Survival Rate; Treatment Outcome; Vinblastine; Vinorelbine | 2004 |
The role of taxanes in the treatment of breast cancer.
Topics: Anthracyclines; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Chemistry, Pharmaceutical; Chemotherapy, Adjuvant; Disease-Free Survival; Docetaxel; Drug Therapy, Combination; Female; Humans; Lymphatic Metastasis; Neoplasm Metastasis; Paclitaxel; Randomized Controlled Trials as Topic; Taxoids; Trastuzumab | 2005 |
Herceptin (trastuzumab): adjuvant and neoadjuvant trials.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Gene Expression Regulation, Neoplastic; Humans; Lymphatic Metastasis; Multicenter Studies as Topic; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Randomized Controlled Trials as Topic; Receptor, ErbB-2; Trastuzumab; Up-Regulation | 2006 |
[Testis germ cell tumours: which chemotherapy, for which patients?].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Ifosfamide; Lymphatic Metastasis; Male; Neoplasm Staging; Neoplasm, Residual; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Positron-Emission Tomography; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Seminoma; Testicular Neoplasms; Testis; Vinblastine | 2007 |
[Modern chemotherapy of invasive bladder cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Doxorubicin; Gemcitabine; Humans; Lymphatic Metastasis; Methotrexate; Neoadjuvant Therapy; Neoplasm Invasiveness; Paclitaxel; Treatment Outcome; Urinary Bladder Neoplasms; Vinblastine | 2007 |
Memorial Sloan-Kettering Cancer Center experience with paclitaxel in the treatment of breast cancer.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Growth Substances; Humans; Lymphatic Metastasis; Paclitaxel; Quality of Life; Randomized Controlled Trials as Topic | 1995 |
[Chemotherapy of uterine endometrial cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Endometrial Neoplasms; Female; Humans; Irinotecan; Lymphatic Metastasis; Neoplasm Invasiveness; Paclitaxel | 1995 |
Remission of recurrent cervical cancer with paclitaxel and carboplatin: a case report and review of literature.
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Recurrence, Local; Paclitaxel; Uterine Cervical Neoplasms | 1996 |
[Chemosensitivity test of breast cancer].
Topics: Antineoplastic Agents; Breast Neoplasms; Docetaxel; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Paclitaxel; Predictive Value of Tests; Taxoids; Tumor Cells, Cultured | 2000 |
138 trial(s) available for paclitaxel and Lymph Node Metastasis
| Article | Year |
|---|---|
Effect of Epirubicin Plus Paclitaxel vs Epirubicin and Cyclophosphamide Followed by Paclitaxel on Disease-Free Survival Among Patients With Operable ERBB2-Negative and Lymph Node-Positive Breast Cancer: A Randomized Clinical Trial.
Topics: Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Paclitaxel; Prospective Studies; Receptor, ErbB-2 | 2023 |
NSAS-BC02 substudy of chemotherapy-induced amenorrhea (CIA) in premenopausal patients who received either taxane alone or doxorubicin(A) cyclophosphamide(C) followed by taxane as postoperative chemotherapy.
Topics: Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Bridged-Ring Compounds; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Incidence; Lymphatic Metastasis; Mastectomy; Middle Aged; Paclitaxel; Premenopause; Prognosis; Prospective Studies; Receptors, Estrogen; Retrospective Studies; Taxoids; Young Adult | 2020 |
Chemotherapy-induced neutropenia as a prognostic factor in patients with pancreatic cancer treated with gemcitabine plus nab-paclitaxel: a retrospective cohort study.
Topics: Aged; Albumins; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neutropenia; Paclitaxel; Pancreatic Neoplasms; Peritoneal Neoplasms; Prognosis; Retrospective Studies; Survival Rate | 2020 |
Involved-Field Irradiation in Definitive Chemoradiotherapy for Locoregional Esophageal Squamous Cell Carcinoma: Results From the ESO-Shanghai 1 Trial.
Topics: Aged; Chemoradiotherapy; China; Cisplatin; Confidence Intervals; Dose Fractionation, Radiation; Drug Administration Schedule; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Feasibility Studies; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Irradiation; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Prospective Studies; Radiotherapy, Intensity-Modulated; Time Factors; Treatment Failure | 2021 |
Morbidity and Mortality of Patients Who Underwent Minimally Invasive Esophagectomy After Neoadjuvant Chemoradiotherapy vs Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Randomized Clinical Trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Cisplatin; Disease Progression; Dose Fractionation, Radiation; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Female; Humans; Intention to Treat Analysis; Laparoscopy; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Paclitaxel; Postoperative Complications; Prospective Studies; Quality of Life; Survival Rate; Thoracoscopy | 2021 |
A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Cisplatin; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Prognosis; Survival Rate | 2017 |
Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Epirubicin; Female; Humans; Lymphatic Metastasis; Middle Aged; Paclitaxel; Risk Factors; Survival Rate | 2018 |
Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitax
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cancer Survivors; Cardiovascular System; Chemotherapy, Adjuvant; Cohort Studies; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Paclitaxel; Quality of Life; Receptor, ErbB-2; Trastuzumab; Ventricular Dysfunction, Left | 2017 |
21-Gene Recurrence Score for prognosis and prediction of taxane benefit after adjuvant chemotherapy plus endocrine therapy: results from NSABP B-28/NRG Oncology.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Genetic Testing; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Mastectomy; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 2018 |
Comparison of Neoadjuvant Nab-Paclitaxel+Carboplatin vs Nab-Paclitaxel+Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results.
Topics: Adult; Aged; Albumins; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Treatment Outcome; Triple Negative Breast Neoplasms | 2018 |
Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial.
Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Carboplatin; Chemotherapy-Induced Febrile Neutropenia; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Double-Blind Method; Doxorubicin; Female; Genes, BRCA1; Genes, BRCA2; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Middle Aged; Mutation; Neoadjuvant Therapy; Paclitaxel; Survival Rate; Thrombocytopenia; Treatment Outcome; Triple Negative Breast Neoplasms; Tumor Burden | 2018 |
The influence of prior ramucirumab treatment on the clinical activity of FOLFIRI as third-line therapy in patients with metastatic gastric Cancer.
Topics: Adenocarcinoma; Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Esophageal Neoplasms; Esophagogastric Junction; Female; Fluorouracil; Follow-Up Studies; Humans; Irinotecan; Leucovorin; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Peritoneal Neoplasms; Prognosis; Ramucirumab; Stomach Neoplasms; Survival Rate | 2019 |
Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Drug Combinations; Female; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Maintenance Chemotherapy; Male; Middle Aged; Nanoparticles; Oxonic Acid; Paclitaxel; Prognosis; Survival Rate; Tegafur | 2019 |
Local-regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial).
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Lymphatic Metastasis; Mastectomy, Segmental; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Prospective Studies; Radiotherapy, Adjuvant; Receptor, ErbB-2; Survival Analysis; Trastuzumab; Treatment Outcome | 2019 |
Assessing the effectiveness and safety of liposomal paclitaxel in combination with cisplatin as first-line chemotherapy for patients with advanced NSCLC with regional lymph-node metastasis: study protocol for a randomized controlled trial (PLC-GC trial).
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemistry, Pharmaceutical; China; Cisplatin; Clinical Protocols; Deoxycytidine; Disease Progression; Disease-Free Survival; Gemcitabine; Humans; Kaplan-Meier Estimate; Liposomes; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Staging; Paclitaxel; Prospective Studies; Research Design; Time Factors; Treatment Outcome | 2013 |
Lymph node harvest in esophageal cancer after neoadjuvant chemoradiotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Prognosis; Survival Rate | 2013 |
Predictive factors determining neoadjuvant chemotherapy outcomes in breast cancer - a single center experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Cyclophosphamide; DNA Topoisomerases, Type II; Docetaxel; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Paclitaxel; Prognosis; Prospective Studies; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Taxoids | 2013 |
A phase I study of concurrent weekly carboplatin and paclitaxel combined with intensity-modulated pelvic radiotherapy as an adjuvant treatment for early-stage cervical cancer patients with positive pelvic lymph nodes.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Pelvic Neoplasms; Prognosis; Radiotherapy, Intensity-Modulated; Uterine Cervical Neoplasms | 2013 |
Pathologic response and long-term follow-up in breast cancer patients treated with neoadjuvant chemotherapy: a comparison between classifications and their practical application.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm, Residual; Paclitaxel; Treatment Outcome | 2013 |
A phase III adjuvant randomised trial of 6 cycles of 5-fluorouracil-epirubicine-cyclophosphamide (FEC100) versus 4 FEC 100 followed by 4 Taxol (FEC-T) in node positive breast cancer patients (Trial B2000).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Middle Aged; Paclitaxel; Treatment Outcome | 2014 |
Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a random
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Paclitaxel; Puerto Rico; Receptor, ErbB-2; Stroke Volume; Time Factors; Trastuzumab; Treatment Outcome; United States | 2013 |
Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo): an open-label, 2×2 factorial randomised phase 3 trial
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Logistic Models; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Paclitaxel; Proportional Hazards Models; Risk Factors; Time Factors; Treatment Outcome; Tumor Burden; United Kingdom | 2014 |
Response to neoadjuvant chemotherapy with paclitaxel and cisplatin in locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Female; Humans; Hysterectomy; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Tumor Burden; Uterine Cervical Neoplasms | 2013 |
Phase II trial on cisplatin-adriamycin-paclitaxel combination as neoadjuvant chemotherapy for locally advanced cervical adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cystadenocarcinoma, Serous; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Paclitaxel; Prognosis; Survival Rate; Uterine Cervical Neoplasms; Young Adult | 2014 |
A Phase II Study of Concurrent Chemoradiotherapy With Paclitaxel and Cisplatin for Inoperable Esophageal Squamous Cell Carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Dose Fractionation, Radiation; Esophageal Neoplasms; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neutropenia; Paclitaxel; Prospective Studies; Survival Rate | 2016 |
Comparison of doxorubicin and cyclophosphamide versus single-agent paclitaxel as adjuvant therapy for breast cancer in women with 0 to 3 positive axillary nodes: CALGB 40101 (Alliance).
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Treatment Outcome | 2014 |
Dose-dense paclitaxel versus docetaxel following FEC as adjuvant chemotherapy in axillary node-positive early breast cancer: a multicenter randomized study of the Hellenic Oncology Research Group (HORG).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Docetaxel; Female; Humans; Lymphatic Metastasis; Middle Aged; Paclitaxel; Taxoids; Treatment Outcome | 2014 |
Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Fluorouracil; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Mastectomy; Middle Aged; Neoplasm Grading; Neoplasm Staging; Paclitaxel; Treatment Outcome; Young Adult | 2015 |
Trebananib (AMG 386) plus weekly paclitaxel with or without bevacizumab as first-line therapy for HER2-negative locally recurrent or metastatic breast cancer: A phase 2 randomized study.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Recombinant Fusion Proteins | 2015 |
Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741 (Alliance).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Receptors, Estrogen; Treatment Outcome | 2015 |
A randomized controlled trial comparing four versus six courses of adjuvant platinum-based chemotherapy in locally advanced cervical cancer patients previously treated with neo-adjuvant chemotherapy plus radical surgery.
Topics: Adenocarcinoma; Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemotherapy-Induced Febrile Neutropenia; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Paclitaxel; Radiography; Radionuclide Imaging; Survival Rate; Uterine Cervical Neoplasms | 2015 |
SOLTI NeoPARP: a phase II randomized study of two schedules of iniparib plus paclitaxel versus paclitaxel alone as neoadjuvant therapy in patients with triple-negative breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Treatment Outcome; Triple Negative Breast Neoplasms | 2015 |
A phase II study of postoperative concurrent carboplatin and paclitaxel combined with intensity-modulated pelvic radiotherapy followed by consolidation chemotherapy in surgically treated cervical cancer patients with positive pelvic lymph nodes.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy, Adjuvant; Consolidation Chemotherapy; Female; Humans; Lymphatic Metastasis; Middle Aged; Paclitaxel; Postoperative Care; Radiotherapy, Intensity-Modulated; Uterine Cervical Neoplasms | 2016 |
The role of postoperative adjuvant chemotherapy for lymph node-positive esophageal squamous cell carcinoma: a propensity score matching analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Disease-Free Survival; Docetaxel; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Postoperative Period; Propensity Score; Retrospective Studies; Taxoids; Treatment Outcome | 2016 |
A randomized phase 2 study exploring the role of bevacizumab and a chemotherapy-free approach in HER2-positive metastatic breast cancer: The HAT study (BOOG 2008-2003), a Dutch Breast Cancer Research Group trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bone Neoplasms; Breast Neoplasms; Female; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Prognosis; Receptor, ErbB-2; Survival Rate; Trastuzumab | 2016 |
Concurrent paclitaxel/cisplatin chemoradiotherapy with or without consolidation chemotherapy in high-risk early-stage cervical cancer patients following radical hysterectomy: preliminary results of a phase III randomized study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Chemoradiotherapy, Adjuvant; Cisplatin; Consolidation Chemotherapy; Disease-Free Survival; Female; Humans; Hysterectomy; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Prognosis; Radiation Injuries; Treatment Outcome; Uterine Cervical Neoplasms | 2016 |
Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial.
Topics: Adenocarcinoma, Clear Cell; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Case-Control Studies; Chemoradiotherapy, Adjuvant; Cisplatin; Cystadenocarcinoma, Serous; Endometrial Neoplasms; Female; Follow-Up Studies; Gastrointestinal Diseases; Hematologic Diseases; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Nervous System Diseases; Paclitaxel; Prognosis; Quality of Life; Radiotherapy, Adjuvant; Survival Rate | 2016 |
Cardiac safety of adjuvant non-pegylated liposomal doxorubicin combined with cyclophosphamide and followed by paclitaxel in older breast cancer patients.
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Echocardiography; Female; Heart; Heart Failure; Humans; Lymphatic Metastasis; Neoplasm Staging; Paclitaxel; Polyethylene Glycols; Prospective Studies; Stroke Volume | 2017 |
21-Gene Recurrence Score and Locoregional Recurrence in Node-Positive/ER-Positive Breast Cancer Treated With Chemo-Endocrine Therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy, Segmental; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Predictive Value of Tests; Radiotherapy, Adjuvant; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Risk Factors; Tamoxifen; Tumor Burden | 2017 |
Phase I dose finding study evaluating the combination of bendamustine with weekly paclitaxel in patients with pre-treated metastatic breast cancer: RiTa trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Bone Neoplasms; Breast Neoplasms; Disease-Free Survival; Dose-Response Relationship, Drug; Feasibility Studies; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Nitrogen Mustard Compounds; Paclitaxel; Pleural Neoplasms; Survival Rate; Treatment Outcome | 2009 |
A study of weekly paclitaxel plus 5-fluorouracil and cisplatin for patients with advanced or recurrent inoperable gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cisplatin; Drug Administration Schedule; Female; Fluorouracil; Gastrointestinal Diseases; Humans; Infections; Infusions, Intravenous; Kaplan-Meier Estimate; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Peripheral Nervous System Diseases; Salvage Therapy; Stomach Neoplasms | 2009 |
A phase I/II study of extended field radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in patients with cervical carcinoma metastatic to the para-aortic lymph nodes: a Gynecologic Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Cisplatin; Cohort Studies; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Humans; Lymphatic Metastasis; Neoplasm Staging; Paclitaxel; Uterine Cervical Neoplasms | 2009 |
Phase II evaluation of nedaplatin and paclitaxel in patients with metastatic esophageal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Paclitaxel; Prognosis; Survival Rate; Treatment Outcome | 2009 |
[Safety of adjuvant dose-dense chemotherapy with paclitaxel and epirubicin for high-risk breast cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Epirubicin; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Lymphatic Metastasis; Mastectomy; Middle Aged; Nausea; Neoplasm Recurrence, Local; Neoplastic Cells, Circulating; Neutropenia; Paclitaxel; Survival Rate; Vomiting; Young Adult | 2008 |
Phase I pharmacokinetic study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Humans; Infusions, Intravenous; Injections, Intraperitoneal; Lymphatic Metastasis; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Oxonic Acid; Paclitaxel; Peritoneal Neoplasms; Stomach Neoplasms; Tegafur; Tissue Distribution; Treatment Outcome | 2009 |
[Non-small cell lung cancer (NSCLC) stage IIIA/IIIB. A pilot study of neoadjuvant chemotherapy with paclitaxel and carboplatin].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Dose Fractionation, Radiation; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Pilot Projects; Pneumonectomy; Prospective Studies; Radiotherapy, Adjuvant | 1997 |
Final results of sequential doxorubicin plus gemcitabine and ifosfamide, paclitaxel, and cisplatin chemotherapy in patients with metastatic or locally advanced transitional cell carcinoma of the urothelium.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Disease-Free Survival; Doxorubicin; Female; Gemcitabine; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Paclitaxel; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms; Urothelium | 2009 |
Second-line chemotherapy with biweekly paclitaxel after failure of fluoropyrimidine-based treatment in patients with advanced or recurrent gastric cancer: a report from the gastrointestinal oncology group of the Tokyo cooperative oncology group, TCOG GC-0
Topics: Aged; Anorexia; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Drug Administration Schedule; Drug Resistance, Neoplasm; Fatigue; Female; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Peripheral Nervous System Diseases; Pyrimidines; Stomach Neoplasms; Tokyo; Treatment Outcome | 2009 |
Salvage chemotherapy with paclitaxel and gemcitabine plus nedaplatin (TGN) as part of multidisciplinary therapy in patients with heavily pretreated cisplatin-refractory germ cell tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Catheter Ablation; Cisplatin; Deoxycytidine; Disease-Free Survival; Drug Resistance, Neoplasm; Gemcitabine; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Paclitaxel; Radiosurgery; Radiotherapy, Adjuvant; Salvage Therapy; Time Factors; Treatment Outcome; Young Adult | 2009 |
A phase I trial of paclitaxel and trastuzumab in combination with interleukin-12 in patients with HER2/neu-expressing malignancies.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Chemokine CXCL10; Chemokine CXCL9; Cohort Studies; Drug Synergism; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Interferon-gamma; Interleukin-12; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neoplasms; Paclitaxel; Phosphorylation; Receptor, ErbB-2; Trastuzumab; Treatment Outcome | 2009 |
Cyclophosphamide, epirubicin, and Fluorouracil versus dose-dense epirubicin and cyclophosphamide followed by Paclitaxel versus Doxorubicin and cyclophosphamide followed by Paclitaxel in node-positive or high-risk node-negative breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Middle Aged; Paclitaxel | 2010 |
Weekly paclitaxel plus carboplatin is an effective nonanthracycline-containing regimen as neoadjuvant chemotherapy for breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Female; Humans; Immunoenzyme Techniques; In Situ Hybridization, Fluorescence; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Receptors, Estrogen; Receptors, Progesterone; Survival Rate; Treatment Outcome | 2010 |
Paclitaxel, cisplatin and gemcitabine in treatment of carcinomas of unknown primary site, a phase II study.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Neoplasms; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Risk Factors; Treatment Outcome | 2010 |
Intense dose-dense sequential chemotherapy with epirubicin, paclitaxel, and cyclophosphamide compared with conventionally scheduled chemotherapy in high-risk primary breast cancer: mature results of an AGO phase III study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Female; Humans; Lymphatic Metastasis; Middle Aged; Paclitaxel; Treatment Outcome; Young Adult | 2010 |
Akt phosphorylation at Ser473 predicts benefit of paclitaxel chemotherapy in node-positive breast cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Immunoenzyme Techniques; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Paclitaxel; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Serine; Tissue Array Analysis; Treatment Outcome | 2010 |
Phase III multicenter trial of doxorubicin plus cyclophosphamide followed by paclitaxel compared with doxorubicin plus paclitaxel followed by weekly paclitaxel as adjuvant therapy for women with high-risk breast cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Paclitaxel; Risk Factors; Survival Rate; Treatment Outcome; Young Adult | 2010 |
Adjuvant carboplatin-based chemotherapy in resected stage IIIA-N2 non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Squamous Cell; Paclitaxel; Survival Rate; Treatment Outcome; Vinblastine; Vinorelbine | 2010 |
Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Humans; Ifosfamide; Kaplan-Meier Estimate; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Penile Neoplasms; Predictive Value of Tests; Prospective Studies; Radiotherapy, Adjuvant; Risk Factors; Treatment Outcome | 2010 |
A pilot study of adjuvant nanoparticle albumin-bound (nab) paclitaxel and cyclophosphamide, with trastuzumab in HER2-positive patients, in the treatment of early-stage breast cancer.
Topics: Adult; Aged; Albumins; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Feasibility Studies; Female; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Middle Aged; Nanoparticles; Neoplasm Staging; Paclitaxel; Pilot Projects; Receptor, ErbB-2; Time Factors; Trastuzumab; Treatment Outcome; United States | 2010 |
[A prospective comparison between surgery alone and postoperative chemoradiotherapy for locally advanced esophageal squamous cell carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Esophageal Neoplasms; Esophagectomy; Female; Follow-Up Studies; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Prospective Studies; Radiotherapy, Adjuvant; Radiotherapy, High-Energy; Survival Rate | 2010 |
Preoperative concurrent paclitaxel-radiation in locally advanced breast cancer: pathologic response correlates with five-year overall survival.
Topics: Adult; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Chemotherapy, Adjuvant; Chi-Square Distribution; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Mastectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Proportional Hazards Models; Prospective Studies; Radiotherapy Dosage; Radiotherapy, Adjuvant; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; United States | 2010 |
[Efficacy and safety assessment of neoadjuvant paclitaxel and trastuzumab in Chinese women with Her-2 positive operable breast cancer].
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Asian People; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neutropenia; Paclitaxel; Receptor, ErbB-2; Remission Induction; Trastuzumab | 2010 |
Phase I study of pazopanib in combination with weekly paclitaxel in patients with advanced solid tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Indazoles; Lymphatic Metastasis; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Neoplasms; Paclitaxel; Pyrimidines; Sulfonamides; Survival Rate; Tissue Distribution; Treatment Outcome | 2010 |
Phase I study of biweekly intravenous paclitaxel plus intraperitoneal cisplatin and paclitaxel for gastric cancer with peritoneal metastasis.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Humans; Injections, Intraperitoneal; Injections, Intravenous; Lymphatic Metastasis; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Peritoneal Neoplasms; Prospective Studies; Stomach Neoplasms; Survival Rate; Treatment Outcome | 2010 |
Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Epirubicin; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Paclitaxel; Survival Rate; Treatment Outcome; Young Adult | 2011 |
A phase II multi-center study of triple therapy with paclitaxel, S-1 and cisplatin in patients with advanced gastric cancer.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Drug Combinations; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neutropenia; Oxonic Acid; Paclitaxel; Stomach Neoplasms; Survival Rate; Tegafur; Thrombocytopenia; Treatment Outcome | 2011 |
Phase II clinical trial with gemcitabine and paclitaxel sequential monotherapy as first-line treatment for advanced non-small-cell lung cancer (SLCG 01-04).
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Deoxycytidine; Female; Gemcitabine; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Survival Rate; Treatment Outcome | 2011 |
p53 Expression in node-positive breast cancer patients: results from the Cancer and Leukemia Group B 9344 Trial (159905).
Topics: Adult; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Humans; Immunohistochemistry; Lymphatic Metastasis; Middle Aged; Paclitaxel; Predictive Value of Tests; Prognosis; Tumor Suppressor Protein p53 | 2011 |
A randomized phase II study of paclitaxel and bevacizumab with and without gemcitabine as first-line treatment for metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Paclitaxel; Quality of Life; Survival Rate; Treatment Outcome | 2011 |
Phase II study of biweekly paclitaxel plus infusional 5-fluorouracil and leucovorin as first-line chemotherapy in patients with advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Peritoneal Neoplasms; Skin Neoplasms; Stomach Neoplasms; Survival Rate; Time Factors; Treatment Outcome | 2011 |
Prognostic factors in second-line treatment of urothelial cancers with gemcitabine and paclitaxel (German Association of Urological Oncology trial AB20/99).
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Decision Support Techniques; Deoxycytidine; Female; Gemcitabine; Germany; Hemoglobins; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Patient Selection; Regression Analysis; Risk Assessment; Risk Factors; Survival Analysis; Survival Rate; Time Factors; Treatment Outcome; Urologic Neoplasms; Urothelium; Vinblastine | 2011 |
Postoperative dose-dense sequential versus concomitant administration of epirubicin and paclitaxel in patients with node-positive breast cancer: 5-year results of the Hellenic Cooperative Oncology Group HE 10/00 phase III Trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Greece; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Proportional Hazards Models; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Young Adult | 2012 |
Vinorelbine versus paclitaxel for patients with advanced non-small cell lung cancer (NSCLC) and a performance status of 2.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Disease Progression; Female; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Small Cell Lung Carcinoma; Survival Rate; Treatment Outcome; Vinblastine; Vinorelbine | 2012 |
Radiation therapy oncology group protocol 02-29: a phase II trial of neoadjuvant therapy with concurrent chemotherapy and full-dose radiation therapy followed by surgical resection and consolidative therapy for locally advanced non-small cell carcinoma of
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Consolidation Chemotherapy; Disease-Free Survival; Female; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Pneumonectomy; Preoperative Care; Prospective Studies; Radiotherapy Dosage | 2012 |
Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Female; Humans; Hysterectomy; Intention to Treat Analysis; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Ovariectomy; Paclitaxel; Pelvis; Prospective Studies; Salpingectomy; Survival Analysis; Treatment Outcome; Uterine Cervical Neoplasms; Young Adult | 2012 |
Six cycles of doxorubicin and cyclophosphamide or Paclitaxel are not superior to four cycles as adjuvant chemotherapy for breast cancer in women with zero to three positive axillary nodes: Cancer and Leukemia Group B 40101.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Humans; Lymphatic Metastasis; Middle Aged; Paclitaxel; Risk Factors | 2012 |
Methotrexate-paclitaxel-epirubicin-carboplatin as second-line chemotherapy in patients with metastatic transitional cell carcinoma of the bladder pretreated with cisplatin-gemcitabine: a phase II study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Epirubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Staging; Paclitaxel; Prognosis; Prospective Studies; Salvage Therapy; Survival Rate; Urinary Bladder Neoplasms | 2013 |
Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epidermal gr
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; ErbB Receptors; Female; Follow-Up Studies; Heart Failure; Heart Function Tests; Humans; Lymphatic Metastasis; Middle Aged; Models, Statistical; Paclitaxel; Risk Factors; Trastuzumab | 2012 |
Randomized phase II study comparing paclitaxel with S-1 vs. S-1 as first-line treatment in patients with advanced gastric cancer.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Feasibility Studies; Female; Follow-Up Studies; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Oxonic Acid; Paclitaxel; Peritoneal Neoplasms; Prognosis; Stomach Neoplasms; Survival Rate; Tegafur; Young Adult | 2013 |
Recurrent gastric adenocarcinoma with unusual metastatic localization and excellent response to docetaxel and 5-FU continuous infusion.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Cisplatin; Docetaxel; Epirubicin; Fluorouracil; Humans; Infusions, Intravenous; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Spleen; Splenic Neoplasms; Stomach Neoplasms; Taxoids; Treatment Outcome | 2003 |
Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Lymphatic Metastasis; Middle Aged; Paclitaxel; Proportional Hazards Models; Treatment Outcome | 2003 |
Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Prognosis; Survival; Taxoids; Treatment Outcome | 2003 |
Weekly paclitaxel plus estramustine combination therapy in hormone-refractory prostate cancer: a pilot study.
Topics: Adenocarcinoma; Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Drug Administration Schedule; Estramustine; Humans; Infusions, Intravenous; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Pain; Pilot Projects; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Treatment Outcome | 2003 |
Intermittent chemotherapy in metastatic androgen-independent prostate cancer.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Calcitriol; Dexamethasone; Disease-Free Survival; Docetaxel; Humans; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Survival Rate; Taxoids | 2003 |
Adjuvant treatment of breast cancer patients with 1-3 positive lymph nodes: vinorelbine plus epirubicin; vinorelbine plus epirubicin sequential followed up by paclitaxel; epirubicin plus cyclophosphamide; epirubicin plus cyclophosphamide sequential follow
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Female; Humans; Lymphatic Metastasis; Middle Aged; Paclitaxel; Vinblastine; Vinorelbine | 2003 |
Are nodal metastases in ovarian cancer chemoresistant lesions? Analysis of nodal involvement in 105 patients treated with preoperative chemotherapy.
Topics: Adenocarcinoma, Mucinous; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Endometrioid; Cystadenocarcinoma, Serous; Drug Resistance, Neoplasm; Female; Humans; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Second-Look Surgery; Treatment Outcome | 2004 |
A phase II trial of preoperative concurrent radiation therapy and weekly paclitaxel/carboplatin for patients with locally advanced non-small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Paclitaxel; Pneumonectomy; Postoperative Complications; Survival Rate; Thoracotomy; United States | 2004 |
Combination of pegylated liposomal doxorubicin (PLD) and paclitaxel in patients with advanced soft tissue sarcoma: a phase II study of the Hellenic Cooperative Oncology Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Doxorubicin; Female; Histiocytoma, Benign Fibrous; Humans; Leiomyosarcoma; Liposarcoma; Liposomes; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Safety; Sarcoma; Survival Rate; Time Factors; Treatment Outcome | 2004 |
[A tolerability study of A cremophor-free albumin bound nanoparticle paclitaxel intravenously administered in patients with advanced solid tumor].
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Diplopia; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Maximum Tolerated Dose; Middle Aged; Nanotechnology; Nasopharyngeal Neoplasms; Neutropenia; Paclitaxel | 2004 |
Randomized parallel study of doxorubicin plus paclitaxel and doxorubicin plus cyclophosphamide as neoadjuvant treatment of patients with breast cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Infusions, Intravenous; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Treatment Outcome | 2004 |
A phase II study on the safety and efficacy of 5-fluorouracil, epirubicin, cyclophosphamide (FEC) followed by paclitaxel in the adjuvant treatment of breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Middle Aged; Neoplasms, Ductal, Lobular, and Medullary; Paclitaxel; Safety; Survival Rate; Treatment Outcome | 2005 |
Early prediction of response to chemotherapy in metastatic breast cancer using sequential 18F-FDG PET.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Cyclophosphamide; Epirubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Middle Aged; Paclitaxel; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Treatment Outcome | 2005 |
Bi-weekly chemotherapy of paclitaxel and cisplatin in patients with metastatic or recurrent esophageal cancer.
Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Diarrhea; Esophageal Neoplasms; Fatigue; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Paclitaxel; Survival Analysis; Thrombocytopenia; Time Factors; Treatment Outcome; Vomiting | 2005 |
Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast can
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Heart; Heart Failure; Humans; Incidence; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Receptor, ErbB-2; Trastuzumab; Ventricular Dysfunction, Left | 2005 |
Erlotinib and chemoradiation followed by maintenance erlotinib for locally advanced pancreatic cancer: a phase I study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deoxycytidine; ErbB Receptors; Erlotinib Hydrochloride; Female; Follow-Up Studies; Gastrointestinal Diseases; Gemcitabine; Hematologic Diseases; Humans; Life Tables; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Proteins; Paclitaxel; Pancreatectomy; Pancreatic Neoplasms; Quinazolines; Radiotherapy, Conformal; Survival Analysis; Treatment Outcome | 2005 |
Five-year update of an expanded phase II study of dose-dense and -intense doxorubicin, paclitaxel and cyclophosphamide (ATC) in high-risk breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Paclitaxel; Time Factors | 2005 |
Phase II trial of low-dose paclitaxel and cisplatin in patients with advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Paclitaxel; Peritoneal Neoplasms; Stomach Neoplasms; Vomiting, Anticipatory | 2005 |
[A randomized controlled trail of taxol-based combination regimens for advanced gastric cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorouracil; Humans; Leucovorin; Leukopenia; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Prospective Studies; Remission Induction; Stomach Neoplasms; Thrombocytopenia | 2005 |
Paclitaxel and leucovorin-modulated infusional 5-fluorouracil combination chemotherapy for metastatic gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Diarrhea; Disease Progression; Female; Fluorouracil; Humans; Infusions, Intravenous; Leucovorin; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Mucositis; Multivariate Analysis; Neutropenia; Paclitaxel; Prognosis; Stomach Neoplasms; Survival Analysis; Treatment Outcome | 2006 |
Randomised trial: survival benefit and safety of adjuvant dose-dense chemotherapy for node-positive breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Epirubicin; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Lymphatic Metastasis; Mastectomy, Segmental; Methotrexate; Middle Aged; Paclitaxel; Prognosis | 2006 |
Measuring tumor response and shape change on CT: esophageal cancer as a paradigm.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bryostatins; Esophageal Neoplasms; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Macrolides; Male; Middle Aged; Neoplasm Staging; Neoplasms; Paclitaxel; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
Paclitaxel and epirubicin followed by cyclophosphamide, methotrexate and 5-fluorouracil for patients with stage IIIC breast cancer with ten or more involved axillary lymph nodes.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Paclitaxel; Survival Analysis | 2006 |
[Adjuvant doxorubicin and cyclophosphamide followed by weekly paclitaxel for Japanese women with node-positive breast cancer: a multi-institutional feasibility study in a variety of practice settings in Kyushu].
Topics: Adult; Aged; Alopecia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Feasibility Studies; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Mastectomy, Segmental; Middle Aged; Neutropenia; Paclitaxel; Vomiting, Anticipatory | 2006 |
Efficacy and tolerability of capecitabine with weekly paclitaxel for patients with metastatic breast cancer: a phase II report of the SAKK.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Deoxycytidine; Female; Fluorouracil; Humans; Lymphatic Metastasis; Maximum Tolerated Dose; Middle Aged; Paclitaxel; Survival Rate; Treatment Outcome | 2006 |
[A phase II study of weekly paclitaxel for advanced or recurrent breast cancer].
Topics: Adult; Aged; Alopecia; Antiemetics; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Breast Neoplasms; Dexamethasone; Diphenhydramine; Drug Administration Schedule; Female; Humans; Leukopenia; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Ranitidine; Survival Rate | 2007 |
Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: the Cancer and Leukemia Group B Experience.
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Humans; Leukemia, Myeloid, Acute; Lymphatic Metastasis; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Paclitaxel | 2007 |
[Prospective non-randomized study of chemotherapy combined with radiotherapy versus chemotherapy alone in patients with metastatic or relapsed esophageal squamous cell carcinoma].
Topics: Adolescent; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Fatigue; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neutropenia; Paclitaxel; Prospective Studies; Radiotherapy; Radiotherapy, High-Energy; Survival Analysis | 2007 |
Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00.
Topics: Adult; Aged; Androstadienes; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Epirubicin; Estrogens; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasms, Hormone-Dependent; Neoplasms, Second Primary; Paclitaxel; Peripheral Nervous System Diseases; Tamoxifen | 2008 |
Dose-escalation of filgrastim does not improve efficacy: clinical tolerability and long-term follow-up on CALGB study 9141 adjuvant chemotherapy for node-positive breast cancer patients using dose-intensified doxorubicin plus cyclophosphamide followed by
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Filgrastim; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Lymphatic Metastasis; Middle Aged; Paclitaxel; Pilot Projects; Recombinant Proteins | 2008 |
Phase II study of weekly albumin-bound paclitaxel for patients with metastatic breast cancer heavily pretreated with taxanes.
Topics: Abdominal Neoplasms; Adult; Aged; Albumin-Bound Paclitaxel; Albumins; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Breast Neoplasms; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Metastasis; Paclitaxel; Survival Analysis; Taxoids; Treatment Outcome | 2007 |
Multi-center phase II study for combination therapy with paclitaxel/doxifluridine to treat advanced/recurrent gastric cancer showing resistance to S-1 (OGSG 0302).
Topics: Adenocarcinoma; Aged; Anemia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Drug Combinations; Drug Resistance, Neoplasm; Female; Floxuridine; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Oxonic Acid; Paclitaxel; Peritoneal Neoplasms; Stomach Neoplasms; Survival Rate; Tegafur; Thrombocytopenia | 2008 |
Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: results of a retrospective non-randomized study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Disease-Free Survival; Esophageal Neoplasms; Female; Humans; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Premedication; Prognosis; Radiation Dosage; Radiotherapy, Adjuvant; Treatment Outcome | 2008 |
Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Cohort Studies; Combined Modality Therapy; Drug Administration Schedule; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Follow-Up Studies; Humans; In Vitro Techniques; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Prognosis; Prospective Studies | 2008 |
Memorial Sloan-Kettering Cancer Center experience with paclitaxel in the treatment of breast cancer: from advanced disease to adjuvant therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cancer Care Facilities; Chemotherapy, Adjuvant; Female; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Lymphatic Metastasis; Neoplasm Metastasis; New York City; Paclitaxel; Quality of Life; Remission Induction; Survival Rate | 1995 |
Concurrent paclitaxel and thoracic radiation for advanced non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Radiotherapy; Radiotherapy Dosage | 1995 |
A late phase II study of RP56976 (docetaxel) in patients with advanced or recurrent breast cancer.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Breast Neoplasms; Carcinoma, Medullary; Carcinoma, Papillary; Docetaxel; Female; Humans; Infusions, Intravenous; Leukopenia; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Paclitaxel; Taxoids; Toxicity Tests | 1996 |
New sequential dosing regimen shows promise in node-positive breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Lymphatic Metastasis; Paclitaxel; Receptors, Granulocyte Colony-Stimulating Factor; Treatment Outcome | 1996 |
Prospective randomized trial of paclitaxel alone versus 5-fluorouracil/doxorubicin/cyclophosphamide as induction therapy in patients with operable breast cancer.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Fluorouracil; Humans; Lymphatic Metastasis; Middle Aged; Paclitaxel; Prospective Studies | 1997 |
Squamous cell granulomas of the neck: histologic regression of metastatic squamous cell carcinoma following chemotherapy and/or radiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Culture Techniques; Diagnosis, Differential; Female; Fibrosis; Fluorouracil; Granuloma, Foreign-Body; Head and Neck Neoplasms; Humans; Immunohistochemistry; Lymphatic Metastasis; Male; Middle Aged; Neck; Neck Dissection; Neoplasm Staging; Paclitaxel; Radiotherapy, Adjuvant; Registries; Remission Induction; Tirapazamine; Triazines | 1998 |
[Late phase II clinical study of RP56976 (docetaxel) in patients with advanced/recurrent gastric cancer: a Japanese Cooperative Study Group trial (group A)].
Topics: Adult; Aged; Alopecia; Antineoplastic Agents, Phytogenic; Docetaxel; Female; Fever; Humans; Leukopenia; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Paclitaxel; Stomach Neoplasms; Taxoids; Vomiting | 1998 |
[A late phase II clinical study of RP56976 (docetaxel) in patients with advanced or recurrent gastric cancer: a cooperative study group trial (group B)].
Topics: Adenocarcinoma; Adult; Aged; Alopecia; Anorexia; Antineoplastic Agents, Phytogenic; Docetaxel; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leukopenia; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Nausea; Paclitaxel; Stomach Neoplasms; Taxoids; Vomiting, Anticipatory | 1999 |
Phase II study of docetaxel in patients with metastatic pancreatic cancer: a Japanese cooperative study. Cooperative Group of Docetaxel for Pancreatic Cancer in Japan.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Ductal, Breast; Docetaxel; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Ovarian Neoplasms; Paclitaxel; Pancreatic Neoplasms; Taxoids | 1999 |
[Docetaxel therapy against anthracycline resistant breast cancer].
Topics: Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Lymphatic Metastasis; Middle Aged; Paclitaxel; Taxoids | 1999 |
Dose intensification of mitoxantrone in combination with paclitaxel in advanced breast cancer: a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease Progression; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Lymphatic Metastasis; Middle Aged; Mitoxantrone; Neoplasm Metastasis; Neoplasm Staging; Paclitaxel; Survival Analysis; Time Factors | 1999 |
[Docetaxel as a single agent in cases of advanced/recurrent breast cancer previously treated with anthracycline].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Paclitaxel; Remission Induction; Taxoids | 1999 |
Docetaxel and cisplatin combination chemotherapy in advanced carcinoma of the urothelium: a multicenter phase II study of the Hellenic Cooperative Oncology Group.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Docetaxel; Female; Follow-Up Studies; Greece; Humans; Linear Models; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Remission Induction; Severity of Illness Index; Survival Rate; Taxoids; Treatment Outcome; Urinary Bladder Neoplasms; Urologic Neoplasms; Urothelium | 1999 |
Combined radiochemotherapy with docetaxel in patients with unresectable locally advanced head and neck tumors.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Docetaxel; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Radiotherapy Dosage; Taxoids; Time Factors; Treatment Outcome | 2000 |
A feasibility study evaluating docetaxel-based sequential and combination regimens in the adjuvant therapy of node-positive breast cancer.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Confidence Intervals; Cyclophosphamide; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Feasibility Studies; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Staging; Paclitaxel; Survival Rate; Taxoids; Treatment Outcome | 2000 |
A phase II study of paclitaxel, weekly, 24-hour continous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Female; Fluorouracil; Humans; Infusions, Intravenous; Leucovorin; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Peritoneal Neoplasms; Stomach Neoplasms; Survival Analysis | 2000 |
The correlation of axillary ultrasonography with histologic breast cancer downstaging after induction chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biopsy, Needle; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Paclitaxel; Physical Examination; Premedication; Prospective Studies; Ranitidine; Remission Induction; Sensitivity and Specificity; Ultrasonography | 2000 |
Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biopsy, Needle; Breast Neoplasms; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Predictive Value of Tests; Sentinel Lymph Node Biopsy; Tamoxifen; Taxoids | 2000 |
Docetaxel and ifosfamide as second line treatment for patients with advanced or metastatic urothelial cancer after failure of platinum chemotherapy: a phase 2 study.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Disease-Free Survival; Docetaxel; Female; Humans; Ifosfamide; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Prospective Studies; Taxoids; Treatment Failure; Urologic Neoplasms | 2001 |
An evaluation of two techniques for beam intensity modulation in patients irradiated for stage III non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Dose Fractionation, Radiation; Esophagus; Follow-Up Studies; Heart; Humans; Lung Neoplasms; Lymphatic Metastasis; Mediastinum; Neoplasm Staging; Paclitaxel; Particle Accelerators; Radiation Pneumonitis; Radiotherapy Dosage; Radiotherapy, Conformal; Radiotherapy, High-Energy; Treatment Outcome | 2001 |
High-dose paclitaxel in combination with doxorubicin, cyclophosphamide and peripheral blood progenitor cell rescue in patients with high-risk primary and responding metastatic breast carcinoma: toxicity profile, relationship to paclitaxel pharmacokinetics
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Paclitaxel; Peripheral Nervous System Diseases; Treatment Outcome | 2001 |
Doxorubicin followed by sequential paclitaxel and cyclophosphamide versus concurrent paclitaxel and cyclophosphamide: 5-year results of a phase II randomized trial of adjuvant dose-dense chemotherapy for women with node-positive breast carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Hospitalization; Humans; Lymphatic Metastasis; Mammography; Mastectomy, Modified Radical; Middle Aged; Paclitaxel | 2001 |
Weekly administration of gemcitabine plus docetaxel in patients with advanced breast cancer: a phase 1 study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Female; Gemcitabine; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Paclitaxel; Taxoids; Treatment Outcome; World Health Organization | 2002 |
[Weekly paclitaxel therapy for metastatic breast cancer].
Topics: Aged; Alopecia; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leukopenia; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Paclitaxel | 2002 |
Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Gastrointestinal Diseases; Hematologic Diseases; Humans; Leucovorin; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Stomach Neoplasms; Survival Rate; Time Factors | 2002 |
334 other study(ies) available for paclitaxel and Lymph Node Metastasis
| Article | Year |
|---|---|
Shorter duration of first-line chemotherapy reflects poorer outcomes in patients with HER2-negative advanced breast cancer: a multicenter retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Female; Follow-Up Studies; Furans; Humans; Ketones; Lymphatic Metastasis; Middle Aged; Paclitaxel; Prognosis; Receptor, ErbB-2; Retrospective Studies; Survival Rate | 2021 |
Adjuvant treatment with paclitaxel plus trastuzumab for node-negative breast cancer: real-life experience.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Receptor, ErbB-2; Retrospective Studies; Trastuzumab | 2022 |
Paclitaxel treatment enhances lymphatic metastasis of B16F10 melanoma cells via CCL21/CCR7 axis.
Topics: Animals; Cell Line, Tumor; Cell Movement; Chemokine CCL21; Ligands; Lymphatic Metastasis; Melanoma; Mice; Paclitaxel; Receptors, CCR7 | 2022 |
[A Case of Meningeal Carcinomatosis of Gastric Cancer Successfully Controlled with Nab-Paclitaxel].
Topics: Aged; Albumins; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Lymphatic Metastasis; Meningeal Carcinomatosis; Paclitaxel; Stomach Neoplasms | 2022 |
A core-satellite micellar system against primary tumors and their lymphatic metastasis through modulation of fatty acid metabolism blockade and tumor-associated macrophages.
Topics: Breast Neoplasms; Fatty Acids; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Matrix Metalloproteinase 2; Micelles; Paclitaxel; Tumor Microenvironment; Tumor-Associated Macrophages | 2023 |
Neoadjuvant chemotherapy does not improve the prognosis and lymph node metastasis rate of locally advanced cervical squamous cell carcinoma: A retrospective cohort study in China.
Topics: Adult; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; China; Female; Follow-Up Studies; Humans; Hysterectomy; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Prognosis; Progression-Free Survival; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms | 2019 |
Conversion surgery for positive peritoneal washing cytology in pancreatic cancer.
Topics: Adenocarcinoma; Albumins; Antineoplastic Agents; Cytodiagnosis; Deoxycytidine; Gemcitabine; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Pancreatectomy; Pancreatic Neoplasms; Peritoneum; Treatment Outcome | 2019 |
Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; BRCA2 Protein; Carcinoma, Pancreatic Ductal; Case-Control Studies; Cisplatin; Deoxycytidine; Fanconi Anemia Complementation Group N Protein; Female; Fluorouracil; Gemcitabine; Germ-Line Mutation; Humans; Irinotecan; Leucovorin; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Pancreatic Neoplasms; Prognosis; Progression-Free Survival; Retrospective Studies | 2020 |
Paclitaxel induces lymphatic endothelial cells autophagy to promote metastasis.
Topics: Autophagy; Breast Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Chloroquine; Drug Resistance, Neoplasm; Endothelial Cells; Female; Humans; Lymphatic Metastasis; Lysosomes; Paclitaxel; Proto-Oncogene Proteins c-akt; Sentinel Lymph Node | 2019 |
Triplet chemotherapy vs doublet chemotherapy plus bevacizumab in metastatic, recurrent, and persistent cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Cisplatin; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Prognosis; Retrospective Studies; Survival Rate; Uterine Cervical Neoplasms | 2020 |
Consolidation chemotherapy in early-stage cervical cancer patients with lymph node metastasis after radical hysterectomy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Consolidation Chemotherapy; Docetaxel; Female; Humans; Hysterectomy; Liposomes; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Paclitaxel; Retrospective Studies; Uterine Cervical Neoplasms | 2020 |
Tumor volume regression during neoadjuvant chemoradiotherapy for esophageal cancer: a prospective study with weekly MRI.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dose Fractionation, Radiation; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Prospective Studies; Time Factors; Tumor Burden | 2020 |
Computed tomography reconstruction for evaluating response in axillary lymph nodes of breast cancer after neoadjuvant chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multidetector Computed Tomography; Neoadjuvant Therapy; Neoplasm, Residual; Paclitaxel; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome | 2021 |
Tailored radical hysterectomy for locally advanced cervical cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Female; Humans; Hysterectomy; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Organ Sparing Treatments; Paclitaxel; Peripheral Nerves; Retrospective Studies; Survival Rate; Uterine Cervical Neoplasms | 2020 |
ATIP3 deficiency facilitates intracellular accumulation of paclitaxel to reduce cancer cell migration and lymph node metastasis in breast cancer patients.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Drug Resistance, Neoplasm; Female; Gene Silencing; HeLa Cells; Humans; Lymphatic Metastasis; Microtubules; Paclitaxel; Tumor Suppressor Proteins | 2020 |
Comparison of FOLFIRINOX and Gemcitabine Plus Nab-paclitaxel for Treatment of Metastatic Pancreatic Cancer: Using Korean Pancreatic Cancer (K-PaC) Registry.
Topics: Aged; Albumins; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Pancreatic Ductal; Cross-Over Studies; Deoxycytidine; Febrile Neutropenia; Female; Fluorouracil; Gemcitabine; Humans; Irinotecan; Leucovorin; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Oxaliplatin; Paclitaxel; Pancreatic Neoplasms; Peripheral Nervous System Diseases; Peritoneal Neoplasms; Progression-Free Survival; Registries; Republic of Korea; Survival Rate; Treatment Outcome | 2020 |
Sirtuin2 correlates with lymph node metastasis, increased FIGO stage, worse overall survival, and reduced chemosensitivity to cisplatin and paclitaxel in endometrial cancer.
Topics: Cisplatin; Endometrial Neoplasms; Female; Humans; Lymphatic Metastasis; Neoplasm Staging; Paclitaxel; Prognosis; Retrospective Studies | 2022 |
Chemoradiotherapy by intensity-modulated radiation therapy with simultaneous integrated boost in locally advanced or oligometastatic non-small-cell lung cancer-a two center experience.
Topics: Adult; Aged; Aged, 80 and over; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Cone-Beam Computed Tomography; Female; Follow-Up Studies; Four-Dimensional Computed Tomography; Hematologic Diseases; Humans; Lung Neoplasms; Lymphatic Irradiation; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Positron Emission Tomography Computed Tomography; Progression-Free Survival; Radiation Injuries; Radiation Pneumonitis; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated; Retrospective Studies; Tumor Burden; Vinorelbine | 2021 |
Outcomes of trimodality CROSS regimen in older adults with locally advanced esophageal cancer.
Topics: Adenocarcinoma; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Esophageal Neoplasms; Esophagectomy; Female; Humans; Length of Stay; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Patient Compliance; Postoperative Complications; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Time Factors | 2021 |
Modified weekly regimen of cisplatin, epirubicin and paclitaxel induced a durable response in two cases of metastatic extramammary Paget's disease.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Drug Administration Schedule; Epirubicin; Genital Neoplasms, Male; Groin; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Paclitaxel; Paget Disease, Extramammary; Scrotum; Skin Neoplasms; Treatment Outcome | 2017 |
Treatment of esophageal cancer with radiation therapy -a pan-Chinese survey of radiation oncologists.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; China; Cisplatin; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Female; Fluorouracil; Four-Dimensional Computed Tomography; Humans; Lymphatic Metastasis; Paclitaxel; Postoperative Care; Practice Patterns, Physicians'; Preoperative Care; Radiation Oncologists; Radiotherapy Planning, Computer-Assisted; Surveys and Questionnaires | 2017 |
Subtypes of stage IV ovarian cancer; response to treatment and patterns of disease recurrence.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Ovarian Epithelial; Chemotherapy, Adjuvant; Cytoreduction Surgical Procedures; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Cystic, Mucinous, and Serous; Neoplasms, Glandular and Epithelial; New Zealand; Ovarian Neoplasms; Paclitaxel; Pleural Effusion, Malignant; Prognosis; Retrospective Studies; Treatment Outcome | 2017 |
Long-term outcome of concurrent chemoradiotherapy with elective nodal irradiation for inoperable esophageal cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Esophageal Neoplasms; Female; Humans; Kaplan-Meier Estimate; Lymph Nodes; Lymphatic Irradiation; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Paclitaxel; Proportional Hazards Models; Retrospective Studies; Salvage Therapy; Treatment Outcome | 2017 |
Retrospective cohort analysis of neoadjuvant treatment and survival in resectable and borderline resectable pancreatic ductal adenocarcinoma in a high volume referral centre.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Pancreatic Ductal; Chemoradiotherapy, Adjuvant; Deoxycytidine; Female; Gemcitabine; Hospitals, High-Volume; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm, Residual; Paclitaxel; Pancreatic Neoplasms; Positron-Emission Tomography; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Survival Rate | 2017 |
High STMN1 Expression is Associated with Cancer Progression and Chemo-Resistance in Lung Squamous Cell Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Apoptosis; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Paclitaxel; Prognosis; RNA, Small Interfering; Stathmin; Survival Rate | 2017 |
A comparative study of neoadjuvant treatment with gemcitabine plus nab-paclitaxel versus surgery first for pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Albumins; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Pancreatectomy; Pancreatic Neoplasms; Prognosis; Prospective Studies; Survival Rate | 2017 |
Long-term complete response to carboplatin plus paclitaxel combined with bevacizumab in a patient with metastatic spindle cell carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bone Neoplasms; Carboplatin; Carcinoma; Drug Administration Schedule; Humans; Lung Neoplasms; Lymphatic Metastasis; Maintenance Chemotherapy; Male; Middle Aged; Neoplasm Invasiveness; Paclitaxel; Pleural Neoplasms; Proteinuria; Tomography, X-Ray Computed; Treatment Outcome; Withholding Treatment | 2017 |
miR-613 inhibits cell migration and invasion by downregulating Daam1 in triple-negative breast cancer.
Topics: 3' Untranslated Regions; Adaptor Proteins, Signal Transducing; Cell Line, Tumor; Cell Movement; Cyclophosphamide; Docetaxel; Down-Regulation; Doxorubicin; Female; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Kaempferols; Lymphatic Metastasis; MCF-7 Cells; Microfilament Proteins; MicroRNAs; Neoplasm Invasiveness; Paclitaxel; rho GTP-Binding Proteins; rhoA GTP-Binding Protein; Signal Transduction; Triple Negative Breast Neoplasms | 2018 |
[Combination Chemotherapy Including Intraperitoneal(IP)Administration of Paclitaxel(PTX)followed by PTX, CDDP and S-1Triplet Chemotherapy for CY1P0 Gastric Cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; Humans; Infusions, Parenteral; Lymphatic Metastasis; Male; Middle Aged; Oxonic Acid; Paclitaxel; Stomach Neoplasms; Tegafur | 2017 |
[A Case of Gemcitabine and Nab-Paclitaxel Therapy for Multiple Metastatic Pancreatic Cancer].
Topics: Albumins; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Fatal Outcome; Gemcitabine; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Pancreatic Neoplasms | 2017 |
Hypoxia-Induced TPM2 Methylation is Associated with Chemoresistance and Poor Prognosis in Breast Cancer.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Hypoxia; Cell Line, Tumor; DNA; DNA Methylation; Down-Regulation; Drug Resistance, Neoplasm; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lymphatic Metastasis; Matrix Metalloproteinase 2; MCF-7 Cells; Middle Aged; Paclitaxel; Prognosis; Promoter Regions, Genetic; RNA Interference; Tropomyosin | 2018 |
Rates, Sites and Times of Recurrence and Clinical Outcome of Endometrial Cancer Patients with Histologically-positive Nodes: An Italian Two-center Retrospective Study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Endometrial Neoplasms; Female; Humans; Italy; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Radiotherapy, Adjuvant; Retrospective Studies | 2018 |
Effective treatment of the primary tumor and lymph node metastasis by polymeric micelles with variable particle sizes.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Delivery Systems; Lymphatic Metastasis; Mice, Inbred BALB C; Micelles; Neoplasms; Paclitaxel; Particle Size; Phosphatidylethanolamines; Polyethylene Glycols | 2018 |
[Salvage Surgery after Radical Chemotherapy for N3 Non-small Cell Lung Cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Salvage Therapy; Treatment Outcome | 2018 |
[A Case of Locally Advanced and Metastatic Breast Cancer Treated with Preoperative Bevacizumab Combination Chemotherapy That Attained Local Control].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Lymphatic Metastasis; Mastectomy; Neoplasm Staging; Paclitaxel | 2018 |
Chemoradiation and the Role of Adjuvant Chemotherapy in Lymph Nodal-Metastatic Cervical Cancer.
Topics: Adult; Antineoplastic Agents; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Chemotherapy, Adjuvant; Female; Humans; Lymphatic Metastasis; Middle Aged; Paclitaxel; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2018 |
Intraperitoneal Administration of Paclitaxel Followed by Paclitaxel, Cisplatin, and S-1 Chemotherapy for Cytology-positive Gastric Cancer: A Feasibility Study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Feasibility Studies; Female; Follow-Up Studies; Humans; Injections, Intraperitoneal; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Oxonic Acid; Paclitaxel; Peritoneal Neoplasms; Prognosis; Prospective Studies; Stomach Neoplasms; Survival Rate; Tegafur | 2018 |
Prognostic factors in patients with metastatic or recurrent pancreatic cancer treated with first-line nab-paclitaxel plus gemcitabine: implication of inflammation-based scores.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Blood Platelets; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Humans; Inflammation; Liver Neoplasms; Lymphatic Metastasis; Lymphocytes; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neutrophils; Paclitaxel; Pancreatic Neoplasms; Prognosis; Retrospective Studies; Survival Rate | 2019 |
Paclitaxel, 5-fluorouracil, and leucovorin combination chemotherapy as first-line treatment in patients with advanced gastric cancer.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Rate; Young Adult | 2019 |
[A Case of Successful Control of Advanced Duodenal Cancer with Liver Metastasis Receiving Paclitaxel Chemotherapy and Potential Radical Resection].
Topics: Aged; Antineoplastic Agents, Phytogenic; Duodenal Neoplasms; Female; Humans; Liver Neoplasms; Lymphatic Metastasis; Paclitaxel; Positron Emission Tomography Computed Tomography | 2018 |
Nomograms predicting survival and patterns of failure in patients with cervical cancer treated with concurrent chemoradiotherapy: A special focus on lymph nodes metastases.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Calibration; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Nomograms; Paclitaxel; Pelvis; Proportional Hazards Models; Uterine Cervical Neoplasms; Young Adult | 2019 |
YWHAE promotes proliferation, metastasis, and chemoresistance in breast cancer cells.
Topics: 14-3-3 Proteins; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Doxorubicin; Drug Resistance, Neoplasm; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Lymphatic Metastasis; MCF-7 Cells; Middle Aged; Neoplasm Grading; Nuclear Proteins; Paclitaxel; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; RNA, Small Interfering; Snail Family Transcription Factors; Survival Analysis; Tumor Burden; Twist-Related Protein 1 | 2019 |
High expression of survivin predicts poor prognosis in cervical squamous cell carcinoma treated with paclitaxel and carboplatin.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; China; Female; Humans; Ki-67 Antigen; Lymphatic Metastasis; Middle Aged; Neoplasm Grading; Paclitaxel; Retrospective Studies; Survivin; Tumor Burden; Uterine Cervical Neoplasms; Vascular Endothelial Growth Factor A | 2019 |
Adjuvant combined-modality therapy for stage IIIC endometrioid and non-endometrioid endometrial cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Endometrioid; Chemoradiotherapy, Adjuvant; Cisplatin; Endometrial Neoplasms; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Paclitaxel; Prognosis; Retrospective Studies; Treatment Outcome | 2019 |
The efficacy and safety of nab paclitaxel plus gemcitabine in elderly patients over 75 years with unresectable pancreatic cancer compared with younger patients.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Pancreatic Neoplasms; Patient Safety; Peritoneal Neoplasms; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome | 2019 |
Early assessment of axillary response with ¹⁸F-FDG PET/CT during neoadjuvant chemotherapy in stage II-III breast cancer: implications for surgical management of the axilla.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Axilla; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Paclitaxel; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; ROC Curve; Trastuzumab | 2013 |
Vulvar and vaginal melanoma: case series and review of current management options including neoadjuvant chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Dacarbazine; Female; Humans; Lymphatic Metastasis; Melanoma; Neoadjuvant Therapy; Paclitaxel; Survival Rate; Temozolomide; Treatment Outcome; Vaginal Neoplasms; Vulvar Neoplasms | 2013 |
Breast-conserving surgery after tumor downstaging by neoadjuvant chemotherapy is oncologically safe for stage III breast cancer patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Docetaxel; Doxorubicin; Female; Fluorouracil; Humans; Ki-67 Antigen; Lymphatic Metastasis; Mastectomy, Segmental; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Survival Rate; Taxoids | 2013 |
Lung resistance-related protein (LRP) expression in malignant ascitic cells as a prognostic marker for advanced ovarian serous carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biomarkers, Tumor; Blotting, Western; Carboplatin; Cystadenocarcinoma, Serous; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Immunoenzyme Techniques; Lymphatic Metastasis; Microfilament Proteins; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Prognosis; Survival Rate; Tumor Cells, Cultured; Vault Ribonucleoprotein Particles | 2013 |
Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: a Gynecologic Oncology Group study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Ovarian Epithelial; Cisplatin; Cyclophosphamide; Disease-Free Survival; Female; Humans; Infusions, Parenteral; Lymphatic Metastasis; Middle Aged; Multicenter Studies as Topic; Multivariate Analysis; Neoplasm Staging; Neoplasm, Residual; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Prognosis; Randomized Controlled Trials as Topic; Retrospective Studies; Survival Rate | 2013 |
Prognostic potential of ERCC1 protein expression and clinicopathologic factors in stage III/N2 non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Chi-Square Distribution; Cisplatin; Deoxycytidine; DNA-Binding Proteins; Female; Gemcitabine; Humans; Immunohistochemistry; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Pneumonectomy; Prognosis; Proportional Hazards Models; Retrospective Studies; Survival Rate; Treatment Outcome | 2013 |
Vulvar adenocarcinoma: visual resemblance to a vulvar abscess.
Topics: Abscess; Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Diagnosis, Differential; Fatal Outcome; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Paclitaxel; Vulvar Diseases; Vulvar Neoplasms | 2013 |
Postoperative radiation therapy with or without concurrent chemotherapy for node-positive thoracic esophageal squamous cell carcinoma.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Esophageal Neoplasms; Esophagectomy; Female; Follow-Up Studies; Humans; Lymph Node Excision; Lymphatic Irradiation; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Postoperative Period; Radiotherapy; Retrospective Studies; Survival Rate; Young Adult | 2013 |
Outcomes of induction chemotherapy followed by chemoradiation using intensity-modulated radiation therapy for esophageal adenocarcinoma.
Topics: Adenocarcinoma; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemoradiotherapy, Adjuvant; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Humans; Induction Chemotherapy; Irinotecan; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Paclitaxel; Platinum Compounds; Radiotherapy, Intensity-Modulated; Survival Rate; Tumor Burden | 2014 |
Postoperative external beam radiation therapy and concurrent cisplatin followed by carboplatin/paclitaxel for stage III (FIGO 2009) endometrial cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Endometrial Neoplasms; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Paclitaxel; Patient Compliance; Radiotherapy, Intensity-Modulated; Retrospective Studies; Survival Rate | 2013 |
Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Combined Modality Therapy; Drug Combinations; Female; Follow-Up Studies; Humans; Injections, Intraperitoneal; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Oxonic Acid; Paclitaxel; Peritoneal Neoplasms; Prognosis; Salvage Therapy; Stomach Neoplasms; Survival Rate; Tegafur | 2014 |
Progress in survival outcomes in patients with advanced ovarian cancer treated by neo-adjuvant platinum/taxane-based chemotherapy and late interval debulking surgery.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cystadenocarcinoma, Serous; Female; Follow-Up Studies; Gynecologic Surgical Procedures; Humans; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Prognosis; Prospective Studies; Retrospective Studies; Survival Rate | 2014 |
Level III axillary lymph nodes involvement in node positive breast cancer received neoadjuvant chemotherapy.
Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biopsy, Fine-Needle; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Retrospective Studies; Sentinel Lymph Node Biopsy; Survival Rate; Tumor Burden; Ultrasonography; Vinblastine; Vinorelbine; Young Adult | 2013 |
Residual esophageal cancer after neoadjuvant chemoradiotherapy frequently involves the mucosa and submucosa.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Biopsy; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Esophageal Neoplasms; Esophagectomy; Female; Humans; Lymphatic Metastasis; Male; Middle Aged; Mucous Membrane; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm, Residual; Paclitaxel; Treatment Outcome | 2013 |
Differences in RRM1 protein expression between diagnostic biopsies and resection specimens, and changes during carboplatin and paclitaxel treatment, in non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Carcinoma, Non-Small-Cell Lung; Female; Humans; Immunohistochemistry; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Ribonucleoside Diphosphate Reductase; Treatment Outcome; Tumor Suppressor Proteins | 2014 |
[Efficacy of postoperative simple chemotherapy and concurrent chemoradiotherapy in FIGO stage IB2-IIB cervical cancer].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Female; Follow-Up Studies; Humans; Hysterectomy; Ifosfamide; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Retrospective Studies; Survival Rate; Taxoids; Uterine Cervical Neoplasms | 2013 |
[Correlation between baseline plasma D-dimer levels and prognosis in patients with non-smal cell lung cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Disease-Free Survival; Female; Fibrin Fibrinogen Degradation Products; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Pneumonectomy; Proportional Hazards Models; Retrospective Studies; Survival Rate; Taxoids; Tumor Burden; Vascular Endothelial Growth Factor A | 2013 |
[A patient with thyroid cancer evaluated according to Response Evaluation Criteria in Solid Tumors during treatment for breast cancer recurrence in hepatic and cervical lymph nodes].
Topics: Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carcinoma; Carcinoma, Papillary; Diagnosis, Differential; Female; Humans; Liver Neoplasms; Lymphatic Metastasis; Neck; Paclitaxel; Recurrence; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2013 |
Comparison of efficacy and toxicity of first line chemotherapy with or without epirubicin for patients with advanced stage soft tissue sarcoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Deoxycytidine; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Ifosfamide; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Paclitaxel; Prognosis; Retrospective Studies; Sarcoma; Survival Rate; Young Adult | 2013 |
Evaluation of progression prior to surgery after neoadjuvant chemoradiotherapy with computed tomography in esophageal cancer patients.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Disease Progression; Esophageal Neoplasms; Esophagectomy; Female; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multidetector Computed Tomography; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Preoperative Care; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome | 2014 |
Translymphatic chemotherapy targeting sentinel lymph nodes using a novel phospholipid polymer-Paclitaxel conjugate.
Topics: Animals; Antineoplastic Agents, Phytogenic; Body Weight; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Inhibitory Concentration 50; Lymph Nodes; Lymphatic Metastasis; Male; Methacrylates; Neoplasms; Paclitaxel; Phosphorylcholine; Rats; Sentinel Lymph Node Biopsy | 2014 |
Prognostic Significance of Standardized Uptake Value of Lymph Nodes on Survival for Stage III Non-small Cell Lung Cancer Treated With Definitive Concurrent Chemoradiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Survival Rate | 2016 |
The relationships between the chemosensitivity of human gastric cancer to paclitaxel and the expressions of class III β-tubulin, MAPT, and survivin.
Topics: Adenosine Triphosphate; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Blotting, Western; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Inhibitor of Apoptosis Proteins; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Grading; Paclitaxel; Prognosis; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stomach Neoplasms; Survival Rate; Survivin; tau Proteins; Tubulin | 2014 |
Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2- breast cancer patients: results from the GEICAM 9906 trial.
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Multicenter Studies as Topic; Outcome Assessment, Health Care; Paclitaxel; Prospective Studies; Randomized Controlled Trials as Topic; Receptor, ErbB-2; Receptors, Estrogen; Reproducibility of Results; Retrospective Studies | 2014 |
Association of DNA base excision repair genes (OGG1, APE1 and XRCC1) polymorphisms with outcome to platinum-based chemotherapy in advanced nonsmall-cell lung cancer patients.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Case-Control Studies; Cisplatin; Deoxycytidine; DNA Glycosylases; DNA-(Apurinic or Apyrimidinic Site) Lyase; DNA-Binding Proteins; Docetaxel; Female; Follow-Up Studies; Gemcitabine; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Polymorphism, Single Nucleotide; Prognosis; Prospective Studies; Survival Rate; Taxoids; X-ray Repair Cross Complementing Protein 1 | 2014 |
[A case of complete response(CR)to S-1 and paclitaxel(PTX)combination therapy in a patient with unresectable gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Humans; Lymphatic Metastasis; Neoplasm Staging; Oxonic Acid; Paclitaxel; Remission Induction; Stomach Neoplasms; Tegafur | 2014 |
Down regulation of miR-143 is related with tumor size, lymph node metastasis and HPV16 infection in cervical squamous cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Chi-Square Distribution; China; DNA, Viral; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Genotype; Human papillomavirus 16; Human Papillomavirus DNA Tests; Humans; Lymphatic Metastasis; MicroRNAs; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Papillomavirus Infections; Real-Time Polymerase Chain Reaction; Treatment Outcome; Tumor Burden; Uterine Cervical Neoplasms | 2014 |
Higher predictive value of tumour and node [18F]-FDG PET metabolic volume and TLG in advanced lung cancer under chemotherapy.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome; Tumor Burden | 2014 |
[Treatment and prognosis of 117 patients with advanced urothelial carcinoma of the bladder].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma, Transitional Cell; Cisplatin; Cyclophosphamide; Deoxycytidine; Disease-Free Survival; Epirubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Leukopenia; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Retrospective Studies; Survival Rate; Thrombocytopenia; Urinary Bladder Neoplasms; Urothelium | 2014 |
[Value of postoperative radiochemotherapy for thoracic esophageal squamous cell carcinoma with lymph node metastasis].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Esophagitis; Female; Follow-Up Studies; Humans; Lymph Node Excision; Lymphatic Irradiation; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neutropenia; Paclitaxel; Particle Accelerators; Postoperative Period; Retrospective Studies; Survival Rate | 2014 |
Impact of surgical staging in stage I clear cell adenocarcinoma of the ovary.
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Diagnostic Techniques, Surgical; Female; Humans; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Retrospective Studies; Survival Analysis; Taxoids; Topotecan | 2014 |
[A case of locally advanced and metastatic breast cancer successfully treated with combination therapy of paclitaxel and bevacizumab].
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bone Neoplasms; Combined Modality Therapy; Female; Humans; Lymph Node Excision; Lymphatic Metastasis; Mastectomy; Middle Aged; Paclitaxel; Triple Negative Breast Neoplasms | 2014 |
Pregnancy complicated by a Krukenberg tumor with an undetermined origin and its management.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cesarean Section; Combined Modality Therapy; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Krukenberg Tumor; Lymphatic Metastasis; Male; Obstetric Labor, Premature; Ovarian Neoplasms; Ovariectomy; Paclitaxel; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Trimester, Third; Salpingectomy; Treatment Outcome | 2014 |
Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy.
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Endometrioid; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cystadenocarcinoma, Serous; Doxorubicin; Endometrial Neoplasms; Female; Follow-Up Studies; Humans; Ifosfamide; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Para-Aortic Bodies; Pelvic Neoplasms; Prognosis; Retrospective Studies; Survival Rate; Young Adult | 2015 |
Influence of serum VEGF levels on therapeutic outcome and diagnosis/prognostic value in patients with cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Grading; Neoplasm Staging; Paclitaxel; Prognosis; Uterine Cervical Neoplasms; Vascular Endothelial Growth Factor A; Young Adult | 2014 |
Positive expression of pro-opiomelanocortin (POMC) is a novel independent poor prognostic marker in surgically resected non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cadherins; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Pro-Opiomelanocortin; Prognosis; Vimentin; Vinblastine; Vinorelbine | 2015 |
Adjuvant carboplatin, paclitaxel, and vaginal cuff brachytherapy for stage III endometrial cancer: analysis of outcomes and patterns of recurrence based on pathologic characteristics.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Chemoradiotherapy, Adjuvant; Disease-Free Survival; Endometrial Neoplasms; Female; Humans; Hysterectomy; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Retrospective Studies; Survival Rate; Treatment Failure | 2015 |
[Dramatic response of penile cancer with inguinal lymph node metastases to neoadjuvant chemotherapy with paclitaxel, ifosfamide and cisplatin : a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Diagnostic Imaging; Humans; Ifosfamide; Inguinal Canal; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Penile Neoplasms; Treatment Outcome; Urogenital Surgical Procedures | 2015 |
Prolonged response to aflibercept in ovarian cancer relapse: a case report.
Topics: Aged; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Ascites; Carboplatin; Cystadenocarcinoma, Serous; Cytoreduction Surgical Procedures; Female; Humans; Lymphatic Metastasis; Molecular Targeted Therapy; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Signal Transduction; Vascular Endothelial Growth Factor A | 2015 |
[A complete response following treatment with Paclitaxel and bevacizumab for metastatic breast cancer].
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Female; Humans; Lymphatic Metastasis; Middle Aged; Paclitaxel; Remission Induction | 2014 |
Efficacy of dose dense doxorubicin and cyclophosphamide followed by paclitaxel versus conventional dose doxorubicin, cyclophosphamide followed by paclitaxel or docetaxel in patients with node-positive breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Paclitaxel; Prognosis; Retrospective Studies; Survival Rate; Taxoids | 2015 |
MTDH/AEG-1-based DNA vaccine suppresses metastasis and enhances chemosensitivity to paclitaxel in pelvic lymph node metastasis.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Drug Resistance, Neoplasm; Lymphatic Metastasis; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Paclitaxel; Pelvic Neoplasms; Prostatic Neoplasms; RNA-Binding Proteins; Survival Rate; Vaccines, DNA | 2015 |
AC1MMYR2 impairs high dose paclitaxel-induced tumor metastasis by targeting miR-21/CDK5 axis.
Topics: Animals; Breast Neoplasms; Carcinogenesis; Cell Movement; Cyclin-Dependent Kinase 5; Dose-Response Relationship, Drug; Drug Synergism; Epithelial-Mesenchymal Transition; Female; Humans; Lymphatic Metastasis; Mice; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; Molecular Targeted Therapy; Neoplasm Metastasis; Paclitaxel; Pyrimidines; Random Allocation; Xenograft Model Antitumor Assays | 2015 |
Long term HER2+ metastatic breast cancer survivors treated by trastuzumab: Results from the French cohort study LHORA.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease-Free Survival; Docetaxel; Female; Follow-Up Studies; France; Humans; Lymphatic Metastasis; Middle Aged; Paclitaxel; Prospective Studies; Receptor, ErbB-2; Retrospective Studies; Survivors; Taxoids; Trastuzumab | 2015 |
[Study of the relationship among expression of Survivin and MRP and the drug resistance in human nasopharyngeal carcinoma].
Topics: Antineoplastic Agents; Carcinoma; Cisplatin; Drug Resistance, Neoplasm; Fluorouracil; Humans; Immunohistochemistry; Inhibitor of Apoptosis Proteins; Lymphatic Metastasis; Multidrug Resistance-Associated Proteins; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Nasopharynx; Paclitaxel; Survivin; Vincristine | 2015 |
[Individualized therapy of synchronous ovarian and colon cancers with lymph].
Topics: Abdominal Pain; Adenocarcinoma; Adenocarcinoma, Papillary; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoembryonic Antigen; Colonic Neoplasms; Drug Administration Schedule; Female; Fever; Fluorouracil; Humans; Immunohistochemistry; Keratin-20; Keratin-7; Laparotomy; Leucovorin; Lymphatic Metastasis; Neoplasms, Multiple Primary; Organoplatinum Compounds; Ovarian Neoplasms; Paclitaxel; Precision Medicine; Treatment Outcome | 2015 |
Analysis on clinical characteristics and influencing factors of patients with locoregionally advanced nasopharyngeal carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Deoxycytidine; Disease-Free Survival; Dose Fractionation, Radiation; Female; Fluorouracil; Follow-Up Studies; Gemcitabine; Humans; Lymphatic Metastasis; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Proportional Hazards Models; Radiotherapy, Intensity-Modulated; Risk Factors | 2015 |
Neoadjuvant chemotherapy followed by large cone resection as fertility-sparing therapy in stage IB cervical cancer.
Topics: Abortion, Missed; Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cervix Uteri; Chemotherapy, Adjuvant; Cisplatin; Conization; Disease Progression; Female; Fertility Preservation; Follow-Up Studies; Humans; Ifosfamide; Lymph Node Excision; Lymphatic Metastasis; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Pelvis; Pregnancy; Pregnancy Rate; Premature Birth; Retrospective Studies; Treatment Outcome; Tumor Burden; Uterine Cervical Neoplasms | 2015 |
Effect of Hyperthermic Intraperitoneal Perfusion Chemotherapy in Combination with Intravenous Chemotherapy as Postoperative Adjuvant Therapy for Advanced Gastric Cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Female; Fluorouracil; Gastrectomy; Humans; Hyperthermia, Induced; Infusions, Intravenous; Infusions, Parenteral; Kaplan-Meier Estimate; Leucovorin; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Stomach Neoplasms; Time Factors; Treatment Outcome | 2014 |
A case of recurrent squamous cell carcinoma of the vulva successfully treated by combination therapy with cetuximab and paclitaxel.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Vulvar Neoplasms | 2016 |
Mutually exclusive mutations in NOTCH1 and PIK3CA associated with clinical prognosis and chemotherapy responses of esophageal squamous cell carcinoma in China.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers, Tumor; Blotting, Western; Carcinoma, Squamous Cell; Cell Proliferation; China; Cisplatin; Class I Phosphatidylinositol 3-Kinases; Esophageal Neoplasms; Female; Fluorouracil; Follow-Up Studies; Genomics; Humans; Immunoenzyme Techniques; Lymphatic Metastasis; Male; Middle Aged; Mutation; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Phosphatidylinositol 3-Kinases; Prognosis; Real-Time Polymerase Chain Reaction; Receptor, Notch1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Rate; Tumor Cells, Cultured | 2016 |
Sperm-associated antigen 9 overexpression correlates with poor prognosis and insensitive to Taxol treatment in breast cancer.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Breast Neoplasms; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Paclitaxel; Prognosis | 2016 |
Candidates for Intensive Local Treatment in cIIIA-N2 Non-Small Cell Lung Cancer: Deciphering the Heterogeneity.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Patient Selection; Radiotherapy Dosage; Vinblastine; Vinorelbine | 2016 |
A patient with gastric cancer with peritoneal carcinomatosis treated with intraperitoneal chemotherapy who survived more than 5 years receiving repeated laparoscopic examinations: a case report.
Topics: Antineoplastic Agents, Phytogenic; Asian People; Carcinoma; Drug Administration Schedule; Female; Gastrectomy; Humans; Injections, Intraperitoneal; Laparoscopy; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Paclitaxel; Peritoneal Neoplasms; Prognosis; Stomach Neoplasms; Treatment Outcome | 2016 |
[A Case of Lymph Node Metastases from Esophageal Cancer Successfully Treated with Weekly Paclitaxel Chemotherapy].
Topics: Antineoplastic Agents, Phytogenic; Esophageal Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Recurrence | 2015 |
GRIM-19 inhibition induced autophagy through activation of ERK and HIF-1α not STAT3 in Hela cells.
Topics: Adult; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Biomarkers, Tumor; Blotting, Western; Case-Control Studies; Cell Proliferation; Drug Resistance, Neoplasm; Female; Fluorescent Antibody Technique; Follow-Up Studies; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lymphatic Metastasis; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NADH, NADPH Oxidoreductases; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Prognosis; RNA, Small Interfering; STAT3 Transcription Factor; Survival Rate; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2016 |
Penile cancer metastasizing to the breast: a case report.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms, Male; Carcinoma, Squamous Cell; Deoxycytidine; Disease Progression; Fatal Outcome; Gemcitabine; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Penile Neoplasms | 2016 |
ERα propelled aberrant global DNA hypermethylation by activating the DNMT1 gene to enhance anticancer drug resistance in human breast cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Biomarkers, Tumor; Breast Neoplasms; Cell Proliferation; DNA (Cytosine-5-)-Methyltransferase 1; DNA Methylation; Drug Resistance, Neoplasm; Epigenomics; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Humans; Lymphatic Metastasis; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Paclitaxel; Prognosis; Promoter Regions, Genetic; Survival Rate; Tumor Cells, Cultured | 2016 |
MicroRNA-16 sensitizes breast cancer cells to paclitaxel through suppression of IKBKB expression.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cell Proliferation; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; I-kappa B Kinase; Lymphatic Metastasis; MicroRNAs; Middle Aged; Neoplasm Invasiveness; Paclitaxel; Prognosis; Survival Rate; Tumor Cells, Cultured | 2016 |
Potential of Baseline Computed Tomography to Predict Long-Term Survival of Patients With Locally Advanced Esophageal Cancer Treated With Preoperative Chemotherapy: A Retrospective Cohort Study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Esophageal Neoplasms; Esophagectomy; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Paclitaxel; Retrospective Studies; Survival Rate; Time Factors; Tomography, X-Ray Computed; Tumor Burden | 2016 |
Targeting the WEE1 kinase as a molecular targeted therapy for gastric cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Mice; Mice, Nude; Molecular Targeted Therapy; Neoplasm Invasiveness; Neoplasm Transplantation; Nuclear Proteins; Paclitaxel; Phenotype; Prognosis; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidines; Pyrimidinones; Stomach Neoplasms | 2016 |
The Prognosis and Risk Stratification Based on Pelvic Lymph Node Characteristics in Patients With Locally Advanced Cervical Squamous Cell Carcinoma Treated With Concurrent Chemoradiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Paclitaxel; Predictive Value of Tests; Prognosis; Retrospective Studies; Risk; Uterine Cervical Neoplasms | 2016 |
Dramatic Response to Carboplatin, Paclitaxel, and Radiation in a Patient With Malignant Myoepithelioma of the Breast.
Topics: Anorexia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Carboplatin; Dose Fractionation, Radiation; Fatigue; Female; Humans; Immunohistochemistry; Lymphatic Metastasis; Middle Aged; Myoepithelioma; Paclitaxel; Radiotherapy, Adjuvant; Rare Diseases; Tomography, X-Ray Computed; Treatment Outcome; Weight Loss | 2016 |
[Radiotherapy of cervix and endometrial carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma; Chemotherapy, Adjuvant; Combined Modality Therapy; Dose Fractionation, Radiation; Endometrial Neoplasms; Female; Humans; Hysterectomy; Lymphatic Irradiation; Lymphatic Metastasis; Organoplatinum Compounds; Organs at Risk; Paclitaxel; Radiation Injuries; Radiotherapy; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Adjuvant; Radiotherapy, Image-Guided; Uterine Cervical Neoplasms | 2016 |
Role of histological regression grade after two neoadjuvant approaches with or without radiotherapy in locally advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asthenia; Capecitabine; Chemoradiotherapy; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Gastrectomy; Gastrointestinal Diseases; Hematologic Diseases; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Retrospective Studies; Stomach Neoplasms; Taxoids; Treatment Outcome | 2016 |
A Nomogram for Predicting the Pathological Response of Axillary Lymph Node Metastasis in Breast Cancer Patients.
Topics: Adult; Axilla; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Female; Gene Expression; Humans; Ki-67 Antigen; Logistic Models; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Nomograms; Paclitaxel; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; ROC Curve; Sentinel Lymph Node Biopsy; Trastuzumab; Tumor Burden | 2016 |
A Case of Mixed Germ Cell Tumor in the Intramedullary Spinal-cord.
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Bleomycin; Chorionic Gonadotropin; Cisplatin; Deoxycytidine; Etoposide; Gemcitabine; Guillain-Barre Syndrome; Humans; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Paclitaxel; Paraplegia; Spinal Cord Neoplasms; Tomography, X-Ray Computed | 2016 |
Survival outcomes in patients with oropharyngeal cancer treated with carboplatin/paclitaxel and concurrent radiotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Retrospective Studies; Survival Rate; Treatment Outcome | 2016 |
[A Case of Axillary Nodal Metastasis of Adenocarcinoma of an Unknown Primary Site Effectively Treated with Anti-HER2plus AC plus Paclitaxel Therapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biopsy, Needle; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Neoadjuvant Therapy; Neoplasms, Unknown Primary; Paclitaxel; Trastuzumab | 2016 |
PET/CT with
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Carboplatin; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Trastuzumab; Young Adult | 2017 |
Analysis of Predictors of Resection and Survival in Locally Advanced Stage III Pancreatic Cancer: Does the Nature of Chemotherapy Regimen Influence Outcomes?
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Albumins; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Fluorouracil; Gemcitabine; Humans; Lymphatic Metastasis; Male; Mesenteric Artery, Superior; Middle Aged; Neoplasm Staging; Paclitaxel; Pancreas; Pancreatectomy; Pancreatic Neoplasms; Radiotherapy; Retrospective Studies; Survival Rate | 2017 |
Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Combinations; Female; Follow-Up Studies; Gastrectomy; Humans; Injections, Intraperitoneal; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Oxonic Acid; Paclitaxel; Peritoneal Lavage; Peritoneal Neoplasms; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Rate; Tegafur | 2017 |
[A Case of Axillary Arterial Bleeding after Axillary Metastatic Lymph Node Necrosis during Treatment with Paclitaxel and Bevacizumabfor Breast Cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Axilla; Bevacizumab; Breast Neoplasms; Carcinoma, Ductal, Breast; Fatal Outcome; Female; Hemorrhage; Humans; Lymph Nodes; Lymphatic Metastasis; Necrosis; Paclitaxel | 2016 |
Swallowing dysfunction is a common sequelae after chemoradiation for oropharynx carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Deglutition Disorders; Disease-Free Survival; Female; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Radiation Injuries; Radiotherapy; Radiotherapy Dosage; Retrospective Studies; Risk Factors | 2008 |
[Carboplatin and paclitaxel induction chemotherapy for patients with oropharynx carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate | 2008 |
Sentinel lymph node biopsy after neoadjuvant chemotherapy in a patient with operable breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Axilla; Biopsy, Needle; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Docetaxel; False Negative Reactions; Feasibility Studies; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Sentinel Lymph Node Biopsy; Taxoids | 2008 |
Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5-fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Deoxycytidine; Feasibility Studies; Female; Fluorouracil; Follow-Up Studies; Gemcitabine; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Maximum Tolerated Dose; Middle Aged; Nasopharyngeal Neoplasms; Paclitaxel; Prognosis; Quality of Life; Survival Rate | 2008 |
[Adjuvant epirubicin and cyclophosphamide followed by weekly paclitaxel for Japanese women with node-positive breast cancer: a multi-institutional feasibility study].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Epirubicin; Feasibility Studies; Female; Humans; Japan; Lymphatic Metastasis; Middle Aged; Paclitaxel; Time Factors | 2008 |
TP53 codon 72 polymorphism associated with prognosis in patients with advanced gastric cancer treated with paclitaxel and cisplatin.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Codon; Disease Progression; Female; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Polymorphism, Single Nucleotide; Prognosis; Stomach Neoplasms; Survival Rate; Time Factors; Treatment Outcome; Tumor Suppressor Protein p53 | 2009 |
A new neoadjuvant chemotherapy regimen for penile cancer with nodal metastases: a step forward.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Fluorouracil; Humans; Lymphatic Metastasis; Male; Paclitaxel; Penile Neoplasms | 2009 |
Examining expression of folate receptor in squamous cell carcinoma of the head and neck as a target for a novel nanotherapeutic drug.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Carrier Proteins; Female; Folate Receptors, GPI-Anchored; Folic Acid; Head and Neck Neoplasms; Humans; Immunohistochemistry; Lymphatic Metastasis; Male; Middle Aged; Nanomedicine; Nanotechnology; Paclitaxel; Receptors, Cell Surface; Young Adult | 2009 |
[Recurrence of skin and lymph nodes from asynchronous breast cancer successfully treated with paclitaxel and toremifene therapy--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Lymphatic Metastasis; Mastectomy, Radical; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Skin Neoplasms; Toremifene; Ultrasonography | 2008 |
Translymphatic chemotherapy by intrapleural placement of gelatin sponge containing biodegradable Paclitaxel colloids controls lymphatic metastasis in lung cancer.
Topics: Absorption; Animals; Antineoplastic Agents, Phytogenic; Colloids; Delayed-Action Preparations; Female; Gelatin Sponge, Absorbable; Humans; Lactic Acid; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Microspheres; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Xenograft Model Antitumor Assays | 2009 |
High-dose extended-field irradiation and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic lymph nodes.
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Humans; Iridium Radioisotopes; Lymphatic Metastasis; Middle Aged; Paclitaxel; Radiotherapy; Radiotherapy Dosage; Remission Induction; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms | 2009 |
[Clinicopathological evaluation of preoperative chemotherapy with doxorubicin plus cyclophosphamide followed by paclitaxel for locally advanced breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Paclitaxel; Receptor, ErbB-2; Receptors, Estrogen | 2009 |
Metronomic paclitaxel and thalidomide for rapidly metastatic primary vulvar malignant rhabdoid tumor.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Paclitaxel; Pleural Neoplasms; Rhabdoid Tumor; Thalidomide; Vulvar Neoplasms; Young Adult | 2009 |
Feasibility of AC/EC followed by weekly paclitaxel in node-positive breast cancer in Japan.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Epirubicin; Feasibility Studies; Female; Humans; Japan; Lymphatic Metastasis; Middle Aged; Paclitaxel | 2009 |
[Complete response obtained with first-line therapy as S-1, followed by second-line 5'-DFUR plus paclitaxel therapy in a patient with multiple liver and lymph node metastases from gastric cancer].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Drug Combinations; Floxuridine; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Oxonic Acid; Paclitaxel; Remission Induction; Stomach Neoplasms; Tegafur; Tomography, X-Ray Computed | 2009 |
[A case of multiple hepatic metastases of gastric cancer that showed complete regression by systemic chemotherapy using paclitaxel and UFT-E].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; CA-19-9 Antigen; Carcinoembryonic Antigen; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Stomach Neoplasms; Tegafur; Tomography, X-Ray Computed; Uracil | 2009 |
Supraclavicular lymph node metastases of unknown origin: HPV-typing identifies the primary tumour.
Topics: Antineoplastic Agents, Phytogenic; Biopsy; Carcinoma, Squamous Cell; DNA, Viral; Female; Human papillomavirus 16; Humans; Incidental Findings; Lymphatic Metastasis; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Positron-Emission Tomography; Uterine Cervical Neoplasms | 2009 |
Clinical significance of axillary microresiduals after neoadjuvant chemotherapy in breast cancer patients with cytologically proven metastases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Chemotherapy, Adjuvant; Clavicle; Cyclophosphamide; Doxorubicin; Female; Humans; Keratins; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Prognosis; Prospective Studies; Survival Rate; Treatment Outcome | 2009 |
[Retrospective study on regimens of capecitabine-based chemotherapy in the treatment for advanced gastric cancer].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Signet Ring Cell; Cisplatin; Deoxycytidine; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Humans; Leukopenia; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Remission Induction; Retrospective Studies; Stomach Neoplasms; Survival Rate; Taxoids; Vomiting; Young Adult | 2009 |
[Efficacy of neoadjuvant chemotherapy with FEC and TEC regimen on breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Remission Induction; Survival Rate | 2009 |
Node-positive adenocarcinoma of the endometrium: outcome and patterns of recurrence with and without external beam irradiation.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Endometrial Neoplasms; Female; Humans; Hysterectomy; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovariectomy; Paclitaxel; Radiotherapy, Adjuvant; Treatment Outcome | 2009 |
Chemotherapy followed by surgery in patients with carcinoma of the distal esophagus and celiac lymph node involvement.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Fine-Needle; Carboplatin; Carcinoma, Squamous Cell; Celiac Plexus; Cisplatin; Databases, Factual; Esophageal Neoplasms; Esophagectomy; Female; Humans; Kaplan-Meier Estimate; Laparoscopy; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Retrospective Studies | 2009 |
Aerosol delivery of liposomal formulated paclitaxel and vitamin E analog reduces murine mammary tumor burden and metastases.
Topics: Administration, Inhalation; Aerosols; Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Death; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Female; Immunohistochemistry; Liposomes; Lymph Nodes; Lymphatic Metastasis; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Neovascularization, Pathologic; Paclitaxel; Tumor Burden; Vitamin E | 2009 |
[A case of gastric cancer with posterior mediastinal lymph node metastasis responding to combination therapy of Paclitaxel and S-1].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Neoadjuvant Therapy; Oxonic Acid; Paclitaxel; Stomach Neoplasms; Tegafur | 2009 |
A multicenter retrospective analysis of survival outcome following postoperative chemoradiotherapy in non-small-cell lung cancer patients with N2 nodal disease.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Disease-Free Survival; Etoposide; Female; Gemcitabine; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multivariate Analysis; Paclitaxel; Postoperative Care; Radiotherapy Dosage; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Treatment Outcome | 2010 |
[A case of advanced gastric cancer that a medical therapy effect was provided grade 3 by a histopathological diagnosis after long-term chemotherapy].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Drug Combinations; Humans; Irinotecan; Lymphatic Metastasis; Male; Middle Aged; Oxonic Acid; Paclitaxel; Stomach Neoplasms; Tegafur | 2009 |
An exploratory study of sunitinib plus paclitaxel as first-line treatment for patients with advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Female; Humans; Indoles; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Maximum Tolerated Dose; Middle Aged; Paclitaxel; Pilot Projects; Pyrroles; Sunitinib; Survival Rate; Tissue Distribution; Treatment Outcome | 2010 |
[Advanced lung cancer with mediastinal lymph node metastasis and recurrence of brain metastasis completely responsive to combination chemotherapy and gamma knife radiosurgery--a case report].
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Mediastinum; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Radiosurgery | 2009 |
Breast cancer: complete response with the combination of sunitinib and trastuzumab in a patient with grade III ductal carcinoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Diarrhea; Female; Heart Function Tests; Humans; Hypothyroidism; Indoles; Lymphatic Metastasis; Middle Aged; Paclitaxel; Pyrroles; Remission Induction; Sunitinib; Trastuzumab | 2010 |
Complete response of anaplastic pancreatic carcinoma to paclitaxel treatment selected by chemosensitivity testing.
Topics: Adenosine Triphosphate; Biopsy, Needle; Carcinoma; Cell Survival; Drug Screening Assays, Antitumor; Endosonography; Female; Humans; Lymphatic Metastasis; Middle Aged; Paclitaxel; Pancreatic Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Tubulin Modulators | 2010 |
[Comparison of outcomes of Taxol + Cisplatin and Taxol + Nedaplatin chemotherapy regimens for advanced non-small cell lung cancer].
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Cisplatin; Humans; Leukopenia; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Paclitaxel; Remission Induction; Survival Rate; Taxoids; Young Adult | 2010 |
Metastatic apocrine carcinoma of the scalp: prolonged response to systemic chemotherapy.
Topics: Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carboplatin; Carcinoma; Carcinoma, Squamous Cell; Drug Administration Schedule; Fatal Outcome; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Paclitaxel; Scalp; Sweat Gland Neoplasms; Young Adult | 2010 |
A case of HER-2-positive advanced inflammatory breast cancer with invasive micropapillary component showing a clinically complete response to concurrent trastuzumab and paclitaxel treatment.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Papillary; Female; Humans; Inflammatory Breast Neoplasms; Lymphatic Metastasis; Paclitaxel; Receptor, ErbB-2; Trastuzumab; Treatment Outcome | 2010 |
GRP78 as potential predictor for breast cancer response to adjuvant taxane therapy.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Breast Neoplasms; Cyclophosphamide; Docetaxel; Doxorubicin; Endoplasmic Reticulum Chaperone BiP; Female; Heat-Shock Proteins; Humans; Lymphatic Metastasis; Menopause; Middle Aged; Multivariate Analysis; Neoplasm Staging; Paclitaxel; Predictive Value of Tests; Taxoids; Treatment Outcome | 2011 |
Sporotrichoid metastases to the skin from cutaneous squamous cell carcinoma in an immunocompetent patient.
Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Arm; Carcinoma, Squamous Cell; Cisplatin; Fatal Outcome; Fluorouracil; Hand; Humans; Immunohistochemistry; Lymphatic Metastasis; Male; Paclitaxel; Radiotherapy; Skin Neoplasms | 2010 |
[A case of gastric cancer with para-aortic lymph node metastasis successfully treated with S-1/paclitaxel/lentinan combination therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Biopsy; Combined Modality Therapy; Drug Combinations; Gastrectomy; Humans; Lentinan; Lymphatic Metastasis; Male; Oxonic Acid; Paclitaxel; Stomach Neoplasms; Tegafur; Tomography, X-Ray Computed | 2010 |
[A case of advanced gastric cancer responding to S-1/paclitaxel/lentinan as neoadjuvant chemoimmunotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Gastrectomy; Humans; Lentinan; Liver Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Neoadjuvant Therapy; Neoplasm Staging; Oxonic Acid; Paclitaxel; Stomach Neoplasms; Tegafur; Tomography, X-Ray Computed | 2010 |
HER2 and chromosome 17 effect on patient outcome in the N9831 adjuvant trastuzumab trial.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chromosomes, Human, Pair 17; Clinical Trials, Phase III as Topic; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Laboratories; Lymphatic Metastasis; Middle Aged; Paclitaxel; Pathology, Clinical; Proportional Hazards Models; Randomized Controlled Trials as Topic; Receptor, ErbB-2; Trastuzumab; Treatment Outcome | 2010 |
Failure rates and patterns of recurrence in patients with resected N1 non-small-cell lung cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Pneumonectomy; Proportional Hazards Models; Retrospective Studies; SEER Program; Treatment Failure; Vinblastine; Vinorelbine | 2011 |
[Digital necrosis related to gemcitabine].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Deoxycytidine; Fingers; Gemcitabine; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Necrosis; Paclitaxel; Palliative Care | 2010 |
Treatment of stage IB2, IIA bulky cervical cancer: a single-institution experience of neoadjuvant chemotherapy followed by radical hysterectomy and primary radical hysterectomy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Dose Fractionation, Radiation; Female; Fluorouracil; Humans; Hysterectomy; Kaplan-Meier Estimate; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Paclitaxel; Radiotherapy, Adjuvant; Retrospective Studies; Treatment Outcome; Tumor Burden; Uterine Cervical Neoplasms | 2011 |
Multidrug resistance gene (MDR-1) and risk of brain metastasis in epithelial ovarian, fallopian tube, and peritoneal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biomarkers, Tumor; Brachytherapy; Brain Neoplasms; Carboplatin; Carcinoma, Ovarian Epithelial; Cisplatin; Cohort Studies; Combined Modality Therapy; Docetaxel; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fallopian Tube Neoplasms; Female; Follow-Up Studies; Humans; Immunoenzyme Techniques; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Retrospective Studies; Risk Factors; Survival Rate; Taxoids; Treatment Outcome | 2011 |
[A case of a patient with a triple negative breast cancer and complete response of lung, mediastinal and skeletal metastases after treatment with paclitaxel and bevacizumab].
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Phytogenic; Bevacizumab; Bone Neoplasms; Breast Neoplasms; Carcinoma, Lobular; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Mediastinum; Paclitaxel; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Remission Induction | 2010 |
Genetic polymorphisms in the endothelial nitric oxide synthase gene correlate with overall survival in advanced non-small-cell lung cancer patients treated with platinum-based doublet chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Humans; Introns; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Minisatellite Repeats; Neoplasm Staging; Nitric Oxide Synthase Type III; Paclitaxel; Polymorphism, Single Nucleotide; Survival Rate; Treatment Outcome | 2010 |
[Clinicopathologic study on 61 cases of uterine papillary serous carcinoma with or without adjuvant therapy].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Papillary; Chemotherapy, Adjuvant; Cisplatin; Cystadenocarcinoma, Serous; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Menopause; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Radiotherapy, Adjuvant; Survival Rate; Uterine Neoplasms | 2010 |
[Clinical characteristics and prognosis of large cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Pneumonectomy; Proportional Hazards Models; Retrospective Studies; Survival Rate; Taxoids; Tumor Burden; Young Adult | 2010 |
Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradio-therapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue. Early r
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease Progression; Docetaxel; Feasibility Studies; Female; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Kaplan-Meier Estimate; Laryngeal Neoplasms; Leukopenia; Lymphatic Metastasis; Male; Neoadjuvant Therapy; Neoplasm Staging; Opportunistic Infections; Paclitaxel; Positron-Emission Tomography; Radiodermatitis; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Salvage Therapy; Taxoids; Thrombocytopenia; Tomography, X-Ray Computed; Tongue Neoplasms; Treatment Outcome | 2011 |
Polymorphism in epidermal growth factor receptor intron 1 predicts prognosis of patients with esophageal cancer after chemoradiation and surgery.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; DNA, Neoplasm; ErbB Receptors; Esophageal Neoplasms; Esophagectomy; Female; Fluorouracil; Follow-Up Studies; Humans; Introns; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Polymerase Chain Reaction; Polymorphism, Genetic; Prognosis; Survival Rate | 2011 |
The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Female; Humans; Hysterectomy; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Proportional Hazards Models; Radiotherapy, Adjuvant; Retrospective Studies; Survival Analysis; Time Factors; Uterine Cervical Neoplasms; Vinblastine; Young Adult | 2011 |
Regression of paclitaxel-induced maculopathy with oral acetazolamide.
Topics: Acetazolamide; Administration, Oral; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carbonic Anhydrase Inhibitors; Female; Humans; Lymphatic Metastasis; Macular Edema; Melanoma; Middle Aged; Paclitaxel; Skin Neoplasms; Tomography, Optical Coherence; Vision Disorders; Visual Acuity | 2012 |
Bevacizumab in the treatment of metastatic breast cancer: three case reports.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bone Neoplasms; Breast Neoplasms; Capecitabine; Carcinoma in Situ; Carcinoma, Ductal; Combined Modality Therapy; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Humans; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Paclitaxel; Survival Analysis; Taxoids; Treatment Outcome; Vascular Endothelial Growth Factor A | 2011 |
[A case of gastric cancer with lung, Virchow and para-aortic lymph node metastases treated successfully using PTX/5'-DFUR].
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Combined Modality Therapy; Fatal Outcome; Floxuridine; Gastrectomy; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Stomach Neoplasms; Tomography, X-Ray Computed | 2011 |
Type II radical hysterectomy and adjuvant therapy for pelvic lymph node metastasis with stage IB-IIB cervical carcinoma: a retrospective study of 288 patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brachytherapy; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Cohort Studies; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Humans; Hysterectomy; Ifosfamide; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Pelvic Neoplasms; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms; Young Adult | 2011 |
Selective organ preservation in operable locally advanced head and neck squamous cell carcinomas guided by primary site restaging biopsy: long-term results of two sequential brown university oncology group chemoradiotherapy studies.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Follow-Up Studies; Gamma Rays; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoplasm Recurrence, Local; Neoplasm Staging; Organ Preservation; Paclitaxel; Remission Induction; Survival Rate; Treatment Outcome | 2011 |
Second-line chemotherapy in patients with primary unknown cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma; Carcinoma, Squamous Cell; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Irinotecan; Kaplan-Meier Estimate; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Predictive Value of Tests; Retrospective Studies; Risk Factors; Taxoids; Time Factors; Treatment Failure; Treatment Outcome | 2011 |
[Histological evaluation of cervical carcinomas in FIGO stage Ib2/IIa after neoadjuvant chemotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Female; Humans; Hysterectomy; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Preoperative Period; Prognosis; Retrospective Studies; Uterine Cervical Neoplasms; Vincristine; Young Adult | 2011 |
A case of chemotherapy-responsive paraneoplastic rubral tremor.
Topics: Adenocarcinoma, Clear Cell; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Ataxia; Autoantibodies; Brain Stem Neoplasms; Breast Neoplasms; Carboplatin; Electromyography; Enzyme-Linked Immunosorbent Assay; Female; Glasgow Coma Scale; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Nerve Tissue Proteins; Ovarian Neoplasms; Paclitaxel; Paraneoplastic Syndromes, Nervous System; Tomography, X-Ray Computed | 2011 |
Early gastric cancer combined with multiple metachronous osteosclerotic bone and bone marrow metastases that responded to chemoradiotherapy.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Bone Neoplasms; Camptothecin; Chemoradiotherapy; Drug Combinations; Female; Humans; Lymphatic Metastasis; Oxonic Acid; Paclitaxel; Stomach Neoplasms; Tegafur; Treatment Outcome | 2011 |
Association between c-myc amplification and pathological complete response to neoadjuvant chemotherapy in breast cancer.
Topics: Adult; Aged; Analysis of Variance; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; DNA Topoisomerases, Type II; DNA-Binding Proteins; Epirubicin; Female; Fluorouracil; Gene Amplification; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Ki-67 Antigen; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Odds Ratio; Oligonucleotide Array Sequence Analysis; Paclitaxel; Poly-ADP-Ribose Binding Proteins; Predictive Value of Tests; Proto-Oncogene Proteins c-myc; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Treatment Outcome; Ultrasonography, Mammary | 2011 |
Safety of intraperitoneal administration of paclitaxel after gastrectomy with en-bloc D2 lymph node dissection.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Female; Follow-Up Studies; Gastrectomy; Humans; Injections, Intraperitoneal; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Peritoneal Neoplasms; Postoperative Complications; Prospective Studies; Safety; Stomach Neoplasms; Survival Rate; Treatment Outcome | 2012 |
Multimodal treatment for multistation mediastinal lymph node adenocarcinoma: a case report.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Chemotherapy, Adjuvant; Cisplatin; Humans; Immunohistochemistry; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Multimodal Imaging; Neoplasms, Unknown Primary; Paclitaxel; Positron-Emission Tomography; Recurrence; Reoperation; Thoracoscopy; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) following carboplatin-paclitaxel administration in a patient with lung cancer.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lung; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Paclitaxel; Vasopressins | 2011 |
[A case of pagetoid carcinoma of the breast in nearly complete response by primary systemic therapy].
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Paclitaxel; Paget's Disease, Mammary; Trastuzumab | 2011 |
Concurrent chemoradiotherapy for locoregionally advanced salivary gland malignancies.
Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Carcinoma; Chemoradiotherapy; Cisplatin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Radiotherapy Dosage; Retrospective Studies; Salivary Gland Neoplasms | 2012 |
Durable complete response induced by paclitaxel-nimotuzumab-methotrexate chemotherapy in a patient with metastatic head and neck squamous cell carcinoma.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Multimodal Imaging; Paclitaxel; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
The role of chemoradiotherapy in patients with unresectable T4 breast tumors.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemoradiotherapy; Deoxycytidine; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Prognosis; Remission Induction; Survival Rate; Taxoids | 2013 |
[Invasive ductal carcinoma and chronic lymphocytic leukemia: a unique case of collision tumor in breast].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclophosphamide; Epirubicin; Female; Follow-Up Studies; Humans; Immunohistochemistry; Leukemia, Lymphocytic, Chronic, B-Cell; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Neoplasms, Multiple Primary; Paclitaxel | 2011 |
[Neoadjuvant chemotherapy with paclitaxel and cisplantin or carboplatin for patients with locally advanced uterine cervical cancer].
Topics: Adenocarcinoma; Adult; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Female; Follow-Up Studies; Humans; Hysterectomy; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Remission Induction; Serpins; Uterine Cervical Neoplasms | 2011 |
Prediction of response and prognosis by a score including only pretherapeutic parameters in 410 neoadjuvant treated gastric cancer patients.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Female; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Prognosis; Retrospective Studies; Risk Factors; Stomach Neoplasms; Survival Rate; Young Adult | 2012 |
Response of metastatic renal medullary carcinoma to carboplatinum and Paclitaxel chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carboplatin; Carcinoma, Medullary; Fatal Outcome; Humans; Kidney Neoplasms; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Randomized Controlled Trials as Topic; Sickle Cell Trait; Treatment Outcome | 2012 |
A population-based study on the patterns of use of different chemotherapy regimens in Swiss patients with early breast cancer.
Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bridged-Ring Compounds; Capecitabine; Carboplatin; Confidence Intervals; Cyclophosphamide; Deoxycytidine; Doxorubicin; Epirubicin; Female; Fluorouracil; Gemcitabine; Health Services Accessibility; Humans; Logistic Models; Lymphatic Metastasis; Medication Adherence; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Staging; Odds Ratio; Paclitaxel; Receptors, Estrogen; Switzerland; Taxoids; Vinblastine; Vinorelbine | 2012 |
The role of surgery in patients with advanced gynaecological cancers participating in phase I clinical trials.
Topics: Adenocarcinoma, Papillary; Adult; Afatinib; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoma, Squamous Cell; Clinical Trials, Phase I as Topic; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Ovarian Neoplasms; Paclitaxel; Pelvic Neoplasms; Phthalazines; Piperazines; Quinazolines; Uterine Cervical Neoplasms | 2012 |
Laparoscopic lymph node dissection should be performed before fertility preserving treatment of patients with cervical cancer.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Squamous Cell; Cervix Uteri; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Female; Fertility Preservation; Follow-Up Studies; Humans; Ifosfamide; Laparoscopy; Lymph Node Excision; Lymphatic Metastasis; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Pelvis; Prospective Studies; Uterine Cervical Neoplasms | 2012 |
[Clinical analysis of the current treatment status of gastric cancer in 636 patients].
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Chemotherapy, Adjuvant; China; Cisplatin; Disease-Free Survival; Female; Gastrectomy; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Retrospective Studies; Salvage Therapy; Stomach Neoplasms; Survival Rate; Trastuzumab; Young Adult | 2012 |
Curative chemoradiotherapy in patients with stage IVB cervical cancer presenting with paraortic and left supraclavicular lymph node metastases.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Feasibility Studies; Female; Fluorouracil; Humans; Lymphatic Irradiation; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Paclitaxel; Retrospective Studies; Survival Rate; Uterine Cervical Neoplasms | 2012 |
Carboplatin plus paclitaxel in the successful treatment of advanced inflammatory myofibroblastic tumor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Neoplasm Staging; Neoplasms, Muscle Tissue; Paclitaxel; Positron-Emission Tomography; Radiography; Thoracic Vertebrae; Treatment Outcome | 2012 |
Metastatic human papillomavirus-positive nasopharyngeal carcinoma with an unusual pattern of aggressive hematogenous spread.
Topics: Alphapapillomavirus; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biomarkers, Tumor; Carboplatin; Carcinoma; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Diagnosis, Differential; Drug Administration Schedule; Fatal Outcome; Fluorodeoxyglucose F18; Fluorouracil; Heart Failure; Humans; Hypertension, Pulmonary; Hypoxia; Immunohistochemistry; Laryngoscopy; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Neoplasm Staging; Paclitaxel; Papillomavirus Infections; Positron-Emission Tomography; Pulmonary Artery; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Randomized Controlled Trials as Topic; Thrombophilia; Tomography, X-Ray Computed; Vascular Neoplasms | 2012 |
Novel model for basaloid triple-negative breast cancer: behavior in vivo and response to therapy.
Topics: Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biomarkers, Tumor; Blotting, Western; Breast Neoplasms; Cell Movement; Disease Models, Animal; Female; Humans; Immunoenzyme Techniques; Lung Neoplasms; Lymphatic Metastasis; Mice; Mice, Nude; Neovascularization, Pathologic; Paclitaxel; Real-Time Polymerase Chain Reaction; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2012 |
The 2002 AJCC TNM classification is a better predictor of primary small cell esophageal carcinoma outcome than the VALSG staging system.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Esophagectomy; Etoposide; Female; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Radiotherapy, High-Energy; Retrospective Studies; Societies, Medical; Survival Rate; United States | 2013 |
Diagnostic validity of CT gastrography versus gastroscopy for primary lesions in gastric cancer: evaluating the response to chemotherapy, a retrospective analysis.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Female; Follow-Up Studies; Gastroscopy; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Oxonic Acid; Paclitaxel; Prognosis; Retrospective Studies; Stomach Neoplasms; Taxoids; Tegafur; Tomography, X-Ray Computed; Validation Studies as Topic | 2013 |
[Complete response of advanced breast cancer with lymph node metastases to nab-paclitaxel therapy-report of a case].
Topics: Albumins; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Paclitaxel | 2012 |
Targeting Chk2 improves gastric cancer chemotherapy by impairing DNA damage repair.
Topics: Amino Acid Chloromethyl Ketones; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Checkpoint Kinase 2; Cisplatin; Cyclin B; DNA Repair; Humans; Lymphatic Metastasis; Mitosis; Paclitaxel; Protein Serine-Threonine Kinases; Stomach Neoplasms; Taxoids | 2013 |
Epidermal growth factor receptor mutation status and adjuvant chemotherapy in resected advanced non-small-cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; DNA, Neoplasm; ErbB Receptors; Female; Follow-Up Studies; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mutation; Neoplasm Staging; Paclitaxel; Polymerase Chain Reaction; Prognosis; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate; Vinblastine; Vinorelbine | 2013 |
Docetaxel improves survival and reduces risk of relapse in node-positive early-stage breast cancer.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Clinical Trials, Phase III as Topic; Docetaxel; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Paclitaxel; Postoperative Care; Secondary Prevention; Survival Rate; Taxoids | 2002 |
[Ureteroplasty using the appendix: apropos of a case].
Topics: Antineoplastic Combined Chemotherapy Protocols; Appendix; Carcinoma, Transitional Cell; Combined Modality Therapy; Cystectomy; Deoxycytidine; Gemcitabine; Humans; Laparotomy; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Nephrostomy, Percutaneous; Paclitaxel; Prostatectomy; Retroperitoneal Space; Transplantation, Autologous; Transplantation, Heterotopic; Ureter; Ureteral Neoplasms; Urinary Bladder Neoplasms | 2002 |
[A case of advanced gastric cancer with invasion of pancreas effectively treated by combined chemotherapy of TS-1 and paclitaxel (TXL)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Administration Schedule; Drug Combinations; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Oxonic Acid; Paclitaxel; Pancreatic Neoplasms; Pyridines; Quality of Life; Stomach Neoplasms; Tegafur | 2002 |
[A case of recurrent gastric cancer that responded dramatically to docetaxel and 5'-DFUR combination chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Administration Schedule; Floxuridine; Fluorouracil; Gastrectomy; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Paclitaxel; Pancreatic Neoplasms; Stomach Neoplasms; Taxoids; Treatment Outcome | 2002 |
Decreased axillary lymph node retrieval in patients after neoadjuvant chemotherapy.
Topics: Antibiotics, Antineoplastic; Axilla; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Mastectomy, Modified Radical; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Retrospective Studies | 2002 |
[Induction chemoradiotherapy in small adenocarcinoma of the lung with bulky mediatinal lymph node metastasis].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Drug Administration Schedule; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Paclitaxel; Preoperative Care | 2002 |
The effect of platinum-based combination chemotherapy on the lymph nodes in advanced-stage epithelial ovarian cancer: does it decrease the incidence of lymph node involvement?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Female; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Ovarian Neoplasms; Paclitaxel | 2002 |
[Two cases of effective weekly paclitaxel administration and concurrent radiation for metastatic breast cancer].
Topics: Adult; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Radiation-Sensitizing Agents | 2003 |
[A case of advanced gastric cancer treated with paclitaxel and TS-1].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combinations; Gastrectomy; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Oxonic Acid; Paclitaxel; Pyridines; Remission Induction; Stomach Neoplasms; Tegafur | 2003 |
[Treatment outcomes with paclitaxel for advanced gastric cancer patients previously treated with TS-1].
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Drug Administration Schedule; Drug Combinations; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Oxonic Acid; Paclitaxel; Pyridines; Remission Induction; Stomach Neoplasms; Tegafur; Treatment Outcome | 2003 |
[Histoculture drug response assay (HDRA) guided induction concurrent chemoradiotherapy for mediastinal node-positive non-small cell lung cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Docetaxel; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Pneumonectomy; Taxoids; Tumor Cells, Cultured | 2003 |
[A case of advanced recurrent breast cancer responding to treatment with weekly docetaxel combined with doxorubicin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Docetaxel; Doxorubicin; Drug Administration Schedule; Female; Floxuridine; Humans; Lung Neoplasms; Lymphatic Metastasis; Mastectomy, Modified Radical; Medroxyprogesterone Acetate; Middle Aged; Paclitaxel; Skin Neoplasms; Taxoids | 2003 |
Adjuvant chemotherapy for node-positive breast cancer patients: which is the reference today?
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; France; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Paclitaxel; Prospective Studies; Randomized Controlled Trials as Topic; Survival Analysis; Taxoids; Treatment Outcome | 2003 |
Metastatic cutaneous squamous cell carcinoma arising from a previous area of chronic hypertrophic lichen planus.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Chronic Disease; Cisplatin; Groin; Humans; Leg; Lichen Planus; Lymphatic Metastasis; Male; Paclitaxel; Skin Neoplasms | 2003 |
[Clinical efficacy analysis of chemotherapy to lymph node metastasis in epithelial ovarian cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Retrospective Studies; Taxoids | 2003 |
[Weekly paclitaxel administration in the adjuvant therapy of primary breast cancer].
Topics: Adult; Aged; Alopecia; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Drug Administration Schedule; Feasibility Studies; Female; Humans; Lymphatic Metastasis; Mastectomy, Segmental; Middle Aged; Paclitaxel | 2003 |
[Evaluation of weekly paclitaxel and doxifluridine (5'-DFUR) combination therapy in patients with advanced or recurrent breast cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Feasibility Studies; Female; Floxuridine; Humans; Leukopenia; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Pilot Projects | 2003 |
Neovascular targeting therapy: paclitaxel encapsulated in cationic liposomes improves antitumoral efficacy.
Topics: Animals; Cricetinae; Liposomes; Lymphatic Metastasis; Male; Mesocricetus; Microscopy, Fluorescence; Neoplasms, Experimental; Paclitaxel | 2003 |
[Clinical study of weekly administration of paclitaxel for advanced and metastatic gastric cancer].
Topics: Aged; Alopecia; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leukopenia; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Stomach Neoplasms | 2003 |
Induction chemotherapy with paclitaxel and cisplatin and CT-based 3D radiotherapy in patients with advanced laryngeal and hypopharyngeal carcinomas--a possibility for organ preservation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Combined Modality Therapy; Female; Humans; Hypopharyngeal Neoplasms; Imaging, Three-Dimensional; Laryngeal Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Paclitaxel; Prospective Studies; Radiation Injuries; Tomography, X-Ray Computed | 2003 |
[Lung adenocarcinoma with multiple pulmonary metastases completely responsive to combination chemotherapy with carboplatin and weekly paclitaxel--a case report].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Remission Induction | 2003 |
[Two cases of recurrent breast cancer successfully treated with paclitaxel weekly therapy].
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Paclitaxel; Taxoids | 2003 |
[Examination of therapy using trastuzumab in patients with metastatic breast carcinoma].
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Female; Humans; Infusions, Intravenous; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Paclitaxel; Remission Induction; Trastuzumab | 2003 |
Development of an orthotopic model to study the biology and therapy of primary human lung cancer in nude mice.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cell Line, Tumor; Fibroblast Growth Factor 2; Humans; Interleukin-8; Lung Neoplasms; Lymphatic Metastasis; Mice; Mice, Nude; Models, Biological; Neoplasm Metastasis; Neovascularization, Pathologic; Paclitaxel; Vascular Endothelial Growth Factor A | 2003 |
Activity of first-line epirubicin and paclitaxel in metastatic breast cancer is independent of type of adjuvant therapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase II as Topic; Disease-Free Survival; Epirubicin; Female; Humans; Lymphatic Metastasis; Middle Aged; Paclitaxel; Randomized Controlled Trials as Topic; Receptors, Estrogen; Survival Rate; Treatment Outcome | 2004 |
Weekly one-hour paclitaxel as first-line chemotherapy for metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Biopsy, Needle; Breast Neoplasms; Chemotherapy, Adjuvant; Dexamethasone; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Norway; Paclitaxel; Premedication; Prognosis; Prospective Studies; Risk Assessment; Sampling Studies; Survival Analysis; Treatment Outcome | 2004 |
Major tumor regression after paclitaxel and carboplatin polychemotherapy in a patient with advanced penile cancer.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Penile Neoplasms; Penis; Remission Induction; Survival Analysis; Tomography, Emission-Computed | 2004 |
Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter?
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Docetaxel; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Life Tables; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Paclitaxel; Prednisone; Prognosis; Receptors, Progesterone; Risk; Survival Analysis; Tamoxifen; Taxoids; Transcription Factors; Vincristine | 2004 |
[A case of advanced gastric cancer effectively treated by combined chemotherapy of paclitaxel (TXL) and CDDP].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Gastrectomy; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Paclitaxel; Stomach Neoplasms | 2004 |
[A case of advanced gastric cancer successfully treated with neoadjuvant chemotherapy of combined weekly paclitaxel and doxifluridine (5'-DFUR)].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Administration Schedule; Floxuridine; Gastrectomy; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Paclitaxel; Stomach Neoplasms | 2004 |
[Complete response of gastric cancer with interaorticocaval lymph node recurrence to weekly administration of paclitaxel--a case report].
Topics: Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Gastrectomy; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Remission Induction; Stomach Neoplasms | 2004 |
[Weekly paclitaxel therapy for locoregional lymph node recurrence of estrogen-receptor-negative breast cancer].
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Receptors, Estrogen | 2004 |
Case 3: infiltrating ductal breast carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphatic Metastasis; Mastectomy, Modified Radical; Middle Aged; Paclitaxel; Radiotherapy, Adjuvant; Sentinel Lymph Node Biopsy | 2004 |
Antitumour activity of paclitaxel and interferon-alpha in a case of metastatic eccrine porocarcinoma.
Topics: Acrospiroma; Aged; Antineoplastic Combined Chemotherapy Protocols; Humans; Interferon alpha-2; Interferon-alpha; Lymphatic Metastasis; Male; Paclitaxel; Recombinant Proteins; Sweat Gland Neoplasms | 2004 |
[Metastatic breast cancer treated with trastuzumab and paclitaxel--a case report with clinically complete response].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Receptor, ErbB-2; Remission Induction; Trastuzumab | 2004 |
[Efficacy of combined paclitaxel and oxaliplatin therapy in patients with pretreated advanced non-small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Treatment Outcome | 2004 |
[Weekly administration of paclitaxel might be beneficial against TS-1-resistant recurrent gastric cancer--a case report].
Topics: Adenocarcinoma; Adrenal Gland Neoplasms; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Administration Schedule; Drug Resistance, Neoplasm; Gastrectomy; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Paclitaxel; Remission Induction; Stomach Neoplasms; Tomography, X-Ray Computed | 2004 |
[A case of recurrent stomach cancer treated with 5-fluorouracil responding to weekly paclitaxel therapy].
Topics: Aged; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Drug Resistance, Neoplasm; Fluorouracil; Gastrectomy; Humans; Lymphatic Metastasis; Male; Neoadjuvant Therapy; Paclitaxel; Quality of Life; Stomach Neoplasms | 2004 |
Pseudoneoplastic proliferation of histiocytes with paclitaxel-induced ultrastructural changes in a mastectomy specimen.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Proliferation; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Histiocytes; Humans; Intermediate Filaments; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Mastectomy, Modified Radical; Middle Aged; Paclitaxel; Sentinel Lymph Node Biopsy; Tubulin | 2004 |
[Taxol based chemotherapy in the treatment of advanced gastric cancer].
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Quality of Life; Remission Induction; Stomach Neoplasms | 2004 |
[Weekly paclitaxel therapy is useful for gastric carcinoma as second-line chemotherapy].
Topics: Adenocarcinoma, Scirrhous; Alopecia; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Duodenal Neoplasms; Humans; Jaundice, Obstructive; Leukopenia; Lymph Nodes; Lymphangitis; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Paclitaxel; Stomach Neoplasms | 2004 |
Efficacy of weekly paclitaxel in patients with docetaxel-resistant metastatic breast cancer.
Topics: Antineoplastic Agents, Phytogenic; Bone Neoplasms; Breast Neoplasms; Disease Progression; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Paclitaxel; Retrospective Studies; Salvage Therapy; Taxoids; Treatment Outcome | 2005 |
Lymph node spread in stage III or IV primary peritoneal serous papillary carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Carcinoma, Papillary; Combined Modality Therapy; Cystadenocarcinoma, Serous; Female; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Paclitaxel; Peritoneal Neoplasms; Retrospective Studies | 2005 |
[A case of non-curatively resected scirrhous gastric cancer successfully treated over 2 years with weekly administration of paclitaxel].
Topics: Adenocarcinoma, Scirrhous; Aged; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Drug Administration Schedule; Female; Gastrectomy; Humans; Lymph Nodes; Lymphatic Metastasis; Paclitaxel; Peritoneal Neoplasms; Quality of Life; Splenectomy; Stomach Neoplasms; Survivors | 2005 |
Patupilone (epothilone B, EPO906) inhibits growth and metastasis of experimental prostate tumors in vivo.
Topics: Animals; Antineoplastic Agents; Body Weight; Cell Line, Tumor; Epothilones; Humans; Lymphatic Metastasis; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Paclitaxel; Prostatic Neoplasms; Xenograft Model Antitumor Assays | 2005 |
Survival impact of planned restaging and early surgical salvage following definitive chemoradiation for locally advanced squamous cell carcinomas of the oropharynx and hypopharynx.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Carcinoma, Squamous Cell; Female; Fluorouracil; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Laryngoscopy; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Palliative Care; Radiation Dosage; Radiation Injuries; Remission Induction; Retrospective Studies; Salvage Therapy; Tomography, X-Ray Computed; Treatment Outcome | 2005 |
Intensity-modulated radiation therapy in head and neck cancers: dosimetric advantages and update of clinical results.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Oropharyngeal Neoplasms; Osteoradionecrosis; Paclitaxel; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Retrospective Studies; Salvage Therapy; Treatment Outcome | 2005 |
[An unresectable advanced gastric cancer with Virchow's metastasis, carcinomatous ascites and rectal stenosis, effectively managed with combined chemotherapy of biweekly paclitaxel and TS-1].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Ascites; Carcinoma, Signet Ring Cell; Constriction, Pathologic; Drug Administration Schedule; Drug Combinations; Female; Humans; Lymphatic Metastasis; Oxonic Acid; Paclitaxel; Peritonitis; Pyridines; Rectal Diseases; Stomach Neoplasms; Tegafur | 2005 |
[Experience of weekly paclitaxel combined with orally administered doxifluridine therapy for advanced and recurrent gastric cancer-preliminary study].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Feasibility Studies; Female; Floxuridine; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Stomach Neoplasms | 2005 |
[Prediction and treatment of peritoneal dissemination in gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combinations; Female; Floxuridine; Humans; Ileus; Lymphatic Metastasis; Male; Middle Aged; Oxonic Acid; Paclitaxel; Peritoneal Cavity; Peritoneal Lavage; Peritoneal Neoplasms; Predictive Value of Tests; Prognosis; Pyridines; Stomach Neoplasms; Survival Rate; Tegafur | 2005 |
Role of gross tumor volume on outcome and of dose parameters on toxicity of patients undergoing chemoradiotherapy for locally advanced non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Deoxycytidine; Dose-Response Relationship, Drug; Female; Gemcitabine; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Prognosis; Radiotherapy Dosage; Radiotherapy, Conformal; Retrospective Studies; Survival Analysis; Survival Rate | 2005 |
[A case of stage IV gastric cancer previously treated with TS-1 completely responding to second-line chemotherapy with weekly paclitaxel therapy].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Chemotherapy, Adjuvant; Drug Administration Schedule; Drug Combinations; Female; Gastrectomy; Humans; Kidney Neoplasms; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Oxonic Acid; Paclitaxel; Pyridines; Remission Induction; Stomach Neoplasms; Tegafur | 2005 |
[A paclitaxel-resistant case of recurrent breast cancer responded to combination therapy of capecitabine and trastuzumab].
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Breast Neoplasms; Capecitabine; Carcinoma, Ductal, Breast; Deoxycytidine; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Lung; Lymphatic Metastasis; Lymphatic System; Neoplasm Recurrence, Local; Paclitaxel; Trastuzumab | 2005 |
Dose-dense adjuvant chemotherapy for node-positive breast cancer in women 60 years and older: feasibility and tolerability in a subset of patients in a randomized trial.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Epirubicin; Feasibility Studies; Female; Filgrastim; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Paclitaxel; Randomized Controlled Trials as Topic; Recombinant Proteins; Retrospective Studies | 2006 |
Prospective multicenter study of combined treatment with chemotherapy and radiotherapy in breast cancer women with the rare clinical scenario of ipsilateral supraclavicular node recurrence without distant metastases.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clavicle; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Prospective Studies; Radiotherapy Dosage; Survival Analysis | 2006 |
Papuloerythematous rash due to intralymphatic cutaneous metastasis of cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Carcinoma; Head and Neck Neoplasms; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Lymphatic Metastasis; Lymphedema; Male; Middle Aged; Paclitaxel; Prednisolone; Respiratory Insufficiency; Skin; Skin Neoplasms; Thyroid Neoplasms | 2006 |
[Two cases of stage IV breast cancer with severe hypercalcemia].
Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Drug Administration Schedule; Female; Goserelin; Humans; Hypercalcemia; Imidazoles; Leuprolide; Lymph Nodes; Lymphatic Metastasis; Paclitaxel; Quality of Life; Tamoxifen; Zoledronic Acid | 2006 |
[A long-term survivor with stage IV gastric cancer due to postoperative weekly paclitaxel and 5'-DFUR combination therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Combined Modality Therapy; Drug Administration Schedule; Female; Floxuridine; Gastrectomy; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Paclitaxel; Quality of Life; Salvage Therapy; Stomach Neoplasms; Survivors | 2006 |
Metastatic myoepithelial carcinoma of the vulva treated with carboplatin and paclitaxel.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Female; Humans; Lymphatic Metastasis; Myoepithelioma; Paclitaxel; Treatment Outcome; Vulvar Neoplasms | 2006 |
[Combined chemotherapy with weekly Paclitaxel and doxifluridine for advanced and recurrent gastric cancers].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Floxuridine; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Retrospective Studies; Stomach Neoplasms; Survival Analysis | 2006 |
Impact of a scientific presentation on community treatment patterns for primary breast cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Chemotherapy, Adjuvant; Congresses as Topic; Drug Approval; Drug Prescriptions; Evidence-Based Medicine; Female; Humans; Logistic Models; Lymphatic Metastasis; Multicenter Studies as Topic; Multivariate Analysis; Neoplasm Staging; Paclitaxel; Practice Patterns, Physicians'; Randomized Controlled Trials as Topic; SEER Program; Taxoids; Time Factors; United States; United States Food and Drug Administration | 2006 |
Scientific meetings might affect prescribing.
Topics: Aged; Breast Neoplasms; Congresses as Topic; Delivery of Health Care; Drug Prescriptions; Education, Medical, Continuing; Female; Humans; Lymphatic Metastasis; Paclitaxel; Practice Patterns, Physicians' | 2006 |
Targeting platelet-derived growth factor receptor on endothelial cells of multidrug-resistant prostate cancer.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Blotting, Western; Bone Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Endothelial Cells; Fluorescent Antibody Technique; Humans; Imatinib Mesylate; Immunohistochemistry; In Situ Nick-End Labeling; Lymphatic Metastasis; Male; Mice; Mice, Nude; Microcirculation; Neoplasm Transplantation; Neovascularization, Pathologic; Paclitaxel; Phosphorylation; Piperazines; Prostatic Neoplasms; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Random Allocation; Receptors, Platelet-Derived Growth Factor; Reverse Transcriptase Polymerase Chain Reaction; Tibia; Tumor Cells, Cultured | 2006 |
A feasibility study of sequential paclitaxel and S-1 (PTX/S-1) chemotherapy as postoperative adjuvant chemotherapy for advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Combinations; Feasibility Studies; Female; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Oxonic Acid; Paclitaxel; Prognosis; Stomach Neoplasms; Survival Rate; Tegafur | 2006 |
[A case of non-curatively resected gastric cancer successfully treated over 3 years with biweekly paclitaxel therapy].
Topics: Aged; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Gastrectomy; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Neutropenia; Paclitaxel; Stomach Neoplasms; Survivors | 2006 |
Preoperative clinical, mammographic and sonographic assessment of neoadjuvant chemotherapy response in breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Epirubicin; Female; Humans; Lymphatic Metastasis; Mammography; Middle Aged; Neoplasm Staging; Paclitaxel; Physical Examination; Retrospective Studies | 2006 |
[A case of malignant melanoma from the esophagus responding to weekly paclitaxel therapy].
Topics: Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administration Schedule; Esophageal Neoplasms; Humans; Kidney Neoplasms; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Paclitaxel; Quality of Life | 2006 |
[A case of inoperable gastric small cell carcinoma effectively treated by chemotherapy and radiotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Drug Administration Schedule; Drug Combinations; Etoposide; Humans; Irinotecan; Lymph Nodes; Lymphatic Metastasis; Male; Oxonic Acid; Paclitaxel; Stomach Neoplasms; Tegafur | 2006 |
[A case of advanced gastric cancer responding remarkably to paclitaxel + low-dose FP therapy in a neoadjuvant setting].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluorouracil; Humans; Laparoscopy; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Neoadjuvant Therapy; Paclitaxel; Stomach Neoplasms | 2006 |
[A case of recurrent gastric cancer effectively treated by combined chemotherapy of weekly paclitaxel (PTX) and CDDP].
Topics: Antineoplastic Combined Chemotherapy Protocols; CA-19-9 Antigen; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Gastrectomy; Humans; Liver Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Peritoneal Neoplasms; Quality of Life; Stomach Neoplasms | 2006 |
Pharmacokinetics of paclitaxel in a hemodialysis patient with advanced gastric cancer: A case report.
Topics: Antineoplastic Agents, Phytogenic; Area Under Curve; Fatal Outcome; Humans; Kidney Failure, Chronic; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Renal Dialysis; Stomach Neoplasms | 2006 |
[Two cases of recurrent breast cancer with regional lymph node metastases showing a complete response to trastuzumab and paclitaxel treatment].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Receptor, ErbB-2; Remission Induction; Trastuzumab | 2006 |
Therapy of multidrug resistant human prostate tumors in the prostate of nude mice by simultaneous targeting of the epidermal growth factor receptor and vascular endothelial growth factor receptor on tumor-associated endothelial cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Endothelial Cells; ErbB Receptors; Humans; In Situ Nick-End Labeling; Lymphatic Metastasis; Male; Mice; Mice, Nude; Paclitaxel; Phosphorylation; Prostatic Neoplasms; Purines; Receptors, Vascular Endothelial Growth Factor; Xenograft Model Antitumor Assays | 2006 |
[A case of advanced gastric cancer--efficacy of combination therapy of doxifluridine and weekly paclitaxel].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Combined Modality Therapy; Drug Administration Schedule; Floxuridine; Gastrectomy; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Paclitaxel; Remission Induction; Stomach Neoplasms | 2006 |
[A case of squamous cell carcinoma of unknown primary site with involvement of cervico-mediastinal lymph nodes successfully treated by chemoradiotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Administration Routes; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Mediastinum; Neck; Neoplasms, Unknown Primary; Paclitaxel | 2006 |
Multiple cutaneous metastases from male breast carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Combined Modality Therapy; Cyclophosphamide; Disease Progression; Doxorubicin; Epirubicin; Fatal Outcome; Fluorouracil; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Mastectomy, Radical; Megestrol Acetate; Middle Aged; Paclitaxel; Palliative Care; Skin Neoplasms | 2006 |
Cerebral and parotid metachronous metastases from an ovarian carcinoma.
Topics: Adenocarcinoma, Mucinous; Anticonvulsants; Carboplatin; Chemotherapy, Adjuvant; Combined Modality Therapy; Cranial Irradiation; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Palliative Care; Parotid Neoplasms; Supratentorial Neoplasms; Topotecan | 2006 |
[Two cases of radiofrequency ablation (RFA) therapy for control of liver metastases from breast cancer].
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Catheter Ablation; Docetaxel; Fatal Outcome; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Lymphatic Metastasis; Mastectomy; Middle Aged; Paclitaxel; Taxoids; Trastuzumab | 2006 |
[Pulmonary pleomorphic carcinoma with rapid and peculiar metastases; report of a case].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Large Cell; Cisplatin; Combined Modality Therapy; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Muscle Neoplasms; Paclitaxel; Pancreatic Neoplasms; Pneumonectomy; Skin Neoplasms | 2007 |
[A successful case of lower gingival cancer with pulmonary metastases by adjuvant chemotherapy including paclitaxel, cisplatin and 5-fluorouracil following a surgical procedure].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Female; Fluorouracil; Gingival Neoplasms; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Paclitaxel; Pneumonectomy; Remission Induction; Thoracic Surgery, Video-Assisted | 2007 |
Doxifluridine combined with weekly paclitaxel for second-line treatment in patients with gastric cancer resistant to TS-1.
Topics: Abdominal Neoplasms; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Floxuridine; Humans; Japan; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Pilot Projects; Silicates; Stomach Neoplasms; Survival Analysis; Time Factors; Titanium; Treatment Outcome; Tumor Burden | 2007 |
Salivary duct carcinoma: a clinical and histologic review with implications for trastuzumab therapy.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Ductal; Carcinoma, Intraductal, Noninfiltrating; Chemotherapy, Adjuvant; Facial Paralysis; Female; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Radiotherapy, Adjuvant; Receptor, ErbB-2; Retrospective Studies; Salivary Gland Neoplasms; Trastuzumab | 2007 |
[Medical treatment for stage III non-small-cell lung cancer (NSCLC)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Gefitinib; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Mitomycin; Neoplasm Staging; Paclitaxel; Pneumonectomy; Quinazolines; Radiotherapy Dosage; Radiotherapy, Adjuvant; Survival Rate | 2007 |
[A case of S-1-resistant recurrent gastric cancer successfully treated with weekly administration of paclitaxel].
Topics: Antineoplastic Agents, Phytogenic; Chemotherapy, Adjuvant; Drug Administration Schedule; Drug Combinations; Drug Resistance, Neoplasm; Gastrectomy; Humans; Leukopenia; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Oxonic Acid; Paclitaxel; Peripheral Nervous System Diseases; Stomach Neoplasms; Tegafur | 2007 |
[A case of breast metastasis of gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Signet Ring Cell; Cisplatin; Drug Combinations; Female; Gastrectomy; Humans; Lymphatic Metastasis; Middle Aged; Neoplastic Cells, Circulating; Oxonic Acid; Paclitaxel; Stomach Neoplasms; Tegafur; Uracil | 2007 |
[A case of severe hand-foot syndrome caused by capecitabine].
Topics: Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Deoxycytidine; Drug Administration Schedule; Female; Fluorouracil; Foot Dermatoses; Hand Dermatoses; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Mastectomy; Middle Aged; Paclitaxel; Paresthesia; Postoperative Period; Syndrome | 2007 |
[Clinical characteristics of cancer of unknown primary (CUP)--a summary of 22 cases].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Unknown Primary; Paclitaxel; Prognosis; Survival Rate | 2007 |
[Dose dense chemotherapy in the postoperative adjuvant treatment for breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Drug; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Liver Neoplasms; Lymphatic Metastasis; Mastectomy; Middle Aged; Nausea; Neutropenia; Paclitaxel; Postoperative Period; Retrospective Studies; Taxoids | 2007 |
Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Carboplatin; Contrast Media; Cyclophosphamide; Doxorubicin; Female; Gadolinium DTPA; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Mastectomy; Mastectomy, Segmental; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Predictive Value of Tests; Receptor, ErbB-2; Retrospective Studies; Sensitivity and Specificity; Trastuzumab; Treatment Outcome | 2007 |
Progression of disease despite good endoscopic local control of upper tract urothelial carcinoma.
Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Papillary; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Deoxycytidine; Disease Progression; Docetaxel; Electrocoagulation; Gemcitabine; Humans; Kidney Neoplasms; Kidney Pelvis; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Nephrectomy; Paclitaxel; Taxoids; Ureteroscopy | 2007 |
Patterns of care study of breast-conserving therapy in Japan: comparison of the treatment process between 1995 1997 and 1999 2001 surveys.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Humans; Japan; Lymphatic Metastasis; Mastectomy, Segmental; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Neoplasm Staging; Paclitaxel; Population Surveillance; Practice Patterns, Physicians'; Radiotherapy, Adjuvant; Tamoxifen; Vinblastine; Vincristine | 2007 |
Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation?
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Frozen Sections; Humans; Ifosfamide; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Paclitaxel; Preoperative Care; Reproducibility of Results; Uterine Cervical Neoplasms | 2008 |
Management of advanced nodal disease following chemoradiation for head and neck squamous cell carcinoma: role of magnetic resonance imaging.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neck Dissection; Neoplasm Recurrence, Local; Neoplasm, Residual; Paclitaxel; Retrospective Studies; Sensitivity and Specificity; Survival Rate; Treatment Outcome | 2007 |
The number of residual metastatic lymph nodes following neoadjuvant chemotherapy predicts survival in patients with stage III NSCLC.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neutropenia; Paclitaxel; Predictive Value of Tests; Prognosis; Retrospective Studies; Survival Analysis; Taxoids; Vinblastine; Vinorelbine | 2008 |
The successfully curative treatment of advanced gastric adenocarcinoma with multiple liver metastases and paraaortic lymph node metastases by salvage operation following the biweekly paclitaxel and S-1 combination chemotherapy: a case report.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Drug Combinations; Endoscopy, Gastrointestinal; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Oxonic Acid; Paclitaxel; Remission Induction; Salvage Therapy; Stomach Neoplasms; Tegafur; Tomography, X-Ray Computed | 2007 |
Comparison among different classification systems regarding the pathological response of preoperative chemotherapy in relation to the long-term outcome.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Docetaxel; Doxorubicin; Drug Monitoring; Estrogens; Female; Fluorouracil; Follow-Up Studies; Humans; Japan; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Paclitaxel; Progesterone; Prognosis; Retrospective Studies; Taxoids; Trastuzumab; Treatment Outcome | 2009 |
Utility of positron emission tomography compared with mediastinoscopy for delineating involved lymph nodes in stage III lung cancer: insights for radiotherapy planning from a surgical cohort.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Humans; Lung Neoplasms; Lymphatic Metastasis; Mediastinoscopy; Neoplasm Staging; Paclitaxel; Positron-Emission Tomography; Radiography; Sensitivity and Specificity | 2008 |
[Concurrent chemoradiation with paclitaxel and platinum for locally advanced esophageal cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Esophageal Neoplasms; Esophagitis; Female; Follow-Up Studies; Humans; Leukopenia; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Particle Accelerators; Radiotherapy Dosage; Radiotherapy, High-Energy; Remission Induction; Survival Rate; Thrombocytopenia | 2007 |
[Analysis of therapeutic result and prognostic factor in primary fallopian tube carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Cystadenocarcinoma, Papillary; Fallopian Tube Neoplasms; Female; Follow-Up Studies; Humans; Hysterectomy; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Ovariectomy; Paclitaxel; Survival Rate; Taxoids | 2007 |
Evaluation of biological pathways involved in chemotherapy response in breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Drug Resistance, Neoplasm; E2F3 Transcription Factor; Female; Fluorouracil; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, p53; Humans; Ki-67 Antigen; Lymphatic Metastasis; Middle Aged; Mutation; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Receptors, Estrogen; Signal Transduction; Treatment Outcome | 2008 |
[A case of occult breast cancer successfully treated by capecitabine in combination with weekly paclitaxel followed by FEC (75)].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Cyclophosphamide; Deoxycytidine; Epirubicin; Female; Fluorouracil; Humans; Lymphatic Metastasis; Paclitaxel; Positron-Emission Tomography; Treatment Outcome | 2008 |
Extra-pelvic metastasis of endometrioid carcinoma; resistance to chemo-radiation therapy--response to paclitaxel treatment. Case report.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoplasms, Multiple Primary; Ovarian Neoplasms; Paclitaxel | 1995 |
Typhlitis resulting from treatment with taxol and doxorubicin in patients with metastatic breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Carcinoma, Intraductal, Noninfiltrating; Cecal Diseases; Doxorubicin; Female; Humans; Inflammation; Lymphatic Metastasis; Middle Aged; Paclitaxel | 1993 |
Paclitaxel-induced cardiotoxicity. An ultrastructural study.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carcinoma, Ductal, Breast; Cardiomyopathies; Chemotherapy, Adjuvant; Female; Heart; Humans; Lymphatic Metastasis; Middle Aged; Myocardium; Paclitaxel | 1996 |
Sequential adjuvant therapy with doxorubicin/paclitaxel/cyclophosphamide for resectable breast cancer involving four or more axillary nodes.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Injections, Intravenous; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Patient Admission; Pilot Projects; Radiotherapy, Adjuvant | 1995 |
The Harry W. Fischer Lecture Session. Contrast Media: a meandering look.
Topics: Adenocarcinoma; Animals; Awards and Prizes; Contrast Media; Diagnostic Imaging; Dose-Response Relationship, Drug; Female; Humans; Lymphatic Metastasis; Male; Paclitaxel; Prostatic Neoplasms; Research; Structure-Activity Relationship | 1996 |
Differential effect of taxol in rat primary and metastatic prostate tumors: site-dependent pharmacodynamics.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Division; DNA, Neoplasm; Drug Resistance; Immunohistochemistry; Inguinal Canal; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Paclitaxel; Pancreatic Neoplasms; Rats; Thymidine; Tumor Cells, Cultured | 1996 |
CA 125: a misleading tumor marker?
Topics: Antineoplastic Agents, Phytogenic; CA-125 Antigen; Cystadenocarcinoma, Mucinous; Docetaxel; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Taxoids | 1996 |
[Docetaxel in lymphangiosis carcinomatosa].
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Paclitaxel; Taxoids; Tomography, X-Ray Computed | 1997 |
[Breast cancer with liver metastasis responsive to docetaxel: case report].
Topics: Alopecia; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Drug Administration Schedule; Female; Humans; Leukopenia; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Taxoids | 1998 |
FDA advisors recommend approval of taxol for node-positive breast cancer.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Drug Approval; Female; Humans; Lymphatic Metastasis; Paclitaxel; United States; United States Food and Drug Administration | 1999 |
Clinical presentation of stage IIIA (N2) non-small cell lung cancer: role of multimodality therapy.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Pneumonectomy; Radiotherapy, Adjuvant; Time Factors | 1999 |
Histology and sensitivity to anticancer drugs of two human non-small cell lung carcinomas implanted in the pleural cavity of nude mice.
Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Doxorubicin; Ellipticines; Etoposide; Female; Gemcitabine; Humans; Lung Neoplasms; Lymphatic Metastasis; Mice; Mice, Nude; Neoplasm Metastasis; Paclitaxel; Pleural Neoplasms; Topotecan; Transplantation, Heterologous; Tumor Cells, Cultured; Vinblastine; Vinorelbine | 2000 |
Nail alterations secondary to pactitaxel [corrected] therapy.
Topics: Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Lymphatic Metastasis; Middle Aged; Nail Diseases; Neoplasm Recurrence, Local; Paclitaxel; Pigmentation Disorders | 2000 |
Complete regression of choroidal metastases from breast cancer after docetaxel-based systemic chemotherapy.
Topics: Adjuvants, Immunologic; Adult; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Choroid Neoplasms; Docetaxel; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; Humans; Lenograstim; Lung Neoplasms; Lymphatic Metastasis; Magnetic Resonance Imaging; Paclitaxel; Recombinant Proteins; Skin Neoplasms; Taxoids; Treatment Outcome | 2000 |
The feasibility of minimally invasive surgery for stage IIA, IIB, and IIIA breast carcinoma patients after tumor downstaging with induction chemotherapy.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Chi-Square Distribution; Cyclophosphamide; Doxorubicin; Feasibility Studies; Female; Fluorouracil; Humans; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Minimally Invasive Surgical Procedures; Neoadjuvant Therapy; Neoplasm Staging; Neoplasm, Residual; Paclitaxel; Prospective Studies; Radiotherapy, Adjuvant; Remission Induction | 2000 |
Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biopsy; Breast Neoplasms; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Paclitaxel; Prednisolone; Radiopharmaceuticals; Sensitivity and Specificity; Taxoids; Tomography, Emission-Computed; Vincristine | 2000 |
Fibroblast growth factors: an epigenetic mechanism of broad spectrum resistance to anticancer drugs.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Division; Culture Media, Conditioned; Doxorubicin; Drug Resistance, Neoplasm; Fibroblast Growth Factor 1; Fibroblast Growth Factor 2; Fluorouracil; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Paclitaxel; Prostatic Neoplasms; Rats; Suramin; Tumor Cells, Cultured | 2000 |
[A case of advanced breast cancer associated with humoral hypercalcemia that responded to medroxyprogesterone acetate and docetaxel].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Docetaxel; Drug Administration Schedule; Female; Humans; Hypercalcemia; Lymph Nodes; Lymphatic Metastasis; Medroxyprogesterone Acetate; Neoplasm Invasiveness; Paclitaxel; Taxoids | 2000 |
[A case of effective chemotherapy using CAF followed by docetaxel for advanced breast cancer].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Fluorouracil; Humans; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Taxoids | 2000 |
Paclitaxel-induced remission in docetaxel-refractory anthracycline-pretreated metastatic breast cancer.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carcinoma, Ductal, Breast; Docetaxel; Drug Resistance, Neoplasm; Drug Therapy, Combination; Female; Humans; Lymphatic Metastasis; Paclitaxel; Remission Induction; Salvage Therapy; Taxoids | 2000 |
Chemotherapy-induced noncardiogenic pulmonary edema related to gemcitabine plus docetaxel combination with granulocyte colony-stimulating factor support.
Topics: Adrenal Cortex Hormones; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Deoxycytidine; Docetaxel; Drug Therapy, Combination; Female; Gemcitabine; Granulocyte Colony-Stimulating Factor; Humans; Liver Neoplasms; Lymphatic Metastasis; Paclitaxel; Pulmonary Edema; Radiography; Taxoids | 2000 |
Paclitaxel enhances the effects of the anti-epidermal growth factor receptor monoclonal antibody ImClone C225 in mice with metastatic human bladder transitional cell carcinoma.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Transitional Cell; Cell Division; Cetuximab; Combined Modality Therapy; Dose-Response Relationship, Drug; Dose-Response Relationship, Immunologic; Down-Regulation; Endothelial Growth Factors; Endothelium; ErbB Receptors; Fibroblast Growth Factor 2; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Inhibitory Concentration 50; Interleukin-8; Lymphatic Metastasis; Lymphokines; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Fluorescence; Neoplasm Transplantation; Neovascularization, Pathologic; Organ Size; Paclitaxel; RNA, Messenger; Time Factors; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |
Taxane evidence inconclusive in adjuvant setting.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Chemotherapy, Adjuvant; Consensus Development Conferences, NIH as Topic; Disease-Free Survival; Europe; Evidence-Based Medicine; Female; Humans; Lymphatic Metastasis; Multicenter Studies as Topic; Paclitaxel; Survival Analysis; United States | 2001 |
[Recurrent breast cancer successfully treated with a weekly dose of paclitaxel--a case report].
Topics: Antineoplastic Agents, Phytogenic; Axilla; Breast Neoplasms; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Hydrothorax; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Paclitaxel; Pleural Effusion, Malignant | 2001 |
[A case of recurrent breast cancer successfully treated with docetaxel].
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Paclitaxel; Taxoids; Treatment Outcome | 2001 |
Two special types of breast cancer presenting as progressive disease after neoadjuvant chemotherapy with docetaxel plus doxorubicin.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Squamous Cell; Disease Progression; Docetaxel; Doxorubicin; Female; Humans; Lymphatic Metastasis; Mammography; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Sternum; Taxoids | 2001 |
[Local therapy for stage IV advanced breast cancer with brain metastasis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Docetaxel; Female; Humans; Lymphatic Metastasis; Middle Aged; Paclitaxel; Quality of Life; Radiosurgery; Tamoxifen; Taxoids | 2001 |
[Two cases of effective weekly paclitaxel administration for metastatic breast cancer].
Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel | 2001 |
Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cohort Studies; Cyclophosphamide; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Doxorubicin; Female; Humans; Inflammation; Lung; Lymphatic Metastasis; Middle Aged; Paclitaxel; Pneumonia; Radiation-Sensitizing Agents; Retrospective Studies; Time Factors; Treatment Outcome | 2001 |
[Combination of taxotere and doxorubicin in chemotherapy of disseminated breast cancer].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Doxorubicin; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Paclitaxel; Taxoids; Time Factors | 2001 |
Docetaxel induced durable response in advanced extramammary Paget's disease: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Administration Schedule; Epirubicin; Fluorouracil; Humans; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Paclitaxel; Paget Disease, Extramammary; Radiography; Scrotum; Skin Neoplasms; Taxoids; Vincristine | 2002 |
[A case of effective paclitaxel therapy for adriamycin resistant metastatic breast cancer with brain metastases].
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Breast Neoplasms; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Paclitaxel; Radiation-Sensitizing Agents | 2002 |